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Abstract 
 
Orientia tsutsugamushi is an obligate intracellular bacterium which causes the neglected human 
disease scrub typhus. The cell biology of Orientia is relatively poorly studied compared to other 
human pathogens of equivalent severity and prevalence. Due to the lack of tools for genetic 
manipulation, this project initially focused on developing a toolkit of probes for labelling bacteria 
for fluorescence microscopy. By successfully labelling Orientia with antibodies, dyes and chemical 
probes, key biological questions can be investigated.  
 
One of these key questions is whether Orientia synthesises peptidoglycan. Bacterial cell walls 
typically contain a thick polymer structure of sugars cross-linked by amino acid bridges called 
peptidoglycan, which is the main determinant of cell shape and which is essential in protecting 
bacteria from osmotic stress. The fact that it is both essential and unique to bacteria means that 
eukaryotic cells have evolved to recognize it as a highly immunostimulatory PAMP, and it is also 
an important target for antibiotic therapy. Obligate intracellular bacteria have evolved to replicate 
exclusively inside host cells, and the resulting proximity to peptidoglycan receptors such as 
NOD1/NOD2 may cause selective pressure to reduce the amount of immunostimulatory 
peptidoglycan in their cell wall.  
 
Of the two major groups of obligate intracellular bacteria, the Chlamydiales and Rickettsiales, the 
peptidoglycan structure in the Chlamydiales has been more extensively studied. It was previously 
reported that Orientia does not contain a peptidoglycan structure in its cell wall, even though it 
encodes most of the genes required for production. The research described in this thesis 
demonstrates that Orientia does possess a peptidoglycan-like structure in its cell wall. Orientia 
also has an outer membrane comprising of a network of disulphide crosslinked proteins, and this 
works together with the peptidoglycan-like structure to confer structural rigidity and osmotic 
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protection. The minimal peptidoglycan-like structure of Orientia presents striking similarities with 
that of the unrelated Chlamydiales group, suggesting convergent evolution to selective pressures 
of the obligate intracellular lifestyle.    
 
Based on the similarities between Orientia and Chlamydia, a bioinformatics analysis of the 
peptidoglycan biosynthesis pathway was performed on all major obligate intracellular bacteria, 
including several Rickettsiales species. This led to the prediction that some – but not all – 
Rickettsiales would possess minimal peptidoglycan-like structures with similarities to those seen 
in Orientia and Chlamydia. This motivated the third part of this thesis, in which peptidoglycan was 
studied in five diverse species from the order Rickettsiales (Rickettsia canadensis, Wolbachia, 
Anaplasma marginale, Anaplasma phagocytophilum, Ehrlichia chaffeensis). This comparative 
study revealed differences in peptidoglycan-like structures in these organisms that were 
supported by bioinformatic predictions, leading to hypotheses about how differences in their life 
cycles and cell tropism led to various selective pressures on their cell wall composition.  
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Objectives 
 
1.  To develop tools to label Orientia for fixed and live imaging 
 To (commercially) generate and test antibodies specific for membrane proteins of 
Orientia 
 To develop a toolkit of commercially available chemical probes that could be used to 
label genetically intractable obligate intracellular bacteria for fluorescence microscopy 
imaging 
 
2. To test whether Orientia possesses peptidoglycan in its cell wall 
 To investigate if Orientia is sensitive to peptidoglycan targeting drugs 
 To use D-alanine based peptidoglycan-specific chemical probes to determine the 
presence or absence of a peptidoglycan structure in O. tsutsugamushi 
 To measure the sensitivity of O. tsutsugamushi to osmotic stress  
 
3. To identify peptidoglycan in Rickettsiales species and classify species in specific groups 
 To develop protocols for growing multiple Rickettsiales species in different cell lines 
(Rickettsia canadensis, Anaplasma marginale, Anaplasma phagocytophilum, Ehrlichia 
chaffeensis, Wolbachia) 
 To investigate if Rickettsiales species are sensitive to peptidoglycan targeting drugs 
 To use D-alanine based peptidoglycan-specific chemical probes to determine the 
presence or absence of a peptidoglycan structure in Rickettsiales species 
 To measure the sensitivity of the Rickettsiales species to osmotic stress 
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Chapter 1 
Literature review: Introduction to Orientia and other Rickettsiales species 
 
1.1 Introduction 
 
Rickettsiales are an order of alphaproteobacteria which comprise of a group of obligate 
intracellular bacteria and these commonly infect eukaryotes (Figure 1) [2]. There are three known 
families: Anaplasmataceae, Holosporaceae, and Rickettsiaceae [1]. Many species in these 
families cause well known zoonotic diseases and extensive agricultural damage. With better 
diagnostics and surveillance mechanisms, the incidence of disease is now easier to record and 
recent data shows that these bacteria are becoming a public health threat [3].  
This thesis will focus on (i) developing tools for labelling and (ii) studying peptidoglycan in the cell 
wall of two main families: Anaplasmataceae and Rickettsiaceae, and especially the rickettsial 
bacterium Orientia tsutsugamushi (Figure 2). The presence and structure of peptidoglycan is well 
researched in free living bacteria. However, for obligate intracellular bacteria such as the 
Rickettsiales order this is not the case [1]. These obligate intracellular bacterial species are 
difficult to work with, as host cell culture is necessary. Also, some species such as Orientia 
tsutsugamushi and most Rickettsia species require biosafety containment laboratories which are 
expensive and difficult to maintain [4].   
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Figure 1. Phylogenetic tree of bacterial species [1] 
Highligted genus of Rickettsia. In this area of the tree, the Rickettsiales order is found. 
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1.2 Orientia tsutsugamushi 
 
1.2.a Scrub typhus 
Scrub typhus is a mite-borne zoonotic disease. The word typhus originates from the Greek word 
‘hazy’ which relates to the patients’ state of mind once infected by Orientia tsutsugamushi. A 
Rickettsial Gram negative obligate intracellular coccobacillus bacterium, it is transmitted to 
humans and small mammals from the bite of arthropod trombiculid larval mites of the genus 
Leptotrombidium, also known as chiggers [5]. Scrub refers to the type of environment the disease 
was classically acquired. After hatching and in order to develop further the larval chiggers need 
to feed on a mammalian host, and in the process, they transfer bacteria from their salivary glands 
to the host antigen presenting cells (APCs). Orientia is able to infect a wide variety of cells in the 
mammalian host including professional phagocytic cells such as epithelial ,macrophage, 
dendritic, polymorphonuclear APC and lymphocyte cells as well as non-professional phagocytic 
cells such as epithelial, endothelial and fibroblast cells [6].  
After an incubation period of 6-21 days, various clinical manifestations may arise such as rash, 
eschar and fever as well as organ failure once the infection progresses. The eschar is the classic 
sign of the disease; this occurs where the chigger has bitten the skin and here the bacteria level 
will be very high, causing a high immune response and leaving the skin red and swollen [7]. 
Serious central nervous system complications may arise such as meningitis, encephalitis and 
seizures [8, 9].   
The mortality associated with scrub typhus may be up to 33-45% in patients who have not been 
treated in endemic areas which are usually rural, but this does not consider endemic areas with 
immunity [10]. Risk of mortality depends on the infecting strain, the physical wellbeing of the 
patient, and treatment given [11]. An estimate of 1 billion people in the Asia-Pacific area are at 
risk of being infected with scrub typhus and 1 million new cases will develop every year [12]. This 
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is likely to be much higher as many cases will go undiagnosed and unreported, especially in rural 
areas of infection where other febrile illnesses may be more commonly known [13]. Scrub typhus 
is also one of the leading causes of sepsis in Southeast Asia [14].  
However, cases of scrub typhus have emerged from Dubai [15] and Chile [16] indicating that the 
disease burden may be not just be limited to the so called ‘tsutsugamushi triangle’ area of 
infection.   
Orientia may be treated with antibiotics such as doxycycline and chloramphenicol which inhibit 
protein synthesis but because of the many antigenically distinct serotypes, relapses and 
reinfections are common [17]. Also, treatment with these antibiotics may be dangerous in 
pregnant women and children. Alternative antibiotic therapy is also established, such as treatment 
with macrolides, quinolones and rifampicin [18].  
Selection for antibiotic resistance is not a major concern, because the bacteria cannot not be 
released back to the natural chigger host from the human host, so there is no selective pressure 
for the bacteria to evolve against antibiotics. There have been strains with reduced antibiotic 
sensitivity reported [19]  but the existence of widespread doxycycline or chloramphenicol 
resistance in Orientia has not been found  [20].  
 
1.2.b Natural ecology of scrub typhus  
  
Orientia is found in the larval stage of Leptotrombidium mites which act as the vector and the 
reservoir of the bacteria. The lifecycle of mites in the family Trombiculidae begins with the egg 
which develops into the 6-legged prelarva, larva and then 8 legged protonymph, deutonymph, 
tritonymph, and adult. The larval, chigger, stage is the only parasitic stage. Using hair follicles to 
attach to mammalian skin, the chiggers form a stylostome which project into the host’s dermis for 
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food intake which facilitates horizontal transmission of Orientia. Feeding time may be from 2-7 
days [18]. The infected human is a dead-end host as the bacteria cannot reinject future chiggers 
which may attach again but infected rodents can reinfect chiggers which attach to them.  
Orientia persists in the mite line. Transovarial transmission occurs, as the bacteria is passed from 
the female to the eggs. Transstadial transmission occurs through the nymph and adult stages.  
Although Trombiculid chiggers are the known vectors (and reservoir) in endemic regions, there 
may be unknown vectors which transmit Orientia in other parts of the world, especially the western 
hemisphere [21].  
 
1.2.c Genome 
Orientia was originally assigned to the genus Rickettsia and was named Rickettsia 
tsutsugamushi. In 1995, it become reclassified to its own genus due to phenotypic and genotypic 
differences such as its seeming lack of peptidoglycan and LPS, traits which Anaplasma and 
Erhlichia species share [22] [23]. There are two species classified in the Orientia genus: Orientia 
tsutsugamushi and Orientia chuto. There are many different strains of Orientia tsutsugamushi 
which are genotypically and antigenically distinct. Orientia chuto was found in a patient who had 
visited the United Arab Emirates, which is far from the usual endemic area of scrub typhus 
infection [15]. Additionally, O. chuto was found in chiggers living on rodents in Kenya [24].  
The first strains of Orientia to be fully sequenced and annotated were Boryong, isolated from a 
patient in Korea [25], and the Ikeda strain, isolated from a patient in Japan [26]. Six further strains 
have recently been completely sequenced: Karp, Kato, Gilliam, TA686, UT76 and UT176 [27].   
Orientia has a circular single chromosome of roughly 2.1Mbp in size, the biggest in the 
Rickettsiales order [28] [27], with a core genome of 657 genes. However, between islands of core 
gene, the genome consists of a high number of repetitive genes which make up over 42% of the 
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genome. This includes the greatly amplified integrative and conjugative element (ICE), the 
rickettsial-amplified genetic element (RAGE) [4]. RAGE is a large genetic element which encodes 
over 30 genes including ankryrin genes, tra genes related to T4SS, effector protein genes, 
integrase and transposase genes. RAGE is found in many copies in the genome but most of these 
elements have been degraded by insertions and deletions, although many genes still remain 
functional. Similarities have been found between RAGE and gene clusters in Rickettsia bellii, an 
ancestral species.  
It is unusual that Orientia encodes many ankyrin repeat containing proteins (Anks), as these are 
more commonly found in eukaryotes. It has been shown that Orientia Anks can be exported using 
a T1SS apparatus into the host cell [29] [30]. Most Anks have been found to localise to the 
nucleus, cytosol or the endoplasmic reticulum, and the roles of some in interacting with host cell 
proteins has been although the majority of the >20 Ank protein families remain uncharacterized 
[29] [31] [32]. 
Orientia encodes many copies of conjugative type 4 secretion system (T4SS) which mediates the 
transfer of DNA among bacteria as well as transporting effector proteins into the host cells [27]. 
Orientia has over 300 tra genes which express components of the T4SS [25]. The genes encoding 
the T4SS are well conserved between Orientia and Rickettsia, indicating their vital role in the 
intracellular lifecycle. It is unknown if the T4SS of Orientia as active nor what it exports. 
With all the above genetic insertions, the genome of Orientia is not organised well and genes with 
related functions are not closely linked as expected. Between strains, the positions of genes do 
not correspond, highlighting the massive reshuffling which has occurred over time [27]. The 
presence of the degraded and non-coding genes would be maintained in a narrow bottleneck 
population like the intracellular population of Orientia, as selection against these genes becomes 
less effective [27]. 
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These adjustments and rearrangements of the genome may be the reason why Orientia serotypes 
are so antigenically diverse, a feature which makes vaccine development nearly impossible [25].   
 
1.2.d Requirement for host nutrients 
What does Orientia need from the host? Firstly, pyruvate is not synthesised by the typical 
glycolysis pathway, but it is most likely taken up from the host instead or synthesised by an 
alternative pathway in which malate is needed from the host. Orientia does not possess acetyl 
CoA for the citrate acid cycle which is also imported from the host. Even though Orientia has most 
of the genes needed for oxidative phosphorylation, ATP is also acquired from the host through 
the ATP/ADP translocase. This allows the bacteria to use up the pool of host ATP first, before 
using their own resources. The ATP/ADP translocases may also import purines needed for 
nucleotide metabolism [33].  
Orientia cannot produce amino acids so it most likely upregulates transporters which yield amino 
acids from the host cell instead [17]. Importantly, alanine racemase which converts L-alanine to 
D-alanine, vital for the structure of peptidoglycan, is absent. Alternatively, Orientia may take D-
amino acids from the host cell or just retain L variants in the polypeptide chain of peptidoglycan 
[34]. Almost all genes required for peptidoglycan synthesis exist; this will be discussed later. Like 
other Rickettsiales, Orientia has the genes to synthesise fatty acids. With no LPS, the bacteria do 
not have the genes for the biosynthesis of lipid A, unlike Rickettsia species [33].  
Bacteria can sense and respond to their environment through two-component regulatory systems 
which leads to alteration of gene expression. Orientia has a histidine kinase sensor system 
associated to proteins which are involved in managing with osmotic or oxidative stress [26].  It is 
currently not possible to manipulate the genome of Orientia and therefore it is not possible to 
specifically delete genes and investigate their role in the bacterial life cycle. Previous work on 
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gene expression analysis showed that genes responsible for protein translation were down 
regulated in macrophages compared to fibroblasts cells, leading to the slower growth of Orientia 
in macrophages [7]. The difference in environment in these host cells may have stimulated 
different responses in Orientia, hence the difference in gene expression.  
It is still not known how Orientia is able to control its genes to down-regulate translation. The 
presence of SpoT genes may play a role in this, as these genes hydrolyse alarmones by detecting 
nutrient stress and responding by limiting hydrolase activity [35]. This stringent response enables 
bacteria to control their gene expression by regulating transcriptional repression of genes needed 
for the translation machinery, and upregulating genes for metabolic enzymes e.g. amino acid 
biosynthesis. Orientia is the only bacterium in Rickettsiales to encode a full-length SpoT/RelA 
homologue [3]. 
 
1.2.e Surface proteins 
Bacterial entry into nonphagocytic host cells is mediated by the interactions between surface 
components on the bacteria and receptors on the host cell. At least 5 major surface antigens of 
Orientia have been identified from patient sera by western blot analysis but for most their functions 
remain largely unidentified. They may be involved in various functions such as bacterial entry and 
they are immunostimulatory. These proteins are TSA56, TSA47, TSA22, TSA110 and ScaC. The 
first three are the type specific antigens which are the most common surface membrane proteins 
[13].  
The TSA56 protein is the most abundant surface protein and the most antigenically varied. 
Identified by the immunoprecipitation of surface proteins from highly reactive rabbit sera [36], the 
TSA56 is strain specific and found on the bacterial outer membrane. Its primary function is the 
adhesion of the bacteria to the host cell, as well as being implicated in the virulence of the bacteria. 
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The TSA47 protein, which is highly conserved across the strains, is also implicated in bacterial 
adhesion to the host cell but to a much lesser degree and may work mutually with TSA56 to initiate 
bacterial entry.  
There are four variable regions in the TSA56 protein which are crucial in distinguishing strains 
[37]. The four main regions of hypervariability are all in the hydrophilic residues of the protein that 
are predicted to reside on the surface of the cell. It also produces the strongest immune response 
in patient’s sera so this antigen would prove useful for a vaccine target or diagnostic marker [38].  
Rickettsial bacteria encode multiple autotransporter domain family proteins and these are used 
to distinguish species. Each rickettsial species may have a different complement set of Sca 
proteins. Orientia encode 5 of these genes also known as the Sca (surface cell antigen) family, 
which are known to be involved in adhesion and immunity. These are ScaA-ScaE [12]. Although 
entry is predominantly initiated by the TSA56 protein, the ScaC surface protein of Orientia also 
plays an essential role in virulence, by facilitating attachment of the bacteria to the host receptor. 
It has been shown that ScaC in Boryong and Ikeda strains, does induce specific antibody 
responses and is expressed in the host cell but it only mediates bacterial adherence to the host 
fibronectin, therefore it is not involved in bacterial ingress [39].  
 
1.2.f Infection and disease 
 
Once a human is bitten by an infected chigger mite, Orientia multiplies at the site of infection, 
which is not always visible but when it becomes so is known as an eschar [40]. The primary 
infection site for Orientia were thought to be endothelial cells but it is now known that Orientia is 
also found in monocytes and dendritic cells [6]. Symptoms typically begin 7-14 days post infection 
and include headache, fever, rash, myalgia and lymphadenopathy. 
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Once infected, a proinflammatory response is activated. This results in either clearance of the 
pathogen or inflammatory-related damage to the organs and tissue damage. If the pathogen is 
not cleared by the immune response and appropriate antibiotic therapy the bacteria spreads to 
multiple organs including the heart, liver, lungs, spleen, kidneys and central nervous system. This 
can lead to multiple organ failure and death. 
 
1.2. g Diagnostics 
Scrub typhus presents symptoms similar to many other infectious diseases (headache, fever, 
rash) making unambiguous diagnostics based on clinical presentation difficult. When an eschar 
is present at the site of the mite bite this is a good indication of scrub typhus. However, eschars 
are not always present and bedside diagnostic tests are required. Serological diagnostic tests 
include the indirect immunofluorescent antibody (IFA) assay which uses a fluorescent anti-human 
antibody to detect specific antibodies from patient serum bound to antigens from three different 
serotypes of Orientia. Although this technique is sensitive, antigenic variation (there are over 20 
different serotypes of Orientia) can create false negatives and the procedure requires expensive 
equipment [41] [42]. Also, to achieve necessary diagnosis accuracy, it is more suitable to have 
two specimens especially in endemic areas.   Another common diagnostic test is the agglutination 
Weil-Felix assay which detects antibodies against antigens of Orientia in patient serum [43]. 
Though relatively simple, cheap and easily available, it does lack sensitivity and specificity [44] 
and this test is rarely used.  
The enzyme-linked immunosorbent assay (ELISA) is another diagnostic test which involves 
antibody detection of IgM and IgG. Highly sensitive, it provides an objective optical density (OD) 
result using an automated plate reader. This generates high throughput and the test is cheap and 
25 
 
easy to perform [18].  However, the cut-off levels of the OD reading in ELISA testing is not well 
validated so may vary from location to location [45].  
Another serological test is rapid point of care tests (RDTs), which detect antibody production in 
response to bacterial infection [46]. These are fast and cheap but need high levels of antibody to 
work efficiently so during early infection it may not be the best test to use [47]. Also, serological 
tests may not be sensitive in endemic regions of scrub typhus as patients may produce antibodies 
against the bacteria for prolonged periods.  
The use of serological diagnostics is key when treating patients in real time. However, genotyping 
and genome sequencing are also an effective way of monitoring Orientia. Quantitative real-time 
polymerase chain reaction  (RT-PCR), quantifies the bacterial copy number of 16s, TSA56, 
TSA47 and groEL genes [48]. TSA56 exhibits high antigenic variability so it is primarily used to 
identify bacterial strains [18]. This technique is very sensitive but a high infection may be 
necessary to avoid false negatives [49] [50] .  Bacteria may be grown in culture before PCR, but 
this is difficult as Orientia is grown in vitro, usually in a level-3 biosafety laboratory (if the risk 
assessment requires this). This is also a long process and it may take up to 4 weeks to receive a 
positive result [42].  
Multi-locus sequencing typing (MLST) which allows strain detection after DNA sequence variation 
in housekeeping genes, results in better evolutionary relationships between isolates. As more of 
the genomes of Orientia become publicly available, this technique may be carried out more 
frequently [18].  Failure to diagnose the disease efficiently will lead to ineffective treatment with 
ꞵ-lactams.  
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1.2.h The infection cycle 
1.2.h.i Entry 
Bacterial invasion occurs by interactions between the bacterial surface component, host cell 
receptors and extracellular components. 
The surface component known to bind with the host cell receptor in the case of Orientia is the 
TSA56 protein, the most abundant protein on the outer cell surface. Its role in entry was 
discovered after protein extracts from the bacteria were incubated with host membranes which 
bound to a protein of TSA56, the same size as the major outer membrane protein of Orientia [36]. 
Fibronectin, a glycoprotein of the extracellular matrix, plays a role as a host cell receptor. There 
has been much research which has shown that many bacteria bind to fibronectin for host entry; 
Escherichia coli, Staphylococcus and Campylobacter jejuni all bind to diverse binding sites on 
fibronectin [38].  
Fibronectin contains many multifunctional domains such as two heparin binding regions, a gelatin 
binding region and a central cell binding domain which contains the arg-gly-asp (RGD) motif which 
is needed for it to interact with α5β1 integrin receptors, the host’s transmembrane receptors. The 
RGD motif was found to also be implicated in Orientia entry as blocking this interaction using anti-
α5β1 integrin antibodies and Arg–Gly–Asp-Ser (RGDS) peptides, infection became inhibited [38]. 
The interaction between the RGD motif in fibronectin and the β1 subunit of the integrin receptor 
is key for invasion, specifically, the antigenic domain 3 and the adjacent c-terminal region of 
TSA56 is the assumed fibronectin binding domain. This was determined by fusing TSA56 with 
glutathione s-transferase (GST) truncated fusion proteins [38]. It is thought that fibronectin 
domains of bacteria are not organized until fibronectin actually binds with the bacteria and this 
ligand binding interaction causes the systematic transition. The ScaC surface protein also has a 
role in adhesion with fibronectin but the details of this remains unknown [39, 51]. Another 
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Rickettsia bacterium, R. conorii, has also been shown to be internalised into host cells by receptor-
ligand interactions. This occurs by the bacteria binding to protein ku70 which shares homology 
with integrin A domains, and which allows it to bind to fibronectin [52].  
Fibronectin is not the only host cell receptor Orientia is able to interact with for infection; it may 
also bind with heparin sulfate proteoglycans (HSPGs) which are also located in the extracellular 
matrix and the membrane of host cells at high concentration. Purified Orientia were shown to bind 
with heparin [53] indicating that HSPGs must also be involved in bacterial uptake as well as 
endocytosis initiation but the exact ligand on the bacterial surface involved in the interaction is yet 
to be identified. It has been shown that infection level does depend on the concentration of 
syndecan-4 on the host cell surface, which interestingly can also interact with fibronectin. HSPGs 
are also implicated in other Rickettsia species host cell adhesion so its involvement in Orientia 
uptake may be expected [53, 54].  
Once the TSA56 surface protein binds to the host cell receptor, integrin activation is triggered to 
begin downstream signalling within the host cell. The activation of α5β1 integrins will in turn 
activate FAK, RhoA and Src tyrosine kinases. Signalling transduction adaptor proteins talin and 
paxilin are recruited and become tyrosine phosphorylated leading to actin rearrangements at the 
cell surface to result in the internalisation of Orientia. It is suggested that GTPase protein Rac1 
effects movements of the actin filaments, to assist bacterial entry which is reported to be 
performed by clathrin mediated endocytosis (CME) [55]. The signalling pathway leading to CME 
is not fully identified. 
Orientia can increase Ca2+ inside non-phagocytic host cells upon infection, which is beneficial to 
the bacteria because many signalling pathways are controlled by Ca2+ such as cytoskeletal 
rearrangements and gene expression. The increase of Ca2+ was found to arise from inside the 
cell to aid in actin rearrangement [56]. The increase of Ca2+ inside host cells is thought to regulate 
actin assembly and disassembly and suggests that interactions with the endoplasmic reticulum is 
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key for its release.  Shigella too is known to induce actin reorganisation by activating the Ca2+ 
signalling pathway for long durations at the sites where they invade [57].    
 
1.2.h.ii Autophagy 
Autophagy is an essential cellular system to clear out unwanted intracellular pathogens and 
initiate innate immunity. Many intracellular pathogens manipulate the autophagy machinery for 
their own survival. Once inside the host cell, Orientia is able to escape the endosome and induce 
autophagy. Its ability to escape autophagy occurs by an unknown mechanism  [58, 59]. It has 
been shown that Orientia induces autophagosomes in dendritic cells [60].  
The bacteria are now free in the cytosol, similar to other Rickettsia but in contrast to other many 
other intracellular bacteria that reside within specialized vacuoles within host cells. Other obligate 
intracellular bacteria such as Listeria and Shigella are also able to escape autophagy. Listeria 
phospholipase proteins have been shown to degrade the phagosome membrane. As Orientia has 
phospholipase D, this could potentially play the same role in autophagy escape [61].  
 
1.2 h.iii Microtubules 
Many obligate intracellular bacteria use the host cytoskeleton for transport within the cell as well 
as cell to cell spread [62]. Rickettsia species hijack cellular actin and are able to polymerise actin 
to propel themselves in the host as well as pushing through neighbouring cell membranes [63]. 
Orientia are unable to polymerise actin but instead localise with host mictotubules during the 
infection cycle.  
Orientia travel to the perinuclear region of the cell after escaping autophagy, by manipulating host 
cell microtubules [64]. Though other obligate bacteria such as Chlamydia, may use microtubules 
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at the early stages of infection, Orientia are the only bacteria to utilise the microtubules of the host 
in this way. As Orientia move to the microtubule organizing center (MTOC), movement is 
dependent on stable microtubules [61]. Once at the MTOC, Orientia begin to divide by binary 
fission at the perinuclear region.  
It is not known yet how Orientia interacts with dynein, which surface protein may be responsible 
for this or and which dynactin complex is involved in the movement of the bacteria.  
 
1.2.h.v Budding and exit 
Once division is achieved, Orientia move into the cytoplasm and begin their exit from the host 
cell, beginning at around 4 days’ post infection. Orientia have been shown to push out of the host 
cell, enclosing themselves in the plasma membrane of the host cell, leaving the host cell still 
intact. This technique would protect them from the extracellular environment before reinfection 
can occur by phagocytosis. The layer of host membrane is then thought to be disintegrated in a 
unknown mechanism [65].  So far, only one bacterium per bud has been seen to occur (data not 
yet published). This unique exit mechanism is very similar to viral budding and is not known to 
occur in any other bacterial species. Chlamydia species are similarly extruded from the host cells 
in a pinch-like manner, but in contrast to Orientia, one extrusion releases hundreds of bacteria 
and involves the use of host actin [66]. 
The exit of Orientia has also been shown to involve of the use of lipid rafts from the host membrane 
[67]. Lipid rafts have been shown to be used by multiple bacteria upon entry but not exit [68].  
Both TSA56 and Htr (TSA47) proteins of Orientia are thought to interact with lipid rafts, to initiate 
the budding from the host cell. 
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Figure 3. The Orientia intracellular mammalian life cycle 
 1. Orientia attach to fibronectin which activates a downstream signalling pathway in the host cell, leading to 
internalisation that is clathrin dependent.  After entry, bacteria are enclosed in an endosome. 2. Orientia are then able 
to escape autophagy by an unknown mechanism. 4. Orientia utilise host microtubules to travel to the perinuclear area, 
aided by dynein. 5. Bacteria then undergo replication by binary fission.  6.  Orientia then move to the host cell membrane 
in an unknown mechanism. 7. Once at the periphery of the host cell, Orientia bud out of the host, enclosed in part of 
the host membrane. [4] 
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1.3 Rickettsia  
 
1.3.a. Introduction 
 
Rickettsia bacteria were discovered by Howard Ricketts in 1906, after taking the blood of patients 
with Rocky Mountain Spotted Fever and infecting Guinea pigs which developed a febrile illness. 
He was also able to find these agents in tick cells. The discovery of the infective agent of louse-
borne typhus came from Von Prowazek and da Rochalima in Europe. All later died from infection 
with rickettsial infections [69]. The genus consists of a diverse number of species which are 
associated with human disease and vectors such as ticks, mites, fleas and lice which pass the 
bacteria on through feeding in their saliva or feces. However, many species have also not shown 
any evidence of pathogenicity in humans [70].  
The genus has been separated into 3 groups based on morphological, antigenic and metabolic 
characteristics of the species. These are: the spotted fever group, the typhus group and the 
ancestral group [22].  With the advent of advanced molecular tools, more Rickettsia species are 
now being discovered in a wide range of invertebrates and arthropods. Rickettsia species which 
are symbiotic to their tick hosts have been discovered and are thought to be non-pathogenic [28]. 
 
1.3.b. Rickettsia: Typhus group 
Rickettsioses are caused by Rickettsia bacteria and are some of the world’s oldest described 
diseases. The plague in Athens during the 5th century BC, was thought to have been caused by 
typhus caused by the Rickettsia bacterial species R. prowazekii and R. typhi [70].  
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R. prowazekii causes epidemic typhus, transmitted by Pediculus humanus corporis lice in colder 
climates. Usually transmitted in poor sanitary conditions, typhus killed over 3 million people in the 
last century [71] . Epidemic typhus appears repeatedly in history, especially during times of war, 
social upheavals and famine. Epidemic typhus has killed millions of people in history and persists 
today although only now in countries where public health is not well regulated. Louse-borne 
typhus is transmitted when human body lice excrete on human skin during feeding. The feces left 
behind may enter the skin as the host scratches the site of the wound or bite. Symptoms include 
rash, headache, fever and scratching of the skin [72]. 
Louse-borne diseases have re-emerged in recent times, such as in jails in Rwanda and refugee 
camps in Burundi. More uncommonly, homeless people in Marseilles, France were found to have 
seroprevalence to R. prowazekii [73]. Even after transmission of R. prowazekii occurs and no 
symptoms arise, years later patients can relapse. R. prowazekii is the only Rickettsia bacteria 
known to be able to persist in patients and this reactivation of the bacteria causes Brill-Zinsser 
disease [70]. R. prowazekii is a select agent due to its ability to be used as a biological weapon 
and with antibiotic resistant strains now emerging [70]. 
R. typhi causes murine typhus which is transmitted by fleas in warmer climates. A zoonotic 
disease, it is transmitted by the rat flea Xenopsylla cheopis to humans after exposure to flea feces 
through disrupted skin or via the respiratory tract. R. typhi occurs worldwide and case numbers 
are most likely under-represented due to its mildness and non-specificity in infection [74]. 
Symptoms include rash, fever and headache [72].  
 
1.3.c. Rickettsia: Spotted fever group 
The species which is most severe in this group is R. rickettsii which causes Rocky Mountain 
Spotted Fever (RMSF). It is transmitted by Dermacentor andersoni and Dermacentor variablis 
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ticks in North America and Amblyomma species and Rhipicephalus sanguineus in central and 
south America. Common symptoms include fever with headache but there may also be 
gastrointestinal complications. The development of a rash is frequent, from the wrist to the trunk 
of the body. The classic symptom is the eschar at the site of the bite, similar to scrub typhus [69].  
R. conorii causes Mediterranean spotted fever (MSF) with most cases in Europe. Transmitted by 
Rhipicephalus sanguineus, eschars can also be found in patients, but this is rare. Symptoms are 
similar to RMSP, with an extreme rash which can even occur on palms and soles [72]. 
Transmission of SFG Rickettsia occurs during feeding of the tick on the skin of the host. As the 
tick inserts its hypostome, blood is ingested and saliva (potentially containing bacteria) is injected.  
 
1.3.d. Rickettsia: ancestral group 
The ancestral group of the Rickettsia bacteria are not well known and may not be pathogenic to 
humans. R. canadensis is an ancestral species and shares characteristics with the spotted fever 
group (has rOmpA and rOmpB proteins) as well as the typhus group (similar G+C content and is 
susceptible to erythromycin). Sequence analysis of 16s show R. canadensis to be similar to R. 
akari or R felis but places it in a distinct lineage which is not well represented. The genome is 
around 1.1mpb [23]. 
Found in Haemaphysalis leporispalustris ticks in Ontario, Canada in 1962 [21], from a 
domesticated rabbit,  R. canadensis is transmitted transtadially and transovarially. The bacteria 
are able to invade the nuclei of cells and may cause febrile illness as shown by infection in Guinea 
pigs. R. belli is another Rickettsia ancestral species. 
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Species Vector Disease 
   
Spotted fever group   
R. rickettsii Tick: Dermacentor andersoni, 
Dermacentor variablis, Rhipicephalus 
sanguineus, Amblyomma 
cajennense, Amblyomma aureolatum 
Rocky Mountain Spotted 
Fever 
R. philipii Tick: Dermacentor occidentalis Pacific coast tick fever 
R. peacockii (east 
side agent) 
Tick: Dermacentor andersoni Non-pathogenic, 
endosymbiont 
R. montanesis Tick: Dermacentor variabilis SF 
R. sibirica Tick: Dermacentor, Haemaphysalis Siberian tick typhus/ 
Lymphangitis associated 
Rickettsiosis 
R. africae Tick: Amblyomma hebraeum African tick bite fever 
R. parkeri Tick: Amblyomma triste Rickettsiosis 
R. conorii Tick: Rhipicephalus sanguineus Mediterranean spotted fever 
R. slovaca Tick: Dermacentor Tick borne lymphadenitis 
R. honei Tick: Ixodes granulatus, 
Rhipicephalus, Amblyomma 
cajennense 
Finders Island spotted fever 
R. heilongjiangensis Tick: Haemaphysalis concinna, 
Dermacentor sylvarum 
Far Eastern tick borne 
Rickettsiosis 
R. japonica Tick: Dermacentor taiwanensis, 
Haemaphysalis flava 
Oriental/Japanese spotted 
fever 
   
R. massiliae Tick: Haemaphysalis juxtakochi, 
Rhipicephalus sanguineus 
Rickettsiosis 
R. rhipicephali Tick: Rhipicephalus sanguineus, 
Haemaphysalis juxtakochi 
Unknown 
R. aeschlimanni Tick: Rhipicephalus turanicus SF 
R. repultii Tick SENLAT (scalp eschar and 
neck lymphadenopathy after 
a tick bite) 
   
R. helvetica Tick: Dermacentor reticulatus, Ixodes 
ricinus 
SF 
R. asiatica Tick: Ixodus ovatus Unknown 
R. tamurae Tick: Amblyomma testudinarium  SF 
R. endosymbiont Tick: Ixodes Non-pathogenic 
R. monacensis Ixodes ricinus SF 
R. akari Mite: Allodermanyssus sanguineus Rickettsial pox 
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R. australis Tick: Ixodes holocyclus, Ixodes 
tasmani 
Queensland tick typhus 
R. felis Flea: Ctenocephalides felis /Aedes 
albopictus 
SF 
R. hoogstralii Tick: Haemaphysalis sulcata, Carios 
capensis  
Unknown 
   
Typhus group   
R. prowazekii Lice: Pediculus humanus corporis 
Tick: Amblyomma imitator   
Flea:  
Endemic typhus/Brill-Zinsser 
disease 
R. typhi Flea: Xenopsylla cheopis, 
Ctenocephalides felis 
lice/mitee 
Murine typhus 
   
Ancestral group   
R. canadensis Tick: Haemaphysalis leporispalustris Unknown 
R. bellii Tick: Amblyomma, Ixodes loricatus.  
Acanthamoeba 
Unknown 
 
Table 1. Rickettsial species and the diseases caused in humans 
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1.3.e. Cell biology 
Rickettsia are rod shaped and have a highly conserved genome, at around 1.1Mb [75]. As they 
live free in the cytosol of host cells, genes required for sugar metabolism as well as lipid, amino 
acid and nucleic acid production are not needed [76]. Rickettsia species encode a glycerol 
phosphate transporter (glpT) which imports glycerol phosphate from the host to allow glycolysis 
and the citric acid cycle to occur. ATP is also imported via ATP/ADP translocases [33]. Like many 
Rickettsiales species, Rickettsia species display a T4SS with the presence of tra clusters [77]. 
All species have an affinity to infect endothelial cells which line the blood vessels in humans and 
animals. Exceptions to this include R. conorii which can infect a wide range of cells and the target 
of R. akari is mainly macrophage cells. Endothelial cells are known to be vital in the role of host 
immune responses and inflammation so by infecting these cells, Rickettsia bacteria are disrupting 
the entire vascular system [71].  
Entry into host cells is by phagocytosis or by inducing phagocytosis in non-phagocytic cells [78] 
(Figure 4). A zipper-like invasion mechanism is thought to occur for most Rickettsia species, 
similar to what is known in Listeria and Yersinia, as the bacteria ligands interact with host ligands 
to allow host membrane to ‘zipper’ around the bacteria aided by actin polymerization. There have 
been 17 surface cell antigen (sca) proteins found in Rickettsia species which resemble 
autotransporter proteins [28]. The major surface proteins of SFG Rickettsia bacteria include many 
surface cell antigens such as rOmpA and rOmpB [79] [80]. rOmpB is the more abundant of the 
two and TG do not express rOmpA. Adhesion is key to infection and begins with the interaction 
between rOpmB and protein kinase, Ku70, found on the cholesterol rich regions of the plasma 
membrane as well as in the nucleus [81] [52]. On the plasma membrane, ku70 mediates cell to 
cell adhesion and interactions with fibronectin by forming a heterodimer with ku80 [79]. For most 
rickettsia species, this interaction between the rOmpB β-peptide domain and ku70 then triggers 
the upstream signaling pathway, via cdc42 GTPase, phosphoinositide 3-kinase and the activation 
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of the ARP 2/3 complex for actin polymerisation. Entry is actin dependent but may also be 
dependent on clathrin or caveolin 2 dependent endocytosis [71, 79]. TG R. prowazekii adheres 
to host cells using adhesion proteins Adr1 and Adr2, and may not need rOmpB for entry [82].  
After entry, Rickettsia are able to quickly escape the lysosome which may be due to 
phospholipase A2 activity, as shown for R. typhi (but no gene has been found to support this) [78]. 
The Rickettsiaceae family are unique in that they can escape the host phagocytic vacuole to 
reside free in the cytoplasm. This may be advantageous to them as they have direct access to 
host metabolites but also very risky to be exposed to components of the host cell which can trigger 
the host immune response.  
Once free in the cytosol, rickettsia divides by binary fission. The SPG Rickettsia undergo actin 
based motility to transport themselves around the host cells, which is dependent on Rickettsial 
protein RickA [83] and occurs 24-48 hours after infection. The formation of the actin tails also 
allows the bacteria to protrude into neighboring host cells without being in the extracellular 
environment. R. parkeri were found to polymerise shorter tails during the first 12 hours of infection 
but at 24 hours, actin tails become longer and more frequent [84]. This pattern may differ 
according to the Rickettsial species and its infection cycle details. Also, rickA may interact with 
host actin but sca2 is thought to drive the motility of the bacteria in a ARP 2/3 dependent manner 
[85].  
With no rickA, TG Rickettsia do not polymerise actin tails, with the exception of R. typhi, which 
polymerise very short tails [28]. TG bacteria lyse the host cell after division to infect neighboring 
host cells. This means that the bacteria number is usually very high in contrast to SFG intracellular 
bacteria numbers. 
Rickettsia species are usually transmitted to arthropod host progeny via vertical transmission with 
some cases of male mortality in beetles and ladybirds [86].  
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Figure 4. The Rickettsial intracellular mammalian life cycle.  
1. Rickettsia attach to the host cell via adhesions rOmpA and/or rOmpB to host cell receptor Ku70 which becomes 
ubiquitinated. After actin rearrangement, bacteria are able to enter the cell in a zipper-like mechanism. 2. Rickettsia become 
enclosed in endosomes after entry in the cytoplasm. 3. Rickettsia escape the endosome as bacterial enzymes, 
phospholipase D and tlyC lyse the vacuole membrane. 3. Bacteria are free in the cytoplasm and may polymerise actin to 
move around the cell by activation of Arp2/3 by RickA.  4. Replication occurs by binary fission. 5. Typhus group Rickettsia 
will disseminate by lysing the host cell 6. Spotted fever group Rickettsia infect neighbouring cells by pushing through the 
host membrane, using actin polymerization to do so.  
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1.4. Anaplasmataceae 
1.4.a. Introduction 
There are 4 distinct genera in this family: Anaplasma, Wolbachia, Ehrlichia and Neorickettsia. 
Whilst all are obligate intracellular bacteria, the bacteria species in Anaplasmataceae all exist in 
membrane bound vacuoles inside the cytoplasm of host cells (Figure 5) which may be vertebrates 
or invertebrates. This contrasts with Rickettsia and Orientia species which are free in the host 
cytosol after entry. 
These bacteria are quite different to the closely related Rickettsia species. Anaplasmataceae are 
sensitive to mechanical stress and osmotic changes. They are also pleomorphic with a lack of 
LPS and in some cases peptidoglycan (as shown in this thesis).  
 
1.4.b. Anaplasma marginale 
1.4.b.i. Disease 
The Anaplasma species are transmitted by ticks, and unlike the other species in 
Anaplasmataceae they cause severe disease in livestock and humans. Anaplasma marginale 
causes bovine anaplasmosis, common in cattle and transmitted worldwide. First described in 
1910 by Arnold Theiler, it causes economic losses such as death, abortion, infertility and weight 
loss in cattle [87]. Although it is more common in cattle, it’s also found in bison, deer, buffalo and 
antelope. The tick populations are controlled by the use of acaricides which is now problematic 
as ticks become resistance to the pesticide and it can be traced in milk and meats [88]. Vaccines 
are used to prevent anaplasmosis which induce protective immunity but do not prevent persistent 
infections. 
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More than 20 species of ticks transmit A. marginale to livestock, including Rhipicephalus and 
Dermacentor species, but the most common is Rhipicephalus microplus. Animals which recover 
from mild anaplosmosis may be reservoirs of the bacteria for life and can re-infect ticks. The 
bacteria may also be passed by gestation from the cow to calf. Tick transmission may occur 
transstadial or intrastadial but not transovarial [89]. A. marginale infect erythrocytes which causes 
the mild to severe hemolytic disease. Infected erythrocytes are then phagocytosed by bovine 
reticuloendothelial cells, resulting in anemia [88]. 
 
1.4.b.ii Cell biology 
A. marginale has a circular genome at 1.2-1.6 mbp [90]. The diversity of A. marginale can be 
classified based on their major surface proteins (MSP), 6 of which are well known. For instance, 
gene Msp1a can distinguish strains worldwide based on the tandem repeats on the N-terminal. It 
is used as a marker for disease severity and multiplication in cattle and ticks. MSP1a is vital for 
infection and transmission in ticks and is also immunostimulatory in cattle. It is the best 
characterized surface protein as it is known to bind with erythrocytes and tick cells. It is not yet 
known what MSP1s binds to on the host cells or how the bacteria enter [87]. MPS1 is also used 
a genetic marker to distinguish A. marginale strains, in particular MSP1a, MSP4 and MSP5 [91]. 
A. marginale can grow in vitro in various endothelial and epithelial cell lines as well as insect cell 
lines derived from mosquito and tick cells.  
The life cycle of A. marginale is complicated and must coordinate with the feeding cycle of the 
tick. At the site of infection, A. marginale will develop in membrane bound vacuoles. The first form 
of the bacteria is the reticulated cell form which may divide by binary fission. This results in large 
colonies with hundreds of bacteria known as morulea.  The reticulates than transform into the 
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dense cell form which are infective for a short period and able to survive outside of the host cells. 
It is the dense form that are transmitted to cattle from the ticks during feeding [92].  
 
 
1.4.c. Anaplasma phagocytophilum 
1.4.c.i. Disease 
This species causes tick-borne fever (TBF) in animals and humans. The disease has been known 
for more than 200 years and transmission occurs in a broad range of hosts, from ticks to sheep, 
goat, cattle, horse, dog, cat, reindeer, squirrels, raccoons and human [93]. Young animals are 
usually affected, and symptoms range from fever, anorexia and low milk yield [94].   
In humans, this febrile illness is known as human granulocytic anaplasmosis (HGA) and involves 
the existence of intravacuolar colonies named morulae in the cytosol of granulocyes  [95]. It is an 
emerging infectious disease in humans and often goes unreported. Symptoms include chills, 
fever, malaise and myalgia. If the patient is immunocompromised, elderly or untreated, the 
disease can be fatal [87].  
A. phagocytophilum is found in tick species Ixodes in the US, Europe and Asia [93]. As ticks take 
up the bacteria during feeding, bacteria are transmitted transtadially from nymph to adult during 
metamorphosis, and then transmitted again to human or animal. They unusually can persist in 
neutrophils which should naturally destroy them [94]. 
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1.4.c.ii. Cell biology 
Anaplasma phagocytophilum was once known as Ehrlichia phagocytophilum due to their close 
relation. Bacteria are around 0.4-2um in size and are pleomorphic coccus shaped. The outer 
membrane is ruffled and there are no genes present encoding LPS or peptidoglycan synthesis. 
The lack of membrane rigidity may give it plasticity inside the inclusion bodies inside granulocytes 
which must travel through tight capillaries [96].  
The genome size is around 1.47mbp, 12.7% of which consists of repetitive DNA [94]. They do not 
have plasmids or transposable elements but do have a T4SS and a partial glycolysis pathway, 
the ability to metabolise pyruvate and most nucleotides [97].  There is little variation between 
strains due to minor differences in groESL or 16S which means distinguishing strains is difficult 
for diagnosis. Strains may also differ in host infectivity [87].  
A. phagocytophilum consist of surface membrane proteins, p44 and Msp2 which are 42-49kDa 
and are encoded for by the msp2 gene family [98]. These are transmembrane beta-barrel proteins 
which display porin activity to allow the transport of hydrophilic nutrients. Antigenic variation can 
be found in the loop region of the protein which is responsible for the persistence of the infection 
in the host. The genome of A. phagocytophilum also displays homologs of Type 1 and Type 4 
secretions systems [99] [100]. 
Like A. marginale and Chlamydia species, they also display biphasic development during their 
intracellular life cycle; in the larger reticulate form and the smaller dense form. Only the dense 
form can bind with mammalian cells whereas both reticulate and dense can bind with tick cells. 
Once the dense form enters new host cells, they will reside in the host-derived vacuole and 
transform to reticulate cells within 12 hours, this is when replication occurs. After 24 hours, there 
will be large numbers of reticulate bacteria inside inclusion vacuoles which expands during 
replication, and after 36 hours, these bacteria will transition to dense form to re-infect host cells 
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[95] [101]. The size of the bacteria is important for uptake; as larger bacteria may be taken up via 
a different pathway (association with LAMP-1 proteins have been shown [102]) than smaller 
dense bacteria in host cells. This indicates that both reticulate and dense forms of A. 
phagocytophilum must utilise different receptors and adhesions when entering a range of host 
cells.  
The dense form of E. chaffeenis, another Rickettsiales, presents outer membrane proteins which 
have been identified as adhesions, which contrasts with the reticulate form. The dense form of A 
phagocytophilum is also known to interact with the host cell. This indicates that the expression of 
the adhesins needed for eukaryotic interactions, must occur during the differentiation stage form 
reticulate to dense form [101].  
The entry mechanism of A. phagocytophilum has been studied frequently in HL-60 endothelial 
cells. The host cell receptor, P-selectin glycoprotein ligand-1 (PSGL-1) initiates a Syk (spleen 
tyrosine kinase) and ROCK-1 dependent signaling cascade which promotes the uptake of the 
bacteria [103]. The PSGL-1 receptor is capped with a o-glycan which has a terminal 
tetrasaccharide. The interaction between the bacteria and this terminal tetrasaccharide may 
promote cellular entry or adhesion or both.  Since ROCK-1 is a regulator of actin organization, 
the bacteria binding to PSGL-1 results in manipulation of actin for entry. HL-60 cells are not 
phagocytic but have presented engulfment of bacteria via their membrane extensions [95].  
The entry of A. phagocytophilum in tick cells is dependent on bacterial surface proteins Msp2, 
Asp55 and Asp62 [104]. Entry is also dependent on host lipid rafts but the signaling pathway here 
is not well understood. It is also known that A. phagocytophilum interacts with GPI-proteins and 
cholesterol-associated membrane proteins, flotillin 1 but not clathrin [105]. 
How do the bacteria persist in neutrophils, their natural niche, for so long? Usually neutrophils 
would kill microorganisms by withholding nutrients or fusing phagosomes with granules containing 
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antimicrobial peptides and lysosomal hydrolytic enzymes. But A. phagocytophilum can avoid the 
lysosome pathway and its inclusion vacuole lacks endosomal characteristic receptors and 
molecules. The inclusion does co-localise with various Rab proteins which regulate endocytic 
recycling, and takes host cholesterol for its expanding double lipid inclusion membrane [106]. A. 
phagocytophilum does not have any of the genes which encode for PAMPs peptidoglycan or LPS. 
Therefore, it is able to avoid being recognized by the NOD-1 receptors which are expressed on 
the surface of granulocytes but still activates Rip2, a downstream adaptor protein of NOD1.  [107]. 
The bacteria are thought to down-regulate TLR1 instead. This has allowed them to remain inside 
the host without being immunostimulatory [97].  
Bacteria can be grown in vitro in myeloid or granulocytic cells and has successfully been 
propagated in human promyeoblast HL-60 cells, myelomocytic THP-1, endothelial and various 
insect cell lines [88]. Division in HL-60 cells occurs by binary fission with division beginning by 12 
hours with the induction of dense cells and formation of morulae. Bacteria load appears highest 
at 24 hours inside cells [95].  
A. phagocytophilum, like other Rickettsiales, uses the T4SS but it is slightly different. The system 
may form a transmembrane channel to transfer DNA and proteins into eukaryotic cells as well as 
hijacking various signalling pathways [108] [109]. The T4SS may secrete virulence factors which 
are responsible for disrupting innate immunity and inhibiting host cell apoptosis. The bacteria may 
express different types of the T4SS in their tick host compared to the mammalian host, so that 
the vir genes are upregulated differently in both systems [110].  
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Figure 5. Anaplasmataceae intracellular mammalian life cycle. 
1. Bacteria enter host cells in dense core infectious state. 2. After capture in the phagosome, no fusion occurs with the lysosome. 3. 
Instead the reticulate form, called the morulae develop after division. 4. Morulae then mature into the infectious dense core cells and 
these are released by host cell lysis or exocytosis. 
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1.4.d. Ehrlichia  
 
1.4.d.i. Disease 
The genus Ehrlichia includes species such as E. chaffeensis which causes human monocytic 
ehrlichiosis (HME) and E. muris and E ruminantium which cause disease in animals such as 
cattle, dogs, cats, goats and rodents [111]. HME is now classified as an emerging disease by the 
CDC and many cases go undiagnosed or unreported with most cases emerging in elderly or 
immunocompromised patients [112]. Ehrlichia species can infect monocytes, macrophages and 
dendritic cells [113]. 
All species are transmitted by ticks and can replicate in the tick and the mammalian host. It is 
mainly the lone star tick Amblyomma americanum which transmits Ehrlichia species to the host 
[114]. These ticks are most commonly found in south central USA, especially in the summer 
months when ticks are more likely to bite animals or humans, but cases have also been reported 
in Europe, Asia, Africa and South America. White tailed deer also act as a reservoir for the 
bacteria [115].  
Around 9 days after the tick bite, patients present headache, fever and body aches and sometimes 
rash. As the bacteria infection develops, the patient may experience vomiting, diarrhea, nausea 
and occasionally respiratory symptoms [111]. These symptoms are very similar to Rickettsial 
infections, but the mortality rate is much lower for Ehrlichosis. Patients are usually diagnosed by 
PCR before given doxycycline [116]. As there is no vaccine, the prevention of tick bites is key.  
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1.4.d.ii. Cell biology 
Ehrlichia is a pleomorphic coccus shaped bacterium with a genome size of up to 1.3Mb, coding 
1200 proteins. It lacks many genes needed for metabolism and amino acid biosynthesis which 
most likely are taken from the host environment but does encode genes needed for aerobic 
respiration and nucleotide biosynthesis [33]. Its major outer membrane protein, 1/P28 is 
conserved amongst the Ehrlichia species [117] .  
Other surface proteins include TRP47, TRP32, TRP120, Omp28, T4SS proteins, Ehrlichia surface 
protein 73 (Esp73) and Ehrlichia entry triggering protein (EtpE). Some of these surface proteins 
are orthologs of A. phagocytophilum surface proteins [115]. Bioinformative studies have shown 
that 18 proteins are likely to be outer membrane proteins (OMPs). These are most likely to be 
involved in interactions with the host cell for entry (map 1 proteins) as well as virulence factors of 
the T4SS [114]. This study also identified 6 new OMPs which could be vaccine targets. Many 
genes also showed inhibition of infection in deer when mutated which indicates which genes are 
important for virulence.  
In vitro, Ehrlichia can grow in a range of cell lines from endothelial, epithelial, monocyte, 
macrophage and tick [118] [111]. 
Ehrlichia are able to enter host cells manipulating the movement of host filopodia by interfering 
with the cellular cytoskeleton by influencing host gene expression. This allows them to 
disseminate from cell to cell without entering the extracellular space and thus allowing them to 
avoid the host immune response [119]. Listeria also manipulate filopodia to exit host cells and 
spread to neighboring cells.  
Like Anaplasma species, Ehrlichia have two morphological distinct states. The infectious form 
called the dense form (DC) enter host cells by adhering the invasion c-terminal region of EtpE to 
GPI anchored DNase X receptor, which is enriched in cholesterol in the cell membrane. These 
48 
 
binding permits entry as the host cytoskeleton remodels and engulfment of the bacteria is 
managed by filopodia. The entry of Ehrlichia into cells is also dependent on host cell caveolin-1 
and tyrosine phosphorylated proteins [115] but not clathrin which is associated with endocytosis 
so entry is most likely occurs by receptor mediated endocytosis[120].    
After entry, Ehrlichia can manipulate vesicular trafficking to avoid being delivered to lysosomes. 
They then differentiate in membrane bound vacuoles called the Ehrlichia containing vacuole 
(ECV), which resembles an early endosome. In the ECV, T1SS effector proteins are secreted 
which allows avoidance of the host immune response. Differentiation then occurs to the reticulate 
bodies (RB) which fuse with transferrin (TfR) endosome. This allows the bacteria to extract iron 
from the host cell as well as halting the JAK/STAT cell signaling pathway to avoid the innate 
response [121]. The RB form can then escape the lysosomal pathway by secreting T4SS effector 
protein ECH_0825 to prevent apoptosis and the production of reactive oxygen species (ROS) 
[114]. Division then occurs by binary fission to form a large colony known as the morula. Morulae 
increase over time and finally become loose to exit host cells, spreading cell to cell via filopodia 
engulfment [122]. This allows the bacteria to avoid interaction with the extracellular environment 
and immune responses. The use of filopodia to move to neighboring cells is actin dependent with 
the need for calcium and iron influx. The TRP proteins such as TRP20 mediates actin 
polymerization by interacting with the ARP2/3 complex [121]. 
Ehrlichia can prolong their survival by mediating TRP120 host interactions by misusing the 
SUMOylation (small ubiquitin-related modifier) pathway [114]. Ehrlichia may also evade host 
responses by interacting with mitochondria via T1SS and T4SS proteins. TRP proteins such as 
TRP120 and TRP47 are expressed in the dense form and are able to interact with many pathways 
of the host cell including entering the host cell nucleus to modify host cell signaling pathways at 
the protein synthesis level [114]. 
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The bacteria taken from tick cells and infected into mice presented a longer infection than bacteria 
taken from vertebrate host cells [123].  
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1.4.e. Wolbachia 
1.4.e.ii. Disease 
Generally, Wolbachia is referred to just by its genus name because of confusion about whether 
all species belong to W. pipentis. The main species is Wolbachia pipentis and there are 8 super-
groups termed A-H. These super-groups are generally associated with one type of invertebrate, 
A, B, E, F, G, H in arthropods and C and D in filarial nematodes [112] but some still have not been 
placed in a specific subgroup. Although it is possible to culture Wolbachia in mouse and mosquito 
cell lines, there is no evidence of the bacteria infecting mammals like other alpha-proteobacteria 
species [124].  
Wolbachia species are quite different from other Rickettsiales. They do not infect vertebrates as 
most Rickettsiales do but more commonly infect a broad range of invertebrates, to which they 
share unusual relationships. Maternally transmitted, Wolbachia do not tend to kill their host, with 
the exception of a few strains, but act as a symbiont, forming a mutualistic relationship instead 
[125]. The bacteria are well known to be required for the survival and the fertility of the host.  
It is thought that over 65% of insect species are infected with Wolbachia. The mutualism 
relationship between the bacteria and its host is most interesting. This relationship may even 
determine the survival of the host as studies have found tetracycline treatment in Onchocerca 
ochengi also caused host fatality [112].  
Wolbachia induce interesting host manipulations which show reproductive parasitism. These 
include: the feminisation of male insect;, the production of unfertilised eggs in females; death of 
male progeny (through testes infection); and cytoplasmic incompatibility (when the uninfected 
female egg cannot be fertilized) [126]. The latter is the most frequent and it reduces the 
transmission of females which are uninfected or infected with a different Wolbachia strain [28].  
51 
 
These unusual properties, especially cytoplasmic incompatibility, of the bacteria make it a suitable 
biological system to control vector-borne diseases. Wolbachia has recently been used 
experimentally to control dengue, a viral disease which affects 5 continents of the world and is 
transmitted by mosquitos of the genus Aedes [127]. These mosquito species are naturally not 
infected with Wolbachia but are an important vector. By infecting female mosquitos with strains 
wMelPop or wMel, the viral lifetime shortens drastically so that transmission is reduced. 
Therefore, releasing infecting female mosquitoes in urban areas can control disease. This is 
possible as Wolbachia inhibits dengue viral replication and growth [128]. Wolbachia may achieve 
this by extracting cholesterol from its host cells to allow its accumulation which negatively affects 
viral growth [129]. Wolbachia has also been shown to trigger the innate immune response of the 
insect to the virus. Infection of bacteria activates the immune deficiency and Toll pathway in the 
mosquito which also promotes the long term colonisation of the bacteria [130]. As this cements 
its symbiotic relationship with the host, Wolbachia are free to manipulate and increase the host’s 
resistance to other pathogens [130]. 
Once in the insect, it is impossible to eradicate the Wolbachia strain and most of the time, one 
insect can be infected with multiple strains of the bacteria, which coexist together [128]. It has 
recently been shown that the addition of Wolbachia to mosquitoes reduces the levels of 
arboviruses including chikungunya and Zika, both of which are transmitted by Aedes mosquitoes. 
This is currently being tested as a control measure in clinical trials [131, 132] .  
The long-term effects of Wolbachia additions to mosquito must be considered.  Over time, dengue 
viruses can reduce their ‘extrinsic incubation time’ in the mosquito which needs to be completed 
before transmission if selection occurs. Wolbachia could also reduce the deleterious effects they 
exhibit on the virus [133] [128]. These are just a few examples of what could occur over time as 
trials take place for disease control.  
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1.4.e.ii. Cell biology 
The genome of Wolbachia is highly recombinogenic as shown by the distant relationship between 
three of the genomes published. The genome is around 1.0-1.8Mb with high number of repeats 
and ankyrin repeats [126]. Its high number of repeats is only second to Orientia in the Rickettsiales 
family [134].  Diverse genomes may reflect the divergent molecules the bacteria target in various 
host cells, but the small genome also reflects the need for only genes needed for their parasitic 
lifestyle. 
Like many of its relatives, Wolbachia has a T4SS which is likely used to transport proteins and 
nucleic acids in and out of the cell but also in the case of Wolbachia, it is used to induce the 
reproductive abnormalities which the bacteria inflict on the host. Also, ankyrin repeat domains 
have also been found in Wolbachia strains which infect Drosophila melanogaster [124].  These 
ankryin proteins may also play a vital role in the mutualistic relationship between the bacterium 
and the host. Also unusual is the presence of the virus-like elements which may be transcribed 
and expressed by a lytic cycle, found in strain wMel. Furthermore, phages may be able to spread 
ankyrin genes within the bacteria [135].  
Wolbachia have three major surface proteins: wsp and its paralogs wsp1 and wsp2 [28]. After 
entry inside host cells, Wolbachia is thought to remain inside the host cell cytoplasm, residing in 
a host derived vacuole. There is not much known about the activity inside the vacuole or the 
infection cycle which follows.  
There may be a link between the bacterial growth and the host cell cycle. Wolbachia growth is 
high in early embryo development for Aedes albopictus but then decreases once the host cells 
decrease cell division [124]. As well as the host division cycle, Wolbachia may play a role in 
regulating host apoptosis. Coevolution has resulted in the host cell outsourcing the regulation of 
apoptosis to the bacteria instead [133]. 
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 Anaplasma 
marginale 
Anaplasma 
phagocytophilum 
Ehrlichia 
chaffeensis 
Rickettsia  Orientia 
tsutsugamushi 
Wolbachia 
VERO 
Epithelial 
[88]  [136] [137] [138]  
THP1 
Monocyte 
 [139] [122]    
C636 
A albopictus 
[140] [140] [140]   [141] 
Aa23 
A albopictus 
[142]   [143]  [144]     
RF/6A 
Endothelial 
[145] [146] [140] [147]   
PTK2 
Epithelial 
      
DH82 
Macrophage 
  [148]    
ISE6 
Tick 
 [149] [150]  [151] [23]   
Trombiculid 
Mite 
    [152]  
U937 
Monocyte 
  [153]     
HL-60 
Promyeloblast 
 [98]     
HMEC-1 
Human 
Endothelial 
 [97]  [154]   
BCE C/D 
Cow 
Endothelial 
[145] [145]     
L929 
Fibroblast 
  [136] [155] [138] [156] 
Erythrocytes [157]      
Leukocytes  [88]     
Neutrophils  [97] [158]    
Eosinophils  [97]     
 
Table 2. Summary of cell tropism of Rickettsiales species in vivo and in vitro. 
 
 
  
    = in vitro growth 
    = in vivo 
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1.5. Peptidoglycan 
 
1.5.a. The bacterial cell envelope 
Bacteria are surrounded by a cell envelope. In Gram positive bacteria, this consists of an inner 
lipid membrane with a rigid cell wall. However, Gram negative bacteria also have an outer lipid 
membrane which surrounds the periplasm [159].  Peptidoglycan, also known as murein, is an 
essential component of the cell wall of most bacterial species. It is located outside the plasma 
membrane and its structure can help to differentiate Gram negative and Gram-positive bacteria 
by the Gram-staining method. Gram positive bacteria have multiple sheets of peptidoglycan in 
their cell wall whereas Gram negative bacteria have only a few layers in the periplasm which is 
protected by the outer membrane [160].  
Bacteria have many important components in their cell envelope. The surface layer, or S-layer, is 
found on the surface of most bacteria and is composed of a hexagonal lattice of identical subunits 
of glycoproteins known as surface layer proteins (SLPs). These contain some of the most 
abundant proteins of the bacteria and the biogenesis of these proteins takes up most of the cell’s 
metabolic sources [161]. In Gram positive bacteria, the S-layer attaches to the peptidoglycan 
whereas in Gram negative bacteria, the S-layer attaches directly to the components of the outer 
membrane, such as the LPS [162].  The S-layer has pores which are thought to act like a 
molecular sieve and can contribute to virulence. In R. typhi and R. prowazekii, proteins of the S-
layer act as immunogens and are potential vaccine targets [163].  
Lipopolysaccharide (LPS) makes up the outer leaflet of the outer membrane in Gram-negative 
bacteria. LPS is a large macromolecule and is made up of hydrophobic and toxic lipid A, the 
hydrophilic core polysaccharide and a repeating hydrophilic o-antigenic polysaccharide side 
chain. The LPS is immuno-stimulatory and is anchored to the outer membrane by lipid A [164]. 
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Like peptidoglycan, LPS is assembled at the plasma or inner membrane. As a pathogen 
associated molecular pattern (PAMP), Lipid A is responsible for the toxicity of the bacteria, as 
lysed LPS fragments of bacteria are recognised by host Toll-like receptor 4 which may lead to 
diarrhea, fever and septic shock. LPS is essential to the structural integrity of the cell wall and 
increases the negative charge of the structure to the phosphate groups at its base. LPS also 
provides protection against chemical attacks and certain antibiotics [165].  
 
1.5.b. The role of peptidoglycan 
Peptidoglycan has 3 major roles in bacteria. These roles are growth, division and providing 
protection from osmotic pressure [166]. 
Peptidoglycan is needed for cell growth and division to occur. Although its biosynthesis is similar 
in all bacteria, its regulation determines the bacterial cell shape [1] [167]. Peptidoglycan synthesis 
occurs at the septum and the lateral wall, serving as a scaffold for components of the cell 
envelope, such as proteins and teichoic acids. The peptidoglycan synthesis machine in these 
locations interact with the cytoskeletal proteins MreB and FtsZ [168].  
Cell division is a tightly coordinated event in bacteria. Peptidoglycan interacts with the bacterial 
tubulin protein, FtsZ. This GTPase protein polymerises into single stranded filaments which form 
the z ring at mid cell. This ring marks the future site of division at the septum and is maintained 
by the treadmilling of FtsZ polymerisation. The speed of treadmilling regulates the rate of 
peptidoglycan synthesis and cell division, which differs among bacterial species [169]. FtsZ 
recruits the divisome, a large protein complex, and with the help of septal transpeptidase penicillin 
binding proteins and amidases, the bacterial cell can divide into two daughter cells. The septa 
then becomes the old poles of the bacteria and peptidoglycan is unable to be synthesised there 
[170].  
56 
 
MreB regulates new peptidoglycan insertion to allow the cell wall to expand for growth. The actin 
homolog MreB forms filaments which localise to the outer cell wall in distinct patches, of most rod-
shaped bacteria. During elongation, MreB interacts with components of the cell wall synthesis 
machinery, such as class A penicillin binding proteins, PBP1A and PBP2 [166] [171]. MreB may 
also form complexes with the precursor proteins such as MurA-MurG and MraY. As well as 
controlling peptidoglycan synthesis, MreB is also involved in the determination of cell shape as it 
has been shown to interact with integral membrane protein RodA and RodZ [172].  
MreB was thought to exist as a helical filament around the periphery of the cell but due to 
advancements in microscopy (deconvolution microscopy or total internal reflection fluorescence 
microscopy, TIRFM), recent research presents MreB as rotating around the long axis of the cell 
in a bidirectional manner [173]. This rotation may depend on the presence of peptidoglycan 
synthesis machinery [174]. When MreB is inhibited, the cell wall may grow but the diameter is no 
longer regulated.   
Lastly peptidoglycan maintains the turgidity of the cell and balances the internal osmotic pressure 
[175]. A decrease in external osmotic pressure causes water influx which may lead to lysis [176]. 
The peptidoglycan structure provides the mechanical strength to resist high intracellular turgor.  
Peptidoglycan in bacteria can also be responsible for its destruction. It is recognised by the host 
as a pathogen-associated molecule pattern molecule (PAMP), alerting innate immune cells 
through Toll-like receptors to invading pathogens [177]. This is particularly dangerous to obligate 
intracellular bacteria such as the Rickettsiales, some of which exist free in the cytoplasm. This 
may explain why many of these bacteria have very little or lack completely peptidoglycan. The 
presence of peptidoglycan is also used as a drug target. Beta-lactam antibiotics such as penicillin 
binds with penicillin binding proteins (DD-transpeptidases) to hinder the production of new 
peptidoglycan. Lysozyme, naturally found in the innate immune system, is able to hydrolyse the 
1,4 beta glycosidic bond between polysaccharide residues [178]. 
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1.5.c. The structure of peptidoglycan 
Peptidoglycan is composed of linear glycan sheets, cross-linked by short peptides. The glycan 
strands consist of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) 
residues which are linked by 1,4 beta glycoside bond [166] (Figure 6). Attached to MurNac are 
short peptide side chains, consisting of L-alanine, D-glutamate, meso-diaminopimelic acid 
(mesoDAP) and two D-alanines.  MurNac, an unusual sugar, mesoDAP and the D-amino acids, 
are unique to the bacterial cell wall. However the structure of peptidoglycan such as the 
organization of the length of the glycan chains and the order of the amino acids in the peptide 
chain can vary among bacterial species [1, 179].  
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Figure 6. The molecular structure of a monomer subunit of peptidoglycan. 
The disaccharide back bone of lipid II is made up of N-acetylglucosamine (GlcNAc) and N-acetylmuramic (MurNAc) 
linked by a ꞵ-1,4 glycosidic bond. In Gram negative bacteria, the peptide chain at position 3 is meso-diaminopimelic 
acid but L-lysine in Gram positive bacteria. [180] 
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Peptidoglycan synthesis begins in the cytoplasm of the bacteria, where UDP-MurNac and the   
pentapeptide is produced, aided by enzymes in the Mur pathway and Ddl ligase. This precursor 
is ligated to undecaprenyl polyprenyl phosphate (C55PP) a universal carrier lipid, by MraY, which 
results in the formation of Lipid I. Now in the bacterial membrane, lipid I progresses to lipid II by 
the addition of a GlcNac residue which is catalyzed by MurG. This lipid precursor can then be 
transported over the inner membrane by flippase for the final steps of peptidoglycan synthesis. 
Lipid II can then be polymerised into the glycan strands by a transglycosylation reaction due to 
the glycosyltransferase activity of PBPs [181]. The polysaccharide strands which result from this 
transglycosylation are covalently linked by the transpeptidation activity of PBPs. This leaves a 
peptide bond which is able to crosslink between the glycan strands. This crosslinkage occurs 
between mesoDAP and D-alanine in Orientia, by DD-transpeptidases  [166, 182].  
 
1.5.d. Penicillin Binding Proteins (PBPs) 
Penicillin binding proteins are named after the enzymes which bind to the antibiotic, as found by 
Alexander Fleming in 1928, who noticed penicillium growing on his bacterial culture plates. As it 
can mimic the ligands for enzymes which are crucial for peptidoglycan synthesis, the binding of 
penicillin prevents growth of bacteria. The beta-lactam ring of penicillin is able to covalently bind 
to active site serine residue of DD-transpeptidase PBPs, blocking the active site by acylation. 
Bacteria have developed resistance to the behavior of beta-lactam antibiotics by producing beta-
lactamase. By hydrolysis of the cyclic amide bond, beta-lactamase inactivates the beta-lactam 
ring [183] [184].   
PBPs exhibit two activities in peptidoglycan synthesis. They may catalyse the polymerization of 
the glycan strands in a transglycosylation reaction, between GlcNAc and MurNAc groups. The 
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second activity is the crosslinking of the peptide chains between glycan strands in a 
transpeptidation reaction [184]. The transpeptidase must recognize the terminal double d-Ala 
residue of the peptide chain and catalyse the reaction between the carbonyl group of d-Ala and 
the adjacent amino at position 3 of the alternate peptide chain to create the new amide bond, 
which is most likely to be mesoDAP. These links are the targets of β-lactams. This DD-
transpeptidase D-Ala4-mesoDAP3 crosslink is common among bacterial species but can alter 
depending on the bacterial species due to structural variation in their peptidoglycan structure. Β-
lactams can mimic the double D-alanine residues on the peptide chain and inactivate the DD-
transpeptidase completely.  The reverse of these activities may also be carried out through 
endopeptidation and transpeptidation [185].  
However, crosslinks can also form between the 3rd residues of the peptide chains by LD-
transpeptidase activity. These crosslinks are not generated by PBPs but are catalysed by LD-
transpeptidases instead, between the two mesoDAP residues. These LD-transpeptidases have 
been identified as the main crosslinking enzyme in Gram positive and negative bacteria such as 
Enterococcus faecium, Mycobacterium tuberculosis, Clostridium difficile and E. coli [186] [187] 
[188]. Also, structurally different, instead of a serine active site, LD-transpeptidases utilise a 
cysteine active site and the crosslink created is therefore resistant to β-lactams. There have been 
reports of antibiotics from the carbapenem class such as imipenem having an effect on the LD-
transpeptidases, so bacterial species such as drug-resistant strains of Mycobacterium 
tuberculosis may be treated [189]. LD-transpeptidases are also able to transfer Braun’s lipoprotein 
on to mesoDAP [190].  
Penicillin binding proteins are divided into two classes based on their molecular mass by SDS-
PAGE results based on E.coli [185]:  high and low molecular mass. High molecular mass PBPs 
are divided into class A and class B. Class A PBPs are bifunctional, as they possess an 
extracellular domain which confers glycosyltranferase 51 activity and a c-terminal domain which 
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catalyses transpeptidation activity. To achieve both activities, the class A PBPs interact with two 
conserved machines, the Rod complex and the divisome [191]. 
Class A have 7 subclasses: A1-A2 consist of Gram-negative PBPs, A3-A5 for Gram-positive. A6 
are PBPs which are unusual as they are not necessarily needed. Class B PBPs on the other 
hand, are only monofunctional, catalyzing the transpeptidation reaction between the peptide 
chains as they consist of a C-terminal transpeptidase penicillin binding domain. The N-terminal 
does not have any catalytic activity and is thought to interact with proteins involved in the cell 
cycle. Class B have 5 subclasses and are vital for resistance against beta-lactam drugs [192].  
Low molecular mass PBPs consist of just 1 group, C (c1, c2 and c3). They have a penicillin binding 
domain and may also have either DD-carboxypeptidase or DD-endopeptidase activity.  
Orientia does not have the genes which encode class A PBPs, which is the PBP normally 
responsible for glycosyltransferase activity. The glycan chains of the peptidoglycan must be 
polymerised through another enzymatic activity. This is also the case for Wolbachia, as 
researchers have hypothesized that a classic peptidoglycan structure is not present but 
unpolymerised lipid 2 precursors may instead form a peptidoglycan-like structure [193].   
 
1.5.e. Peptidoglycan and SEDS 
Peptidoglycan synthesis requires the coordination of multi-protein complexes. The Rod complex, 
also known as the elongasome, drives cell elongation by moving in a circumferential manner 
around the cell axis and is dependent on peptidoglycan synthesis. The divisome synthesizes 
peptidoglycan during cytokinesis. Both the ROD and the divisome interact with PBPs during 
peptidoglycan synthesis. They also interact with the RodA/FtsW proteins from the SEDS family 
(shape, elongation, division and sporulation) during lipid II exportation and interact with Mra/Mur 
proteins for lipid II synthesis [181] [194] 
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RodA and FtsW are integral membrane proteins, responsible for cell growth and cell division 
respectively [195]. There is recent evidence suggesting that the SEDS proteins might perform 
glycosyltransferase activity, since they are structurally similar to membrane anchored 
glycosyltransferases [181]. This indicates they may interact with monofunctional transpeptidases 
such as Ftsl (PBP3) and PBP2. By fluorescence colocalization microscopy it is known that FtsW 
interacts with Ftsl at the septum and RodA interacts with PBP2 along the cell body [196] [195]. 
These partnerships would act as bifunctional PBPs. Some bacterial species are known to be 
missing class A PBPs such as Orientia, Wolbachia and Chlamydia, so a SEDS-class B PBPs 
partnership could explain how these bacterial species polymerise their glycan chains [197].  
 
1.3.f. Immune response to peptidoglycan  
As a PAMP, peptidoglycan is recognised by the host immune system. Bacteria activate the innate 
immune response upon entry into host cells. This involves recognition by intracellular nucleotide-
binding oligomerisation domain containing proteins (NOD) 1 and 2 [198]. Also, pyrin domain-
containing 3 (NLRP3) and peptidoglycan recognition protein 1 (PGLYRP1) and toll-receptor 2 are 
activated [199]. These all trigger inflammatory responses in the host. 
The nucleotide-binding oligomerisation domain (NOD) proteins NOD1 and NOD2, the founding 
members of the intracellular NOD-like receptor family, sense conserved motifs in bacterial cell 
wall peptidoglycan and induce pro-inflammatory and antimicrobial responses [198]. NOD1 
receptor recognises peptidoglycan containing meso-diaminopimelic acid (mesoDAP) which is 
unique to Gram negative bacteria [200]. NOD1 has the ability to activate downstream signalling 
such as mitogen activating kinases which leads to inflammation due to pro-inflammatory cytokines 
such as IL-32 in Orientia [201]. This induces a whole host of other cytokines [202].  NOD2 
recognises muramyl dipeptide (MDP) which subsequently activates NF-κB and MAPK pathways 
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in the host cells, leading to the up-regulation of transcription of pro-inflammatory genes [200] 
[203].  
The secretion of IL-32 is significant because it is found in epithelial cells and regulates (with IL-β) 
the cells inflammation by influencing the expression of cellular adhesion molecules 1 (ICAM-1) 
outside the cell. When an endothelial cell becomes infected, IL-1 and TNFα are released and 
upregulate ICAM-1 as well as p-selectin, e-selectin and VCAM-1. This all promotes cellular influx 
and IL-6 and IL-8 initiate the inflammatory response.  Therefore, the NOD1-IL-32 pathway is a 
modulator of the immune response in endothelial cells to Orientia. After being infected with the 
bacteria, the immune response consists of inflammatory cytokines such as TNF-α IL-1β and IL-6 
which cause high fever and then become reduced after antibiotic treatment [201].  
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Chapter 2 
Materials and Methods 
 
2.1 Eukaryotic cell culture 
For all Orientia experiments, L929 mouse fibroblast cells were used. Mouse fibroblast L929 cells 
(ATCC CCL-1), were provided by Prof Stuart Blacksell at the Mahidol Oxford Tropical Research 
Unit in Bangkok, Thailand. L929 cells were grown in RPMI 1640 Medium with HEPES (Thermo 
Fisher Scientific, 22-400-071, USA) supplemented with 10% heat inactivated FBS (Thermo Fisher 
Scientific, 16140071, USA) in 25cm2 flasks at 35°C and 5% CO2.  
Kidney epithelial Vero cells (ATCC CCL-81) were provided by Dr Nancy Connell at PHRI, Rutgers, 
New Jersey, USA. Vero cells were grown in RPMI 1640 Medium with HEPES, supplemented with 
10% heat inactivated FBS in 25cm2 flasks at 37°C and 5% CO2. 
HEK-Blue™ hNOD1 (Invivogen, chkb-hnod1, USA) cells were taken from human embryonic 
kidney cells. These cells were grown in 25cm2 flasks with growth medium DMEM (Thermo Fisher 
Scientific, 21013, USA) with 4.5 g/l glucose, 10% fetal bovine serum, 100 U/ml penicillin, 100 
mg/ml streptomycin, 100 mg/ml Normocin™ and 2 mM L-glutamine. Selective antibiotics, 30 
µg/ml of blasticidin and 100 µg/ml of Zeocin™ were added after passage 2 to maintain the cell 
line.  
Macrophage-like DH82 cells (ATCC CRL-10389) were grown in 25cm2 flasks with Eagle's 
Minimum Essential Medium (EMEM) (Sigma, M0325, USA) with 10% heat inactivated FBS at 
37°C and 5% CO2. 
Human leukemia HL-60 cells (ATCC CCL-240) were grown in 25cm2 flasks with Iscove's Modified 
Dulbecco's Medium (IMDM) (ATCC 30-2005) with 10% heat inactivated FBS at 37°C and 5% 
CO2. 
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Aedes albopictus clone C6/36 cells (ATCC CRL-1660) were grown in 25cm2 flasks with Eagle's 
Minimum Essential Medium (EMEM) (Sigma, M0325, USA) with 10% heat inactivated FBS at 
28°C and 5% CO2. 
Cell lines were cultured every two or three days and seeded on slides for infection for fixed 
imaging two days previous and for live imaging, one day previously.  
 
2.2 Bacterial propagation 
The Karp-like strain UT76 was used for all Orientia experiments. Bacteria were grown in L929 
cells in 25cm2 flasks at 35°C and 5% CO2 using RPMI 1640 Medium with HEPES and 10% FBS. 
Bacteria were taken from day 7 infections inside host cells. This involved scraping host cells and 
lysing them by force using a bullet blender (NextAdvance, USA) at power 8 for 1 minute. The host 
cell debris was removed by spinning bacteria suspension at 400rcf for 5 minutes. Bacteria were 
then filtered through a 2.0μm membrane filter and spun down at 14500rpm for 5 minutes to be 
resuspended into fresh media or buffer. The full protocol can be found here [138].  
R. canadensis, A. marginale, Wolbachia, A. phagocytophilum and E. chaffeensis were isolated 3-
7 days’ post infection from 6 well plates in 37°C or 28°C (only C6/36 cells) and 5% CO2. R. 
canadensis were taken from intracellular host cells by lysing scrapped host cells with 0.2mm 
beads (Thomas scientific, 11079101, USA) for 1 minute by vortex, using the same protocol as 
previously documented for Orientia. Host cell debris was removed by spinning bacteria 
suspension at 400rcf for 5 minutes.  
A. marginale, Wolbachia, A. phagocytophilum and E. chaffeensis bacteria were taken from 
extracellular media. This was pelleted at 145000rpm, with the media then discarded. The bacterial 
pellet was then resuspended in culture media.  
E. coli and B. subtilus were grown in LB media at 37°C and 5% CO2 until log phase was reached. 
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2.3 Immunofluorescence labelling  
Cells were fixed with 4% paraformaldehyde (PFA) (Thermo Fisher Scientific, 28906, USA) for 10 
minutes at room temperature. Other concentrations of paraformaldehyde were not used or tested. 
After fixation, slides were washed with 3X PBS and then permeabilised with 0.5% triton X100 
(Sigma, X100, USA) for 10 minutes. After additional washes with PBS, the primary antibody was 
added to cells (dilution dependent on the antibody) for 30 minutes at 37°C and 5% CO2.   Excess 
primary antibody was washed off with 3X PBS wash and a corresponding fluorescent secondary 
antibody was added for 30 minutes at 37°C and 5% CO2.  Finally, after a 3X PBS wash, cell were 
coated with VECTASHIELD® Antifade Mounting Medium with DAPI (Vector Laboratories, H-
1200, USA) or Hoechst (Thermo Fisher Scientific, 1399, USA) at 1 µg/ml was added to cells for 
10 minutes at room temperature before the addition of mounting media.  
 
2.4 CFSE/CellTrace FarRed labelling 
CFSE (Thermo Fisher Scientific, C34554, USA) and CellTrace FarRed (Thermo Fisher Scientific, 
C34572, USA) were dissolved in DMSO in 5µM aliquots and stored at -20°C. One aliquot was 
thawed at room temperature and then diluted to 5µM in PBS with 2% Invitrogen™ UltraPure BSA 
(Invitrogen, AM2616, USA). Purified bacteria were taken from lysed host cells and centrifuged at 
14500rpm for 5 minutes at room temperature. Bacteria were then resuspended in the 5µM dye 
solution for 15 minutes at 37°C and 5% CO2 or 15 minutes at room temperature, in the dark. 
Bacteria were then centrifuged at 14500rpm for 5 minutes at room temperature twice to remove 
residual dye. After washes, bacteria were finally resuspended in media containing 10% FBS and 
left for 20-30 minutes to allow the dye to quench before live imaging.  
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2.5 CFSE quantification 
CFSE-labelled bacteria were added to L929 cells seeded on to Ibidi chamber slides (Ibidi, USA). 
Bacterial infection was imaged every day over 7 days by confocal microscopy, using the same 
laser strength and parameters for FITC imaging each time. However, as a comparison, the FITC 
strength was also increased to show weakly labelled bacteria. Alongside this, CFSE-labelled 
Orientia were also kept at 37°C in culture media in an Ibidi slide also, with no host cells. This was 
imaged once a day for 7 days also.   
CFSE labelling over time was quantified using ImageJ [204]. For each time-point, 10 bacteria 
were chosen at random and the brightest pixel in each bacterium was documented for intensity. 
The intensity figures were plotted on GraphPad Prism (GraphPad Software, La Jolla California 
USA, www.graphpad.com). This experiment was completed more than three times and every 
result presented the same conclusion.  
 
2.6 Syto9 labelling 
Syto9 (Invitrogen, S34854, USA) was dissolved in DMSO in 5µl aliquots at 5μm, stored in 20°C.  
The dye was added to media at 5nM and added to infected host cells. The dye was incubated for 
20-30mins at 37°C to allow sufficient labelling. Following this, the media plus the dye was washed 
off host cells and fresh media was added before confocal imaging.  
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2.7 HADA/HALA labelling 
HADA/HALA were kept in aliquots at -20°C and was added to isolated bacteria in fresh culture 
media at 1mM. Bacteria were incubated at 37°C and 5% CO2 for 3 hours and then washed with 
3X PBS.  Bacteria were then imaged live by confocal microscopy or fixed with 4% PFA for 10 
minutes at room temperature.  
 
2.8 Vybrant labelling 
Vybrant dyes, DID, DIO and DIL (LifeTechnologies, V22889, USA) were used to label isolated 
bacteria. Dyes were kept in aliquots at 4°C and used at a final concentration of 100µM to label 
bacteria in 100µl of Opti-MEM buffer (ThermoFisher Scientific, 31985062, UK). Bacteria were 
incubated with the dye at 37°C for 30 minutes. After, bacteria were pelleted at 14500rpm to wash 
off residual dye and washed in 2X PBS. Following the final wash, bacteria were resuspended in 
culture media and then added to host cells for infection and imaging.  
 
2.9 Click chemistry 
The azide or alkyne probe was added to infected cells for a specific duration of time. Following 
this, cells were fixed with 4% PFA for 10 minutes at room temperature. After fixation, cells were 
washed with 3X PBS and permeabilised with 0.5% triton X100 for 10 minutes. Click chemistry 
was performed using the Click-iT™ Cell Reaction Buffer Kit (Invitrogen, C10269, USA) with an 
azide or alkyne Alexa Fluor 488/594 (AF 594 Alkyne, 1297-1 or AF 488 Picolyl Azide 1276-5, 
Click Chemistry Tools, USA) for 1 hour in the dark. After 3X PBS washes, cells were either further 
labelled with antibodies or Hoechst.  
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2.10 EDA/EDA-DA labelling 
EDA (Alfa Aesar, H65798, USA) and EDA-DA (produced in-house by Professor Arkady Mustaev) 
were diluted in water and used at 1mM. Probes were added to infected host cells and incubated 
for various times at 37°C and 5% CO2 and washed with 3X PBS to then be fixed with 4% PFA for 
10 minutes. Incubation times for each species were: B. subtilus and E. coli for 10 minutes, R. 
canadensis for 30 minutes, A. marginale, A. phagocytophilum, Orientia, Wolbachia and Ehrlichia 
for 4 hours. In drug sensitivity assays, EDA and drug were added simultaneously for the same 
duration of time. After fixation, click chemistry was performed. For Orientia imaging, antibody 
labelling using TSA56 followed click labelling, with the secondary antibody, goat anti-Rat IgG 
(H+L) Cross-Absorbed Secondary Antibody, Alexa Fluor 594 (Thermo Fisher Scientific, A-11007, 
USA).  Hoechst at 1 µg/ml was added to cells for 10 minutes at room temperature before imaging.  
 
2.11 RNA FISH labelling 
Infection was fixed at certain time-points with 4% PFA. After washing with 3X PBS, 70% of ethanol 
was added to cells and incubated for 1 hour on ice. Cells were then washed twice with PBS and 
permeabilised with 0.5% triton X100 for 30 minutes on ice. Cells were washed 2X PBS and 
1mg/ml lysozyme in TE buffer was then added for 1 hour at room temperature. BSA (Invitrogen, 
AM2616, USA).) blocking was then carried at 1mg/ml in PBS for 30 minutes at room temperature. 
After another PBS wash, 2x UltraPure SSC (Thermo Fisher Scienfitic,15-557-044, USA) plus 10% 
formamide (Sigma, S4117, USA) was added for 1 minute to equilibrate cells. The 16s probe 
(produced by Suparat Giengham) was produced from 33 oligo sequences of the 16s gene. The 
prob was used at 1ng/µl and diluted in hybridisation buffer (produced in-house), containing 10% 
dextran sulfate (Sigma, 265152, USA), 2 mM vanadyl-ribonucleoside complex (Sigma, 94742, 
USA), 0.02% RNAse-free BSA (Sigma, A9647, USA), 50 µg E. coli tRNA (Sigma, 10109541001, 
USA), 2x UltraPure SSC (Thermo Fisher Scienfitic,15-557-044, USA) and 10% formamide 
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(Sigma, S4117, USA).  This was added to cells for 5-6 hours at 50°C and was then further 
incubated at 37°C overnight. Cell were then incubated with 2x UltraPure SSC with 10% formamide 
for 5 minutes with gentle shaking, twice. In between incubations, cells were washed with 2x 
UltraPure SSC. DNA was labelled with 0.1ug/ml Hoechst, for 10 minutes at room temperature. 
After 3X PBS washing, mounting media was added to the slide for imaging by confocal 
microscopy. 
 
2.12 Methionine labelling 
Probes Click-IT™ L-Homopropargylglycine (HPG) (Thermo Fisher Scientific, C10186, USA) or L-
Azidohomoalanine (Click Chemistry Tools, 1066-25, USA) were added to live bacterial infections 
at 50µM, in methionine free DMEM culture media (Thermo Fisher Scientific, 21013024, USA). 
After 30 minutes, the probe and culture media were discarded, and the cells were fixed with 4% 
PFA for 10 minutes at room temperature. After permeabilisation with 0.5% triton X100 for 10 
minutes, click chemistry was performed. Following this, further labelling may have been carried 
ut such as the addition of antibodies for confocal imaging. 
 
2.13 Hot Shot DNA Extraction 
Lysis buffer (25mM NaOH, 0.2mM EDTA) was added to cells. Cells were then placed in safe-lock 
1.5ml tubes (VWR, 20901-547, USA) and placed in 90°C for 30 minutes. Neutralisation buffer 
(40mM Tris-HCI in ddH2O) was then added to cells, in the equal volume at which lysis buffer was 
added. 1µl of this volume was added to qPCR. 
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2.14 Quantification by qPCR  
Orientia bacteria growth was tested by quantitative real time PCR. Labelled bacteria or mock 
treated bacteria were grown in 24 well plates (BC017, Corning USA) seeded with mammalian 
host cells in 1.9cm2 wells. Each condition was done in triplicate. The plate was washed after 3 
hours to remove extracellular bacteria. After 7 days of growth at 37°C and 5% CO2 bacterial DNA 
was isolated using the hot-shot extraction method. The genome copy number was quantified 
using the TSA47 gene by qPCR using primers, F = TCCAGAATTAAATGAGAATTTAGGAC, R = 
TTAGTAATTACATCTCCAGGAGCAA and probe = TTCCACATTGTGCTGCAGATCCTTC.  
 
Other Rickettsiales species were grown in various cell lines seeded on 96 well plates (VWR, 
25382-342, USA). Bacteria were extracted from host cells using the hot-shot DNA extraction 
method, at multiple time-points. Growth was measured by qPCR using the 16s gene using 
primers, F = CGGTGAATACGTTCTCGG, R = AAGGAGGTAATCCAGCCGCA and probe = 
CTTGTACACACCGCCCGTC. 
qPCR was performed using a Bio-Rad machine and Multiplate™ 96-Well PCR Plates (Bio-Rad, 
MLL9601, USA).  
 
2.15 Mass spectrometry 
Mass spectrometry was performed on lysed bacteria, which were taken from infected L929 host 
cells after 7 days. Bacteria were purified by lysing host cells by mechanical lysis and then filtered 
through a 2µm filter. Bacteria were pelted at 14500rpm and washed several times using 600ul of 
ice-cold 300mM sucrose. After removing supernatant, the bacterial pellet was autoclaved and 
then hydrolysed with 4M HCl at 100°C for 16 hours. The amino acids were transformed into 
volatile N-heptafluorobutyryl-isobutylester derivatives using Protocol 10 of Schumann [205]. The 
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samples were then analysed by GC/MS (320 Singlequad, Varian) and diaminopimelic acid was 
identified as a gas chromatographic peak with a retention time of 22.2 min and a set of fragment 
ions at 380, 324, 306 and 278 m/z.  
 
2.16 Gene expression of Orientia by qRT-PCR 
L929 host cells were infected with UT76. At each time-point over the course of 7 days, infected 
cells were placed on ice and quickly resuspended in RNAProtect Bacteria Reagent (Qiagen, 
76506, USA) and kept at -80°C. RNA extraction was carried out using Qiagen RNeasy Plus kit 
(Qiagen, 74136, USA), as recommended by the manufacturer’s instructions. Purified RNA at 
10µg, was treated with DNaseI (Thermo Fisher Scientific, AM2238, USA) at 37°C for 30–60 min. 
DNaseI-treated RNA was then converted to cDNA using the iScript reverse transcription supermix 
(Biorad,170–8841, USA) with random primers. A reverse transcriptase-free control reaction was 
performed to verify no genomic DNA remained to contaminate the RNA sample. cDNA was then 
stored at -20°C until used as a template for qPCR, using gene specific primers for mipZ, murA, 
murD, murF, ddl and pbp2. qPCR was carried out using the SYBR green qPCR mix (Biotools, 
Houston, USA, catalog number 10.609) and housekeeping gene mipz normalised expression 
levels. 
 
 
2.17 Drug sensitivity  
 
UT76 were grown in 24 well plates seeded with L929 cells. Various drugs were added to the plate 
after infection apart from lysozyme and mutanolysin which cannot enter mammalian cells. For 
lysozyme treatment, bacteria were resuspended in SPG with and without lysozyme, for 15 
minutes at 37°C before being added to L929 cells. For mutanolysin treatment, bacteria were 
resuspended in media with and without mutanolysin for 15 minutes at 37°C before being added 
to L929 cells.  Growth was detected after 7 days by quantification of bacteria by qPCR. Alongside 
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this, bacteria were infected in L929 cells seeded on Ibidi chamber slides (Ibidi, USA) and treated 
with drugs for 24 hours.  
All other Rickettsiales species were grown in 96 well plates in various cell lines. Drugs 
chloramphenicol, penicillin, phosphomycin and d-cycloserine were added to cells 1 hour after 
infection. Growth of bacteria were measured by qPCR 4 days after infection. Only phosphomycin 
was added to infected Ibidi slides for imaging. 
The drug concentrations used were: chloramphenicol 100 ug/ml; penicillin G 150 ug/ml; D-
cycloserine 250 ug/ml; phosphomycin 40 ug/ml; EDTA 1 mM, lysozyme 5 ug/ml; mutanolysin 80 
ug/ml; imipenem 10 ug/ml; meropenem 10 ug/ml; mecillinam 2 mg/ml; tazobactam 100 ug/ml.  
 
2.18 Western blot analysis 
Infected or uninfected L929 cells were mechanically lysed in a Bullet Blender (Next Advance, 
USA), at power 8 for 1 min. Cells were pelleted, washed with PBS 1/2 times and resuspended in 
a small volume of PBS. The protein concentration was measured by nanodrop analysis and the 
sample volume was adjusted to guarantee equal loading. Samples were mixed with SDS-PAGE 
buffer with or without 20% ß-mercaptoethanol (Sigma, M6250, USA) and samples were then 
loaded on 12% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad, 4561043, USA). Monoclonal 
antibody TSA56 was used to compare western blots and probed with secondary antibody 
conjugated with alkaline phosphatase (Promega, S3831, USA). Western blot was developed 
using an alkaline phosphatase detection kit (Promega, USA, catalog number S3841). 
 
 
2.19 DTT treatment of Orientia 
Bacteria were purified from infected cells and then resuspended in cell culture media with and 
without 1mM DTT. Bacteria were incubated at room temperature for 20 minutes and then pelleted 
and washed twice before being resuspended in fresh cell culture media. Bacteria were then added 
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to L929 cells seeded on Ibidi slides (Ibidi, USA) for 24 hours. After infection time had passed, 
cells were fixed with 4% PFA and after antibody labelling, bacterial quantification was performed 
in 100 host cells manually to estimate infection numbers. 
 
2.20 NOD1 activation in Hek blue cells 
Hek-blue hNod1 (Invivogen, hkb-hnod1, USA) were grown in growth medium DMEM with 4.5 g/l 
glucose, 10% heat inactived fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin, 100 
mg/ml Normocin™ and 2 mM L-glutamine, plus selective antibiotics 30 µg/ml of blasticidin and 
100 µg/ml of Zeocin.  Cells were seeded on clear bottom black 96 well plates (Corning, 29444-
008, USA) 2 days before infection. Bacteria were taken from prepared aliquots kept at -80°C in 
sucrose phosphate glutamine (SPG). All bacteria were heat inactivated at 90°C for 30 minutes 
before being added to host cells. All infections were carried out in triplicate. After 3 days of 
infection, growth media was replaced with HEK-blue detection media (Invivogen, hb-det2, USA) 
for SEAP detection.  The plate was further incubated at 37°C and 5% CO2 and quantified by 
spectrophotometry (Synergy H1, Biotek) at 640nm from 6 hours of the addition of detection media. 
Results were added to GraphPad Prism (GraphPad Software, San Diego California USA) and a 
T-test was performed to compare bacterial SEAP levels to positive control E. coli.  
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2.21 Sensitivity of the cell wall to lysozyme and mutanolysin  
A methionine probe, Click-IT™ L-Homopropargylglycine (HPG) (Thermo Fisher Scientific, 
C10186, USA was added to infected host cells for 30 minutes. Bacteria were then isolated from 
host cells and resuspended in sucrose phosphate glutamine (SPG) with and without 5µg/ml 
lysozyme and 5µg/ml mutanolysin. Bacteria were treated for 10 minutes at 37°C. After this time, 
bacteria were pelleted at 14500rpm and then resuspended in 10ul of PBS which was added to 12 
well glass slides. This was dried and then fixed with 4% paraformaldehyde (PFA) for 10 minutes 
at room temperature and then permeabilised with 0.5% triton X100 for 10 minutes. Bacterial 
labelling was completed with click chemistry labelling with the Invitrogen™ Molecular Probes™ 
Click-iT™ Cell Reaction Buffer Kit (C10269, Thermofisher, USA) including AF 488 Picolyl Azide 
(1276-5, Click Chemistry Tools, USA) for 1 hour at room temperature in the dark. Hoechst at 1 
µg/ml was added to cells for 10 minutes at room temperature and the slide was then imaged by 
confocal microcopy.  
 
 
2.22 Sensitivity of the cell wall to osmotic pressure  
A methionine probe, Click-IT™ L-Homopropargylglycine (HPG) (Thermo Fisher Scientific, 
C10186, USA was added to infected host cells for 30 minutes. Bacteria were then isolated from 
host cells and resuspended in sucrose phosphate glutamine (SPG), cell culture media RPMI (22-
400-071, Thermo Fisher Scientific, USA) and water. Bacteria were treated for 10 minutes at 37°C. 
After this time, bacteria were pelleted at 14500rpm and then resuspended in 10ul of PBS which 
was added to 12 well glass slides. This was dried and then fixed with 4% paraformaldehyde (PFA) 
for 10 minutes at room temperature and then permeabilised with 0.5% triton X100 for 10 minutes. 
Bacterial labelling was completed with click chemistry labelling with the Invitrogen™ Molecular 
Probes™ Click-iT™ Cell Reaction Buffer Kit (C10269, Thermofisher, USA) including AF 488 
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Picolyl Azide (1276-5, Click Chemistry Tools, USA) for 1 hour at room temperature in the dark. 
Hoechst at 1 µg/ml was added to cells for 10 minutes at room temperature and the slide was then 
imaged by confocal microcopy. 
 
2.23 Phylogenetics 
Rickettsiales tree was constructed by assembling the FtsZ gene of all species into Clustal Omega 
(EMBL-EBI, https://www.ebi.ac.uk/Tools/msa/clustalo/).  
 
2.24 Microscopy 
All imaging was performed using confocal microscopes, Zeiss LSM700 (Thailand) or Lecia DMi8 
(USA). Mounting media for microscopy was produced in-house (20mM Tris, pH 8.0, 0.5% N- 
propyl-gallate and 90% glycerol). 
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Chapter 3 
 
Labelling Orientia tsutsugamushi  
 
Most of this research has been published: Live imaging of the genetically intractable obligate 
intracellular bacteria Orientia tsutsugamushi using a panel of fluorescent dyes, Atwal S, 
Giengkam S, VanNieuwenhze M, Salje J. 2016. J Microbiol Methods 
 
3.1 Introduction 
Due to the current lack of tools for genetic manipulation of Orientia, the use of genomically 
encoded fluorescent proteins for light microscopy of this organism is not possible [206]. Therefore, 
alternative strategies were developed to label Orientia for light microscopy imaging of both fixed 
and live samples. Two approaches were pursued: (i) generating a panel of Orientia-specific 
antibodies and (ii) optimising the use of a range of chemical probes and dyes.  
 
3.1.a General principles of sample preservation for microscopy 
Whether to image in real time or use fixed samples depends on the research question being 
answered. Live imaging allows dynamic cellular processes to be captured in real time, with less 
chance of experimental artifacts associated with fixation. In this case, bacteria can be tracked 
through their infection cycle over time in their native environment. However, this poses many 
problems, such as maintaining cells in their natural physiological state with regulation to pH, 
temperature and osmolality. Additionally, specifically labelling cells and keeping the toxicity to the 
minimum is very difficult over time [207].    
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Conversely, preserving cells using a fixative allows cells to be captured at a certain time point and 
the option of permeabilisation allows large molecules to enter for immunofluorescence labelling. 
IFM allows the detection of protein in cells which are in low abundance. The downside with using 
fixed cells though is that protein conformations tends to change depending on the fixative used 
and artifacts or false labelling is possibly leading to misleading conclusions [208]. 
For immunofluorescence microscopy to be successful, certain stages must be carried out [209]. 
This involves fixation, permeabilisation and labelling. Aldehyde fixatives crosslink proteins 
through free amino groups. Dehydrating and organic fixatives such as alcohols and acetone 
remove lipids and water from the cell resulting in the denaturation of the cellular macromolecules 
[210]. Permeabilisation must occur after aldehyde fixation to allow antibodies reach intracellular 
or intra-organellar antigens. The cell wall must be broken down to allow antibodies to pass 
through, but not completely broken down that the cell wall loses its structure. Triton x-100 is a 
non-ionic detergent with uncharged hydrophilic head groups which disrupts the hydrogen bonding 
in lipid bilayers as it demolishes the integrity of the membrane [211] [212]. 
 
3.1.b Selecting antigens for antibody generation 
Antibodies were generated against surface proteins of Orientia because these would be easy to 
access for large antibodies, and because the main surface proteins of Orientia have been 
identified and are known to play roles in cell entry and immune stimulation. 
Bacterial interactions into nonphagocytic cells is mediated by surface components on the bacteria 
and receptors on the host.  At least 5 major surface antigens of Orientia have been identified from 
patient sera by western blot analysis [36]. Most of their functions are still unknown but most likely 
immunostimulatory and involved in bacterial entry.  
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Monoclonal and polyclonal antibodies can be generated commercially. Polyclonal antibodies 
recognise multiple epitopes on one antigen whereas monoclonal antibodies are more specific, 
detecting one epitope on an antigen. Polyclonal antibodies are produced when a specific antigen 
is injected into an animal and B cells are then activated. These B cells produce the polyclonal 
antibodies specific to the antigen. However, each B cell may respond to a different epitope on the 
antigen so that the resulting antiserum taken from the animal results in a range of antibodies 
which will target not one epitope but multiple. This is less specific but much cheaper to generate. 
To have a more specific antibody, monoclonal antibodies can instead be produced. Monoclonal 
antibodies arise from a specific antigen injected into the animal which produces antibody 
producing B cells. These are fused with myeloma cells resulting in a hybridoma cell line. This cell 
line is capable of unlimited growth and can produce the antibody continually when grown in culture 
[213]. Each culture of the hybridoma will produce the same identical antibody so there is no batch 
to batch variability, keeping experiments consistent. These antibodies are more expensive, but 
results are more consistent [214].  
Antibodies were generated after selecting major surface proteins of Orientia which are implicated 
in their uptake into host cells and infection cycle. 
 
3.1.c. Chemical dyes and probes for labeling cells 
A number of fluorescent dyes and probes have been developed for labeling live and fixed cells. 
These typically target specific biological molecules such as the lipid bilayer, nucleic acids or 
peptidoglycan. Many have not been tested specifically for use in bacteria.  The applicability of a 
range of commercially available dyes for labeling Orientia was tested. 
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A range of labels were tested to evaluate which could be used to image Orientia for live and fixed 
imaging over the course of the infection cycle. Labels which would allow tracking of bacteria at 
entry and during their infection cycle in host cells were chosen.  
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3.2 Labelling Orientia: Objectives 
Objective 1: To generate and test antibodies specific for membrane proteins of Orientia  
 Approach: To commercially generate antibodies for TSA56, TSA47, TSA22 and 
ScaC and test them by western blot analysis and immunofluorescence 
microscopy. 
 Expected outcome: A collection of validated antibodies against specific proteins in 
Orientia. 
 
Objective 2: To develop a toolkit of probes to label specific components of Orientia cells for 
use in live and fixed microscopy imaging 
 Approach: To test the labelling specificity of the probes listed in Table 3 by live and 
fixed imaging and to determine their effect on bacterial viability by growth inhibition 
measurements. The following criteria will be used to assess each probe: simplicity 
of technique, photostability during live imaging, stability of probe, and effect of 
probe on bacterial viability. 
 Expected outcome: a collection of characterized probes with validated protocols 
for labelling Orientia. 
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Table 3. List of probes to be tested in this chapter and their specific targets  
 
 
 
 
 
 
 
 
 
Probe Target 
Carboxyfluorescein succinimidyl ester 
(CFSE/CellTrace FarRed) 
Primary amines (cytoplasmic proteins) 
SYTO9 DNA 
Vybrant DIO, DID, DIL Lipid membranes 
HCC amino D-alanine (HADA) Peptidoglycan 
Clickable Ethynyl-D-alanine (EDA)/ Ethynyl-
D-alanyl-D-alanine (EDA-DA) 
Peptidoglycan 
Clickable methionine   Methionine in proteins 
RNA fluorescence in situ hybridization (RNA 
FISH) 
RNA transcripts 
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3.3 Results  
3.3.a Antibodies 
Polyclonal and monoclonal antibodies were generated against major surface proteins of Orientia: 
TSA56, TSA47, TSA22 and ScaC. Human serum was also taken from patients infected with 
Orientia to use as a positive antibody control.  These were tested by Western blot for specificity 
to surface protein antigens (Figure 7) and then used for immunofluorescence microscopy imaging 
(Figure 8). The antibodies produced against the major surface proteins of Orientia gave varying 
amounts of success. Time courses were completed over the duration of the infection cycle with 
each antibody to understand protein expression. This indicated changes in protein expression at 
different stages during the infection cycle (not included in this thesis). 
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Figure 7. Specificity of antibodies against Orientia 
Coomassie gel (left) and western blot (right) presenting the specificity of the antibodies produced against the 
surface proteins of Orientia. Maltose binding protein (MBP) was used as a protein expression tag and contained 
the peptide sequence for antibody generation and were purified here.  
Work done by Jantana Wongsantichon. 
SN= supernatant, FT = Flow-through, E1/2/3 = Elution number, MBP = pure maltose binding protein. 22, 47, 56 = 
purified peptide from TSA22, TSA47, TSA56 as negative controls.  
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Antibody name Antigen Protein 
sequence or 
Peptide 
Adjuvant Class Vendor Produced in 
TSA56mono TSA56 KLTPPQPTIMPIS
IADRDF - KLH 
 Monoclonal OxFab Rat 
TSA47mono 47kDa KLH - 
TVQRGDRMLYIA
LPNIN 
Keyhole 
Limpet 
Haemocyanin 
(KLH) 
Monoclonal OxFab Rat 
TSA22kDa poly 22kDa KLH - 
LKIKDFLISDDF 
 Polyclonal OxFab Rabbit 
ScaC1 mono ScaC KSITPEKCKYPQ
AEDIYEEDEEDE
EDEEDEEEIADN
DLLNVVSNMNLD
ISDMGEAREGLR
KDIAEVSKLLCLL
EQSTASSKNLTM
RLQQSDIRETEQ
SNYTGLLITEIESI
NKENNDLQQTN
NQLKIKLQQLEV
KLEQALARNTDL
QQI 
LPETRAEMDNL
WKQNEQLKIQLQ
QLQVKLQNLIPL
QNKDGNAALINR
AKLN 
Keyhole 
Limpet 
Haemocyanin 
(KLH) 
Monoclonal GenScript Mouse 
ScaC2 poly ScaC KLH- 
KIQLQQLQVTLQ
NSLFLQNKNNNP
A (JSA) +                                              
KLH - 
IAEVSKLLCMLE 
(JSB) 
Keyhole 
Limpet 
Haemocyanin 
(KLH)
Polyclonal OxFab Rabbit 
Human serum Multiple   Polyclonal  Patients with 
scrub typhus 
 
Table 4. Antibodies made against the surface proteins of Orientia tsutsugamushi. 
Antibodies were produced by OxFabs, UK.  
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3.3.b CFSE 
Bacterial entry is a rapid process. To follow this event, quick imaging is necessary but can be a 
challenge. Carboxyfluorescein succinimidyl ester (CFSE) (The CellTrace™ Cell Proliferation Kits, 
Molecular Probes USA) is a green fluorescent dye. CFSE is cell permeable and reacts with 
cellular proteins via covalent bonds with amine groups. Firstly the molecule carboxyfluorescein 
diacetate succinimidyl ester (CFDA-SE) diffuses into cells [215]. This molecular is lipophilic and 
not fluorescent. Intracellular esterases cleave two acetyl groups which produces the highly 
fluorescent CFSE, which covalently bonds with free amine groups on proteins.  Once the acetyl 
groups are cleaved off, CFSE is impermeable and unable to leave the cell [216].  It is useful for 
live imaging over long periods of time as it is very photostable. 
CFSE (emission 492, excitation 517) and CellTrace FarRed labelling (emission 630, excitation 
661) with Orientia for the purpose of live imaging was tested. Both dyes were used at 5uM and 
presented cytoplasmic labelling at 0.5-2μm in diameter. The bacteria were labelled separately 
from host cells which resulted in no background or unspecific labelling once the bacteria infected 
cells. 
The dyes are intended to be retained after aldehyde fixation. However high-quality labelling with 
CFSE or CellTrace FarRed after fixation was unsuccessful with acetone or paraformaldehyde. 
After fixation, fluorescence had clearly leached out from the bacteria and no specific bacterial 
shape by fluorescence was visible (Figure 10).  
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Figure 9. Fig: The molecular structure of cell staining dye CFDA-SE and CFSE. 
A: carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) with indicated acetate groups with red arrows, which 
render it highly permeable. Once inside the cell, esterases remove the acetate groups.   
B: Carboxyfluorescein succinimidyl este (CFSE) is the fluorescent product of the removal of acetate groups once inside 
the cell. (Images were taken from Wikipedia:https://en.wikipedia.org/wiki/Carboxyfluorescein_succinimidyl_ester, 
https://en.wikipedia.org/wiki/Carboxyfluorescein_diacetate_succinimidyl_ester) 
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Figure 10. The effect of fixation on CFSE Orientia. 
Purified Orientia were labelled with CFSE or CellTrace FarRed and imaged live or fixed with paraformaldehyde (PFA) 
or acetone. 
Scale bar = 5μm 
 
 
 
 
 
 
90 
 
Bacterial growth was measured when Orientia was labelled with CFSE and CellTrace FarRed 
over seven days using qPCR. There was no difference in bacterial growth after 7 days when 
labelled with either dye compared with mock treated bacteria in DMSO, as shown by one-way 
ANOVA statistical test (Figure 11). Both dyes can be used reliably to follow the infection cycle 
without an effect on bacterial growth.  
 
 
 
 
  
 
Figure 11. Growth of CFSE labelled Orientia 
Graph showing the bacterial copy number of one well from a 24 well plate after 7 days growth with or without CFSE 
green or CT FarRed.. Inoculum used was 1.36 × 104 ± 1.9 × 103 bacteria per well (mean ± SD). Individual replicate 
values are plotted and the mean ± SD is shown. The results of the one-way ANOVA statistical test using the no label 
condition as a comparison are shown.  
Work done by Suparat Giengkam. 
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CFSE has commonly been used to follow mammalian cell proliferation by measuring florescence 
intensity over time using flow cytometry [216]. The stable dye becomes diluted once cell division 
occurs and the decreasing intensity, the division number can be estimated over time [217]. A 
similar approach was used here to estimate division time in Orientia. Bacteria were labelled with 
CFSE and infected into mammalian cells grown on cover slip slides. For 7 days, bacteria were 
imaged inside host cells (Figure 12, A-B). One chamber slide was used for each time point taken 
to avoid photobleaching or cell death during microscopy. During each time point a slide was 
imaged live using confocal microscopy (Zeiss LSM 510) to capture CFSE fluorescence inside 
host cells. Whilst the FITC laser strength was kept constant for each time point, it was also 
increased to detect the presence of replicated bacteria faintly labelled with CFSE. To be sure that 
CFSE had not influenced the infection cycle, slides were fixed and prepared for 
immunofluorescence microscopy. These images were compared in parallel to infected slides with 
non-CFSE but antibody labelled Orientia (Figure 12, C-D). 
 
By day 4, CFSE labelled bacteria were no longer visible by live imaging unless the FITC laser 
was increased up to power 5. Orientia presented the same infection cycle when labelled with 
CFSE compared with unlabelled bacteria as clarified by antibody labelling. Orientia were able to 
move to the nucleus and remain in the perinuclear region after day 1, until division was completed 
and exit the host cell from day 4. Therefore, CFSE does not affect the behavior or the infection 
cycle of intracellular Orientia. 
 
To estimate bacterial division after dilution with CFSE, ten images were taken from live imaging 
at each time point for quantification. Within these images, intracellular bacteria were chosen at 
random and the brightest pixel in each bacterium was measured for FITC intensity using ImageJ, 
a Java based image software program from the US National Institute of Health website 
(http://imagej.nih.gov/ij/). These measurements were compared with bacteria also labelled with 
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CFSE but not infected into host cells, therefore unable to replicate (Figure 12, E-F). These bacteria 
showed no sign of CFSE dilution unlike the bacteria image inside host cells. The decrease in 
dilution of CFSE labelled bacteria correlates with the known division time of Orientia as shown by 
our research group [138]. Whilst qPCR measures the genome number, the measurement of 
CFSE intensity over time can provide a better understanding of bacterial replication.  
 
Bacteria which remain bright after division time has passed may be metabolically inactive or dead. 
CFSE labelled bacteria which remained stationary and bright may be persisting inside host cells. 
This trait is common in other bacteria such as E. coli [218], Chlamydia [219] and Salmonella [220] 
to avoid host immune responses and antibiotic exposure, but is not yet known to exist in Orientia 
intracellular populations.  
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Figure 12. Infection time-course over 7 days showing CFSE labelled bacteria and non-labelled 
bacteria 
A: Purified Orientia were labelled with CFSE and imaged live over 7 days at equivalent imaging conditions including 
laser strength and image acquisition time. 
B: This row shows images taken at higher laser strength at the same time period.  
C: These samples were CFSE labelled but then fixed with formaldehyde at each time point and labelled with TSA56. 
D: Orientia were not labelled with CFSE in this sample but only labelled with TSA56. 
E: Pixel intensity of intracellular bacteria labelled with CFSE over 7 days. 
F: Pixel intensity of bacteria in media labelled with CFSE over 7 days.  
Scale bar = 5μm 
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3.3.c Syto9 
Syto9 (S34854, BacLight™, Molecular Probes, USA) is a cell permeable fluorescent nucleic acid 
stain which can label DNA and RNA live in eukaryotic and bacterial cells. This stain is helpful in 
determining live cells whilst companion component propidium iodide (PI) labels dead cells. Syto9 
(excitation 485, emission 498) enters live and dead cells whilst PI (excitation 533, emission 617) 
will only enter cells with disrupted membranes. When both dyes are present, PI will present a 
stronger affinity for nucleic acid, displacing syto9.   
Syto9 at 5nM was used to detect Orientia by microscopy at various stages of the infection cycle. 
This dye was useful in detecting bacteria during live imaging at specific time points, as the dye 
can easily be added to culture media. Host nuclei will be also labelled but bacteria were obvious 
in infected cells compared to uninfected host cells. Syto9 can be used short term during live 
imaging to locate intracellular bacteria. In host cells infected with Orientia and labelled with syto9 
at day 4 of the infection cycle, bacteria were noted to be moving energetically in the perinuclear 
area. Syto9 cannot be fixed and is toxic to cells, affecting bacterial growth at long durations of 
labelling [221].  
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Figure 13. Purified Orientia labelled with DNA binding label SYTO9 
A: Live and fixed with acetone and PFA, and inside host cells 
B: L929 cells were infected with Orientia and imaged after the addition of SYTO9. The white arrows indicate the 
presence of intracellular bacteria.   
C: Graph showing the bacterial copy number from one well of a 24 well plate with or without DMS0 or SYTO9. One-
way ANOVA test was carried out to compare with the no label condition. Work done by Suparat Giengkam.  
Scale bar = 5μm 
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3.3.d HADA  
Fluorescent dyes or probes may sometimes label unspecifically leading to high background 
labelling or false positives. To avoid this problem, probes which target specific bacterial structures 
have been produced. Specifically, probes have been developed which target the unique structure 
of peptidoglycan in bacteria. It was previously reported that Orientia lacks peptidoglycan [222] but 
recent results have led to this being disputed, which will be discussed later.  
During peptidoglycan biosynthesis, a D-alanine dipeptide is inserted into the peptide chain by 
enzyme MurF. Fluorescent probe, produced by M. VanNieuwenhze, HCC amino D-alanine 
(HADA) can be inserted into sites of new synthesis and is conjugated with a fluorophore (emission 
maximum, 450 nm blue) [223, 224]. This incorporation has already been shown for Chlamydia, 
B. subtilis and E. coli [224] [225]. HADA was used to label Orientia in fixed and live samples. 
When used at 1mM, Orientia labelled as rings, indicating HADA successfully entered a cell wall 
structure. HADA was also shown to have no effect on the growth of bacteria when compared with 
non-HADA labelled bacteria. HADA can be imaged live and is fixable with paraformaldehyde and 
acetone but generates a high background causing imaging to become difficult.  
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Figure 14.  Purified Orientia labelled with peptidoglycan label HADA 
A: Live and fixed HADA labelled Orientia with PFA 
B: L929 cells were infected with Orientia labelled with HADA and imaged immediately after entry 
C: The molecular structure of fluorescent D-amino acid HADA with the fluorophore moiety highlighted. 
D: Graph showing the bacterial copy number in one well of an infected 24 well plate in the presence or absence of 
HADA. One-way ANOVA statistical test was carried out to compare to the no label condition. Work done by Suparat 
Giengkam. 
Scale bar = 5μm 
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3.3.e EDA and EDA-DA 
Using a probe such as HADA gives the advantage of specific bacterial labelling. However the 
incorporation of HADA may not be as efficient because the fluorescent moiety attached to the 
synthetic D-amino acid is quite large (Figure 14, C). An alternative and potentially less perturbative 
label to HADA are clickable probes, Ethynyl-D-alanine (EDA) and Ethynyl-D-alanyl-D-alanine 
(EDA-DA), produced by our collaborator M. VanNieuwenhze [223]). These probes are ‘clickable’ 
alkyne modified D-alanine D-alanine dipeptide probes which label peptidoglycan.  The labelling 
method of these probes involves a click chemistry reaction with a fluorophore conjugated to an 
azide tag, to be visualised after fixation. Instead of a fluorophore, an alkyne tag is attached to the 
probe so allow for better incorporation.  
Both probes were tested with Orientia for specificity (Figure 15). At 1mM both EDA and EDA-DA 
labelled the entire cell and sometimes, like HADA labelling, presented ring-like structures. For 
simplicity, only EDA was used in future experiments due to the similar results generated from both 
probes which led to the conclusion that both are incorporated into the peptidoglycan structure in 
the same way.  
These results indicate EDA and EDA-DA were incorporated into the peptidoglycan peptide 
structure of Orientia, giving evidence that Orientia does in fact have a peptidoglycan-like structure. 
In the case of pathogenic strains Chlamydia, which also possess only minimal peptidoglycan, 
peptidoglycan labelling was only seen at the septum [225]. Septum labelling was never observed 
in Orientia.  
 
 
  
100 
 
  
Figure 15. Intracellular Orientia labelled with peptidoglycan probes Ethynyl-D-alanine (EDA) and 
Ethynyl-D-alanyl-D-alanine (EDA-DA) 
A: The molecular structure of EDA and EDA labelled Orientia inside PTK2 cells day 3 post infection. 
B: The molecular structure of EDA-DA and EDA-DA labelled Orientia inside PTK2 cells day 3 post infection.  
Scale bar = 5μm 
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3.3.f Vybrant dyes 
Membrane dyes are commonly used to label bacteria [226]. Lipophilic dyes DID, DIO and DIL 
(Molecular Probes, USA) can be added directly to cell culture to label lipid membranes and 
fluoresce at a range of colours. Bacteria can be labelled separately form host cells so that there 
is no possibility of diffusion of the label to host cells, decreasing the possibility of non-specific 
labelling. Labelling Orientia with DID, DIO and DIL displayed membrane and cytoplasmic labelling 
(Figure 16). Bacteria were seen clearly entering and inside the host cells during infection. 
However, the dyes were unable to be fixed with paraformaldehyde or acetone. Additionally, the 
labelling protocol of these vybrant dyes, recommends use of a specialised buffer, optimem 
(31985070, ThermoFisher, USA), which affected the growth of Orientia. Labelling may be 
optimised in other buffers, less toxic to the bacteria but these were not tested at this time. As the 
dye is incorporated into the membrane, it may be useful for studying outer membrane vesicles 
which may bud from bacteria during infection. These dyes are best used for short term labelling.  
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Figure 16. Purified Orientia labelled with vybrant membrane labels DID, DIO and DIL 
A: Orientia labelled live with each vybrant dye.  
B: Orientia labelled live with DID and fixed with PFA and acetone.  
C: L929 cells infected with Orientia labelled with DID image live by confocal microscopy. 
D: Graph showing the bacterial copy number of one well from an infected 24 well plate. One-way ANOVA statistical 
test was carried out to compare to the no label condition. **P ≤ 0.01; ***P ≤ 0.001. 
Scale bar = 5μm 
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3.3.g Clickable methionine 
Clickable chemical probes can be used to study the incorporation and localization of specific 
molecules.  One such probe is the methionine derivative, L-Homopropargylglycine (Thermofisher, 
USA) or L-Azidohomoalanine (Click chemistry tools, USA). These are ‘clickable’ probes that 
provide a non-toxic and easy labelling of methionine for protein synthesis detection for fixed 
imaging. These analogs consist of either an alkyne or azide moiety conjugated to methionine 
which are taken up by bacteria during protein synthesis and are visualised in fixed cells after a 
‘click’ reaction with a fluorophore. This technique is commonly used to label host and bacterial 
protein synthesis [227]. These probes were used to label metabolically active Orientia. 
Intracellular bacteria were labelled with 5uM probe for 30 minutes before fixation. This time was 
enough to label Orientia and bacteria labelling was presented as cytoplasmic (Figure 17). This 
technique is advantageous for labelling Orientia as metabolically active bacteria can be 
distinguished at various stages of the intracellular life cycle.  
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Figure 17. Chemical probe methionine azide or alkyne can label metabolically active Orientia 
Intracellular Orientia labelled with HPG methionine probe inside L929 cells, 3 days post infection. The methionine 
binding probe was added 30 minutes prior to fixation.  
Scale bar = 5μm 
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3.3.h RNA FISH 
Immunofluorescence microscopy is used to study expression levels and patterns of proteins 
inside cells. It would be desirable to have a strategy to measure expression levels and patterns 
of RNA transcripts inside cells. This would enable comparison of transcription and translation 
levels and allow the study of genes where antibodies were not available.  This was done by using 
single cell RNA fluorescence in-situ hybridisation (RNA FISH). In this, an oligonucleotide is 
synthesized that is complementary to the gene of interest, and this is conjugated to a fluorophore. 
Cells are fixed and permeabilized, and an overnight hybridisation step allows the probe to bind to 
its target. RNA FISH targeting 16S RNA at 1ng/ul was developed in the lab by Suparat Giengham 
and then I used it to successfully label intracellular Orientia (Figure 18). 16S RNA is expressed in 
ribosomes and since ribosomes will always be present at some level it was assumed that all 
bacteria should be labelled with this stain and this could be used as a control to counterstain all 
bacteria. Using RNA FISH against other genes will allow the study of differences in gene 
expression within a population and at different times after infection. 
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Figure 18. RNA FISH labelling of Orientia 
Intracellular Orientia labelled by RNA fluorescence in situ hybridization (FISH) inside PTK2 cells. Bacteria were fixed 
with PFA at day 3 and labelled with RNA FISH for 16s. 
Scale bar = 5μm 
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3.4 Discussion 
Fluorescent imaging is a vital tool for tracking the infection cycle of an obligate intracellular 
bacterium. Without genetic manipulation, Orientia must be labelled by an alternative mechanism.  
However, the optical and physical properties of the label can affect the function of the bacteria. A 
range of labels were tested for Orientia which successfully labelled the bacterial cytoplasm, the 
cell wall, nucleic acids or the cell membrane. 
First, antibodies were generated against major surface proteins of Orientia. The technique of 
immunofluorescence labeling is relatively easy and fast to carry out. As cells are already 
preserved by fixation, there is no danger of an effect of the antibody to the bacteria.  The only 
concern would be the photostability of the fluorophore used as a secondary antibody, but this was 
not the case as all antibodies were stable and long-lasting for imaging. The monoclonal antibodies 
proved to be highly specific to the antigen it recognised as shown by Western blot and microscopy 
images. The polyclonal antibodies did show some unspecific binding so the protocol for these 
antibodies may require the addition of a blocking buffer such as bovine serum albumin (BSA) to 
reduce non-specific antibody binding.  Each antibody labelled at various times of the infection 
cycle which is useful for understanding the role of surface proteins interactions in the host cell. 
The labelling morphology was also interesting as some surface proteins labelled throughout the 
membrane surface (TSA56, TSA47) whilst others (ScaC and TSA22) appeared to be ‘spotty’. This 
indicates the abundance of the surface protein on the membrane at a given time in the infection 
cycle and may help to understand how Orientia uses its surface proteins to interact with host 
proteins.  
CFSE and CellTrace FarRed dyes successfully labelled the cytoplasm of Orientia. The technique 
of labelling with the dyes is extremely easy and fast as isolated bacteria are labelled before 
infection into host cells. Only live imaging can be carried out as fixation after dye integration 
presented change in fluorescence intensity and bleeding of the dye into the external environment. 
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The CFSE dyes proved to be photostable and long lasting in Orientia labelled with CFSE. Growth 
or behaviour of bacteria was not affected so long-term imaging can be carried out if needed. 
Although CFSE dyes are long lasting, they also dilute over time as the bacteria divide. But this 
was a good and alternate technique to estimate the division of bacteria over time by live imaging 
instead of measuring the copy number of a gene by qPCR. Furthermore, CFSE labelled bacteria 
which remained bright after division indicate that not all bacteria divide inside the host cells. These 
may be dead or captured bacteria about to be disposed but the trait of bacterial persistence could 
also be an option. This has never been shown to exist in Orientia populations but could explain 
cases of persistence in mammals [228].  CFSE dyes also presented specificity to the bacterial 
cytoplasm and did not leach out into host cells.  
SYTO9 successfully labelled DNA in Orientia.  Labelling of SYTO9 was easy and quick as the 
label is directly added to infected cells. Whilst SYTO9 was useful in imaging live bacterial 
movements, the dye cannot be used for fixed imaging as the fluorescence leached out of bacterial 
cells. SYTO9 was not stable and photobleached soon after live imaging was performed. The dye 
also affected the growth of Orientia so cannot be used for long-term imaging. SYTO9 labelled 
DNA in Orientia but also labelled host DNA. This could potentially complicate image analysis 
although bacteria were easy to identify in infected cells. This problem does not arise when imaging 
bacteria isolated from host cells.  
Vybrant lipophilic dyes, DIO, DIL and DID also successfully labelled Orientia but only for live 
imaging. Fixed labelling of the dyes did not image well. The technique is easy as isolated bacteria 
can be labelled and added to host cells for imaging. However, the vybrant dyes affected the 
growth of Orientia and cannot be used for long-term imaging due to the lack of photostability. 
Also, after bacteria were added to host cells post labelling, the dye was seen around the host cell. 
This may have been residual dye or membrane fragments from Orientia. If the latter, it would be 
a useful technique to follow the blebbing of outer membrane vesicles during the infection cycle 
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[229] or to follow bacterial cell division. Although the dye was specific to the lipid membrane in 
most cases, it was also localised in the cytoplasm in some bacteria. Bacteria must be labelled in 
isolation from host cells otherwise the dye will also label the lipid membrane of the host cells. 
Fluorescent probes specific to bacterial peptidoglycan were also tested. HCC amino D-alanine 
(HADA) probe was able to label the cell wall of Orientia for fixed and live imaging. The technique 
of labelling was simple but did take a longer duration to be incorporated into the cell wall. During 
live imaging, the probe was photostable over time and did not affect the growth or behaviour of 
Orientia. Cell wall labelling was clear in fixed and live images. Although the probe appeared to 
label specifically, a high background after fixation was generated, especially inside host cells. 
Also, the probe quickly became bleached during fixed imaging. This would make peptidoglycan 
labelling during the intracellular infection cycle difficult. 
Other peptidoglycan specific, clickable probes, Ethynyl-D-alanine (EDA) and Ethynyl-D-alanyl-D-
alanine (EDA-DA) were used to achieve more specific labelling. These probes do not consist of 
a large attached fluorophore as HADA does. The technique for EDA and EDA-DA labelling is 
slightly more complicated due to the click reaction needed for fluorescence. Only fixed imaging 
can be carried out and the probes must be added to infected cells for a duration of time. Following 
fixation, a click chemistry reaction is performed along with antibody labelling. This allows a counter 
label for the peptidoglycan labelling to show specificity of the probe.  EDA and EDA-DA both were 
photostable and did not bleach easily. Labelling of the probes varied from experiment to 
experiment which indicates there must be other factors affecting labelling or bacterial 
peptidoglycan synthesis is only occurring at certain points of the infection cycle. Probe labelling 
did not vary between EDA and EDA-DA. Labelling was mostly visualised uniformly on the whole 
body of the bacteria and in a small population, the cell wall was labelled. This difference in 
labelling can further be explored by understanding when and how peptidoglycan synthesis occurs 
in Orientia.  
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Another option used for labelling was methionine specific probes. These probes are integrated as 
methionine is incorporated during bacterial protein synthesis. The technique for these probes is 
very easy as just a short incubation time with infected cells is needed for optimal results and there 
is no effect on bacterial growth or behaviour. The probe can only be visualised after fixation and 
click chemistry labelling. The probes were stable and did not bleach after imaging. Probes also 
presented specificity, as labelling was cytoplasmic. However, methionine probes will also label 
the host cell, since the probe does not discriminate between host or bacterial protein synthesis. 
This did not prove to be a problem since the bacteria labelled so intensely. This technique is 
useful for labelling only metabolically active bacteria. This would allow visualisation of when 
protein synthesis begins once bacteria enter host cells, which relates to when the bacteria start 
division or cell wall synthesis. Counter-labelling with an antibody can be performed to compare 
active bacteria vs non active bacteria.  
Lastly, RNA FISH was performed, which was designed by Suparat Giengham to bind with a 
sequence from the 16s gene.  This protocol for RNA FISH is quite lengthy and requires many 
stages for optimal imaging. As it is added after fixation, there is no effect on bacterial growth or 
behaviour. Labelling is specific and bacteria labelling appears to be ‘spotty’ insides the cell, which 
may indicate mRNA and ribosome locations.  
In this research, formaldehyde fixation was commonly used to preserve samples. Images may 
have been improved by using other fixatives such as organic solvents, which may be better to 
preserve nucleic acid content and decrease high backgrounds after immunostaining. Alternate 
fixative techniques will be explored for future work.  
Finding the appropriate label for Orientia was time consuming but valuable for future research. 
Though all are useful, each label is beneficial for a specific research question and at a specific 
time of the bacterial infection cycle.  
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One long standing question is the topic of peptidoglycan in Orientia. The success of the D-alanine 
probe uptake into the cell wall of Orientia may help answer whether the bacteria can synthesise 
peptidoglycan. This will be presented in the next chapter. 
 
 
Label Fixed Live Advantages  Disadvantages  
Antibodies   Specific to 
bacteria proteins, 
no host labelling 
 
Expensive to 
produce 
CFSE/CellTrace 
FarRed 
 
  Can be used to 
estimate division  
Dilutes over time 
SYTO9 
 
  Labels only live 
bacteria 
Toxic, affects 
bacterial growth 
Labels host nuclei 
HADA 
 
  Incorporated into 
the cell wall  
Does not label 
throughout 
infection cycle 
EDA-DA 
 
  Incorporated into 
the cell wall 
Does not label 
throughout 
infection cycle 
Vybrant 
 
  Can be used to 
study outer 
membrane vesicle 
budding 
 
Toxic, affects 
bacterial growth 
 
Clickable 
methionine 
  Labels only 
metabolically 
active bacteria 
 
Does not label all 
bacterial 
population 
RNA FISH 
 
  Can follow gene 
expression over 
infection cycle 
 
Low throughput 
and complicated 
protocol  
 
Table 5. A summary of labels tested for Orientia in this thesis 
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Chapter 4 
Peptidoglycan in Orientia tsutsugamushi 
 
Most of this research has been published: Evidence for a peptidoglycan-like structure in Orientia 
tsutsugamushi, Atwal S, Giengkam S, Chaemchuen S, Dorling J, Kosaisawe N, VanNieuwenhze 
M, Sampattavanich S, Schumann P, Salje J. 2017. Mol. Microbiol 
 
4.1 Introduction 
It was previously thought that Orientia did not synthesise peptidoglycan as major constituents of 
the structure were not found by chemical analysis. Also its insensitivity to β-lactams indicated a 
lack of peptidoglycan structure [222] [230] [231]. However, Orientia has a nearly complete set of 
genes for peptidoglycan synthesis [25] [1] (Figure 19) which makes the existence of some sort of 
peptidoglycan-like structure in its cell wall very likely. Furthermore, Orientia is recognised by host 
immune response Nod1 [201]. But still little is known about the structure of peptidoglycan in 
Orientia. Also, although Gram-negative, Orientia does not have LPS, as shown by the lack of 
detection of lipopolysaccrharide from SDS-PAGE analysis [222] and the lack of any genes for 
LPS biosynthesis [1].  
The obligate intracellular bacterium Chlamydia was also thought to not synthesise peptidoglycan 
even though it is susceptible to drugs which target peptidoglycan and can produce PBPs, as well 
as having most of the genes needed to produce peptidoglycan. The inability to detect 
peptidoglycan become known as the Chlamydia paradox [232]. However, by the use of mass 
spectrometry and fluorescent probes integrated into the peptide structure, peptidoglycan has now 
been shown to exist in Chlamydia [223, 233]. Peptidoglycan was found to exist in the division 
septum at very low amounts. As Chlamydia do not have FtsZ, which coordinates peptidoglycan 
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bacterial division at the septum, other cytoskeleton components such as MreB and RodZ are 
involved in the organisation of division [234]. Peptidoglycan in Chlamydia may instead take the 
role of FtsZ and exist solely as a lipid II precursor [193] not as a distinct sacculus. Without a 
classic peptidoglycan sacculus in its cell wall, Chlamydia species may instead maintain osmotic 
stability from disulfide bonded outer membrane proteins instead during their infection cycle [235] 
[236].  
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Figure 19. The peptidoglycan synthesis pathway  
The proteins involved in peptidoglycan synthesis for Gram-negative bacteria. Purple boxes indicate genes which are 
found in the genome of Orientia. Red boxes indicate genes which are absent in the genome of Orientia.  
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4.2 Peptidoglycan in Orientia: Objectives 
 
Objective 1: To detect peptidoglycan-specific amino acids in Orientia 
 Approach: To use mass spectrometry analysis to assess the presence or absence of 
mesoDAP in isolated Orientia bacteria  
 Expected outcome: If present, mesoDAP in isolated bacteria will be identified based on 
its chromatographic peak compared to the standard mesoDAP control 
 
Objective 2: To measure the expression of genes involved in peptidoglycan synthesis in Orientia 
 Approach: To measure the gene expression of specific genes (murA, murD, murF, ddl 
and pbpA2) using qRT-PCR 
 Expected outcome: If peptidoglycan biosynthesis is occurring it is expected that genes 
involved in this pathway will be expressed  
 
Objective 3: To test the sensitivity of Orientia to cell wall targeting drugs  
 Approach: To measure the sensitivity of cell wall targeting drugs (phosphomycin, 
penicillin, d-cycloserine, meropenem, imipenem, mecillinam and tazobactam) on the 
growth of Orientia by qPCR and to analyse morphology of bacteria by 
immunofluorescence microscopy 
 Expected outcome: The viability and morphology of Orientia will be affected if 
peptidoglycan is present in the cell wall  
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Objective 4: To determine whether peptidoglycan in Orientia has a polymerised glycan backbone 
 Approach: To measure the sensitivity of Orientia to lysozyme and mutanolysin by qPCR 
and fluorescence microscopy 
 Expected outcome: If lipid II is polymerised by glycosyltransferase activity, peptidoglycan 
structure will be affected which would inhibit growth of Orientia.  
 
Objective 5: To identify the subcellular localisation of peptidoglycan in Orientia  
 Approach: To use D-alanine based peptidoglycan-specific chemical probes to label 
Orientia 
 Expected outcome: Presence of peptidoglycan would be shown by localisation of probes 
to the septum or the cell wall. If labelling is disrupted by the addition of a cell wall 
targeting drug, this would be further proof of the presence of peptidoglycan. 
 
Objective 6: To determine the effect of osmotic stress on Orientia  
 Approach: To expose isolated Orientia cells to conditions of varying osmotic pressure and 
to determine the effect on bacterial morphology by immunofluorescence microscopy  
 Expected outcome: The resistance of isolated bacteria to osmotic stress would indicate 
the presence of a load bearing structure such as peptidoglycan  
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Objective 7: To determine if a network of disulphide cross-linked outer membrane proteins confers 
additional structural protection to Orientia  
 Approach:  To treat Orientia with reducing agents and measure the effect on bacterial 
shape (by immunofluorescence microscopy) and infectivity (by host infection studies).  
 Expected outcome: If the addition of reducing agent affects bacterial morphology this 
would suggest that disulphide cross-linked surface proteins play a role in conferring 
structural support 
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4.3 Results  
4.3.a MesoDAP (work done by Peter Schumann and Suwittra Chaemchuen) 
First, to help answer if Orientia has peptidoglycan, detection of a component of this structure was 
sought. Meso-Diaminopimelic acid, also known as mesoDAP, is an amino acid only found in 
bacterial cell walls, unique to the peptide chains of peptidoglycan. Detection of this would be a 
strong indicator of peptidoglycan synthesis. mesoDAP has not previously been detected due to 
the outdated technique of gas chromatography previously used [222]. 
The identification of mesoDAP, was achieved by the more sensitive gas chromatography-mass 
spectrometry (GC/EIMS) analysis in whole bacteria. Although the genome of Orientia does not 
include the genes for the complete pathway of mesoDAP production, mesoDAP was detected in 
purified bacteria. A chromatographic peak was detected matching the peak of mesoDAP (Figure 
20). This indicates that Orientia is synthesising meso-DAP using an alternate and unknown 
pathway. Since the data was taken from whole bacteria, purification of the sacculus will provide 
more reliable and accurate data.  
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Figure 20. Meso-DAP identification in Orientia by mass spectrometry analysis 
Hydrolysed bacteria show  a peak at 22.2 min and a set of fragment-ions at 380, 324, 306 and 278 m/z. 
This work was done Peter Schumann and Suwittra Chaemchuen 
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4.3.b Gene expression (work done by Suparat Giengkam) 
If peptidoglycan synthesis is occurring, then genes involved in its biosynthesis must be switched 
on. With this reasoning, specific peptidoglycan genes were measured by qPCR over the course 
of a 7-day infection. These genes were normalised against the house-keeping gene mipZ. Genes 
murA, murD, murF, ddl and pbp2 were all expressed during the 7-day infection (Figure 21).  
MurA is expressed quite consistently during infection whereas MurD is expressed at much higher 
levels during the first few days of infection. MurD catalyses the addition of D-glutamic to MurNAc-
L-ala in the cytoplasm, which results in the dipeptide L-Ala-D-Glu. This may suggest that MurD is 
preparing new peptidoglycan precursors before new incorporation of peptidoglycan, before the 
bacteria divide. MurF attaches the D-Ala-D-Ala dipeptide to the MurNAc tripeptide, also in the 
cytoplasm and is expressed highly just before division. Pbp2 also presented this pattern of higher 
expression levels just before division. This may suggest that Orientia is preparing for 
peptidoglycan synthesis and accumulating lipid II precursors in preparation. Note that these 
experiments measured the levels of RNA, and these may not reflect differences at the protein 
level.  
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Figure 21.  The expression of genes in the peptidoglycan synthesis pathway for Orientia 
Bacterial genome copy number or relative gene expression of  bacteria grown in mouse fibroblast L929 cells over 7 
days. The relative expression level was determined by qPCR and normalised to the housekeeping gene mipZ. The 
graphs show each individual data point, as well as the mean and standard deviation. 
This work was done by Suparat Giengkam. 
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4.3.c Drug sensitivity 
Drug sensitivity can show if specific components of the peptidoglycan pathway are active. Also, if 
these components result in a lack of peptidoglycan synthesis, are bacteria able to survive and 
grow? To answer this, drugs which specifically target the cell wall were treated with Orientia to 
determine the effect of the drug on bacterial growth (Figure 22, B-E). The growth of Orientia was 
quantified after treatment with chloramphenicol, which inhibits protein synthesis at the 
translational level and is used to clinically treat scrub typhus along with doxycycline. This was 
compared with bacterial growth in the presence of d-cycloserine and phosphomycin. D-
cycloserine targets the Alr/Ddl pathway, which produces the double D-alanine residues which are 
integrated into the peptide chain. Phosphomycin targets MurA which catalyses UDP N-
acetylglucosamine to UDP N-acetylglucosamine enolpyruvate, in a condensation reaction. In all 
drug treatments, growth was impaired. The bacterial membrane structure became disfigured by 
d-cycloserine and bacteria become larger and rounder under the influence of phosphomycin. 
Recovery of Orientia growth treated with D-cycloserine was tried with the addition of exogenous 
D-Alanine but this was not successful (Figure 22, C). 
Orientia is reported to be insensitive to penicillin, which was a key point used in the argument for 
it not synthesising peptidoglycan [231].  To corroborate this, the growth of Orientia was measured 
during treatment of β-lactam antibiotics. Alternative antibiotics were chosen from the carbapenem 
group, which target DD-transpeptidase PBPs. of those tested, imipenem and meropenem are 
highly resistant to β-lactamase and mecillinam exclusively targets PBP2. All carbapenem 
antibiotics presented no effect on Orientia growth. Even when bacteria were treated with penicillin 
plus the β-lactamase inhibitor, tazobactum, the antibiotic did not strengthen in effect. To 
investigate whether PBP2 and PBP3 are resistant to beta-lactam antibiotics in Orientia, active site 
residues were aligned from various bacterial species (Figure 23). Just one residue from PBP2 and 
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PBP3 were found to be mutated in Orientia which may explain why the bacteria are resistant to 
ꞵ-lactams even though peptidoglycan can be synthesised (alignment done by Jeanne Salje).  
Taken together, growth of Orientia is sensitive to peptidoglycan targeting drugs, except for beta-
lactams, indicating that the cell wall structure is necessary for division and cell shape. 
Furthermore, Orientia is insensitive to β-lactam antibiotics as previously reported but still 
synthesises peptidoglycan. 
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Figure 22. Orientia treated with cell wall targeting drugs 
A: A table of the drugs or enzymes used in this study with their molecular target. 
B-E: Bacteria were grown in L929 cells for 7 days and treated with various drugs. The copy number was then 
determined by RT-qPCR using triplicates for each condition. Graph shows each individual data point, as well as the 
mean and standard deviation. Statistical significance was determined using an unpaired t test analysis. P values are 
illustrated as follows: ns (P>0.05); * (P≤0.05); ** (P≤0.01); *** (P≤0.001). Work done by Suparat Giengkam.  
F: Drug sensitivity in Orientia to cell wall targeting drugs. Intracellular bacteria were treated with drugs for 24 hours and 
then fixed and labelled with TSA56 for immunofluorescence microscopy. Drug concentrations are as follows: 
chloramphenicol 100 ug/ml; penicillin G 150 ug/ml; D-cycloserine 250 ug/ml; phosphomycin 40 ug/ml; lysozyme 5 
ug/ml; meropenem 10 ug/ml.  
Scale bar = 5μm 
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4.3.d Glycosyltransferase activity 
Orientia cannot produce class A PBPs which are the bifunctional enzymes that are known to 
possess both transpeptidase and glycosyltransferase activity. Orientia only encodes class B 
PBPs which only possess transpeptidase activity.  Without any class A PBPs is the glycan 
backbone of peptidoglycan in Orientia actually polymerised? To investigate this, enzymes 
lysozyme and mutanolysin were used to measure the sensitivity against Orientia growth. 
Lysozyme is an antimicrobial, found naturally in tears and mucus in animals. It catalyses the 
hydrolysation of the β1,4 linkage between lipid II precursors. Mutanolysin, produced by Gram 
positive Streptomyces globisporus, also cleaves the β1,4 linkage between lipid II precursors by 
its muralytic activity. Therefore, sensitivity to these would indicate the presence of a β1,4 linkage 
between the lipid II precursors.  
Both enzymes were able to cause the lysis of Orientia and prevented growth (Figure 22, D, F). 
This indicates that there is polymerisation between MurNAc and GlcNAc but how this 
polymerisation can occur is unknown.  
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4.3.e EDA  
D-amino acid derivatives have been developed which can be incorporated into peptidoglycan, as 
described in chapter 2. These can be used to visualize peptidoglycan labelling through live or 
fixed imaging. These probes may be monopeptide or dipeptide probes of D-alanine [223] [237] 
[224]. Ethynyl-D-alanine (EDA), an azide D-alanine dipeptide probe, was used to label 
peptidoglycan labelling in Orientia in a click chemistry reaction. EDA was able to label Orientia 
successfully and presented labelling all over the surface (Figure 24), indicating a peptidoglycan 
structure in the cell wall, unlike the septum labelling imaged in Chlamydia [223]. Further proving 
that EDA was taken up during peptidoglycan synthesis, cell wall targeting drug treatment with 
bacteria showed a lack of florescence after probe incorporation. Although the background of 
labelling is high, this was not seen in uninfected cells also labelled with the probes. The reason 
for this high background may be due to low peptidoglycan abundance or shed peptidoglycan in 
host cells. 
It is not known exactly how EDA is incorporated into the peptidoglycan structure in Orientia. The 
integration of D-alanine occurs in the peptide chain by DD-transpeptidase activity, so EDA is 
expected to enter nascent peptidoglycan structure in this manner.  However, EDA could also be 
incorporated during peptidoglycan remodeling in the cell wall again by transpeptidase activity.  
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Figure 24. Orientia labelled with peptidoglycan probe EDA 
EDA was added to L929 cells infected with Orientia at day 3 for 4 hours. After this time, cells were fixed, and a click reaction was 
carried out to allow detection by fluorescence. Bacteria were also labelled with TSA56. 
The top row shows EDA labelling in uninfected L929 cells to compare infected cells.  
Phosphomycin targets MurA.  I = intermediate peptidoglycan 
Scale bar = 5μm 
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4.3.f HADA and HALA 
HADA (7-hydroxycoumarin-3-carboxylic acid-3-amino-D-alanine) is also a fluorescent probe, but 
is comprised of one alanine attached to a fluorophore [224] (Figure 14, C). HADA can also be 
imaged through live or fixed microscopy. The incorporation of HADA in Orientia presented 
labelling all over the surface, indicating like EDA, peptidoglycan synthesis is occurring in the cell 
wall of the bacteria (Figure 25). HADA is also thought to be integrated into the peptide chain, like 
EDA, as single D-alanine.  
The L-isomer form of HADA, HCC-amino-L-alanine (HALA) was also tested. Surprisingly, this 
probe managed to label a sub-population of Orientia and even the control bacterial species E. coli 
(Figure 25). Since we cannot be exactly sure how HADA is taken up during peptidoglycan 
synthesis, HALA may also be incorporated in some way.  
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Figure 25. Fluorescence microscopy of fluorescent probes D-alanine HADA and L-alanine HALA. 
A: HADA and HALA labelling of E. coli with evans blue membrane label. 
B: HADA and HALA labelling of Orientia with TSA56 antibody.  
Scale bar = 5μm 
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4.3.g Response to osmotic stress 
Bacteria can withstand osmotic pressure due to the integrity of their cell wall, particularly by the 
presence of peptidoglycan in the periplasm. Obligate intracellular bacteria live in an osmotically 
protected environment of the host cell cytoplasm. Due to this, there is a reduced need for 
peptidoglycan in their cell wall, especially since peptidoglycan is recognized immunogenically by 
the host NOD1/NOD2 pathway. This may be why obligate bacteria such as Orientia and 
Chlamydia may have reduced the synthesis of peptidoglycan during their life cycle.  
 
To verify if Orientia has a cell wall structure strong enough to confer osmotic protection, the 
bacteria were exposed to buffers to test its vulnerability. Purified Orientia did not lyse when in the 
presence of phosphate buffered saline (PBS), sucrose phosphate glutamate (SPG) buffer or 
water. When resuspended in water, bacteria did become larger but did not lyse, indicating that it 
must have a peptidoglycan-like structure which provides mechanical protection. Bacteria 
resuspended in PBS and water presented a slightly different phenotype from bacteria in SPG, as 
they become less smooth. If peptidoglycan was in fact not present, the bacteria would have lysed 
in water and PBS treatment due to the lack of protection in a high osmotic environment.  
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Figure 26. Testing the structural rigidity of Orientia by immunofluorescence microscopy 
Bacteria were treated with various buffers such as PBS, water and sucrose phosphate glutamate solution, 
to test cell wall support. Orientia were then fixed and labelled with TSA56. 
Scale bar = 5μm 
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4.3.h Cross-linked TSA56 in the outer membrane of Orientia 
Results here show that there is clearly some form of peptidoglycan in the cell wall of Orientia but 
what else is maintaining the structure of the cell wall? Usually in Gram negative bacteria, the 
presence of LPS provides structural integrity. Orientia does not have LPS in its cell membrane, 
therefore there may be another component alongside peptidoglycan providing support. Orientia 
possesses a protein called TSA56 which is highly abundant on its outer membrane and this 
contains three conserved cysteine residues. The cell wall of Chlamydia is known to consist of 
major outer membrane proteins (MOMPs) which are stabilised by disulfide bonds and form a 
cross-linked network along the membrane [235] [238].  This led to the hypothesis that instead of 
LPS, TSA56 proteins may also crosslink along the membrane, held by disulfide bonds between 
cysteine residues. 
To investigate this, DTT, a redox reducing agent was used. Purified bacteria were resuspended 
in SPG and PBS buffers containing DTT and imaged by microscopy with TSA56 antibody labelling 
(Figure 26). Although bacteria remained intact under DTT conditions, bacteria exposed to water 
and DTT presented disfigured cell membranes with variable TSA56 antibody labelling. This 
suggests that the double threat of water and DTT on the cell membrane, rendered Orientia more 
vulnerable as the cell membrane became weaker. E. coli was used a control and did not 
experience the same changes as Orientia which suggests that the cross-linked surface protein in 
Orientia was specifically involved. 
TSA56 is known to aggregate. Reducing agent, β-mercaptoethanol, was used with Orientia to 
show the lack of aggregation by western blot analysis (Figure 27, C). This was done by Suparat 
Giengkam. 
It is known that TSA56 is a key surface protein and it interacts with host receptors to initiate 
bacterial entry. If this is true, how would entry be affected if the protein becomes destabilised by 
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DTT? This was investigated by pre-exposing purified Orientia to DTT then washing bacteria in 
cell culture media before infecting host cells (Figure 27). Compared to bacteria which were not 
treated with DTT, the DTT treated Orientia presented a much lower entry number. This indicates 
that without a cross-linked TSA56 to interact with host fibronectin, entry is extremely reduced. 
Taken together these results support the hypothesis that Orientia has a stable disulfide cross-
linked membrane composed of TSA56 surface proteins which vital for infection and with the 
presence of a peptidoglycan-like structure, essential for structural support.  
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Figure 27. Immunofluorescence microscopy of Orientia treated with DTT in L929 cells 
A: Bacterial entry without any treatment was compared to bacterial entry after 1mM DTT treatment, which was then 
washed off prior to infection.  
B: Orientia were labelled with TSA56 and entry was quantified manually 24 hours after mock treatment or pre-
treatment with DTT. 100 host cells were randomly selected, imaged, and manually counted. The mean and standard 
deviation is shown, with statistical significance determined using an unpaired t test analysis. P values are illustrated 
as follows: ns (P>0.05); * (P0.05); ** (P0.01); *** (P0.001). 
C: Western blot of Orientia and uninfected L929 cells, with or without ꞵ-mercaptoethanol (BME) using a monoclonal 
antibody against TSA56 protein. Work done by Suparat Giengkam.  
Scale bar = 10μm 
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4.4 Discussion 
Orientia has a peptidoglycan-like structure but this not the classic peptidoglycan known in model 
systems such as E. coli. The peptidoglycan in the cell wall is much more reduced in abundance 
and its synthesis may be unconventional.  
This is shown firstly by the identification of mesoDAP. This could be detected but the abundance 
was very low. Some of the genes for its synthesis are absent in Orientia and it is likely that 
alternative pathways are involved.  
Measurement of gene expression of the genes involved in peptidoglycan synthesis over 7 days 
of infection was achieved by qRT-PCR. Expression varied according to the gene but during early 
stages of infection, murD and murF presented high levels of expression. This may indicate that 
the buildup of peptidoglycan precursors is needed as the bacteria prepare for division.  This may 
be further explored in the future by microscopy by the production of RNA FISH probes against 
mur genes. 
Further evidence of the presence of peptidoglycan was shown by treatment of drugs which target 
the cell wall. All carbapenem antibiotics presented no effect on Orientia growth which may be due 
to the mutated position at K310 in PBP3 and PBP2. However other drugs such as phosphomycin, 
d-cycloserine and lysozyme all affected the cell wall of Orientia as well as the viability to the same 
level as chloramphenicol treatment.  
Orientia is missing the amino acid racemases Alr. The presence of the D-form amino acids in the 
peptide chain of peptidoglycan is unique and usually racemase activity is used to convert the L-
form to the D-form amino acid. The D-isomer amino acids are not present in proteins, and the D-
alanine dipeptide is unique to peptidoglycan. Treatment of Orientia and D-cycloserine with high 
levels of D-Alanine could not help bacteria recover and synthesise peptidoglycan which was 
shown to occur in Chlamydia [239]. Orientia does have Ddl suggesting that a D-ala-D-ala 
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dipeptide is present and incorporated into a growing pentapeptide side chain. An alternative 
enzyme is likely to perform the racemase activity, or the synthesis of the peptide chain may rely 
on Ddl.   
Orientia does not encode class A PBPs which exhibit glycosyltransferase activity but still appears 
to have a polymerised glycan backbone as lysozyme and mutanolysin were able to affect bacterial 
viability and structure.  Loss of class A PBP in various bacteria species such as E. coli have 
proven lethal [191]. However, it has been shown in Bacillus subtilis, which encodes 4 class A 
PBPs, and with the removal of all 4, peptidoglycan is still synthesised with minor structural 
differences and slow growth [240]. Furthermore,  Enterococcus faecium also displayed glycan 
chain polymerisation after deletion of all 3 of its class A PBP genes [241].  Taken together, this 
indicates that lacking class A PBPs in bacteria does not mean necessarily mean no peptidoglycan 
structure in the cell wall.  
But how may the peptidoglycan glycan backbone be joined together? One candidate for 
glycosyltransferase activity in Orientia may come from the SEDS family. Some SEDS proteins 
have dual roles as many are involved in peptidoglycan growth and maybe also peptidoglycan 
synthesis. For example, FtsW is thought to transport lipid II across the membrane. MurJ also 
supposedly acts as a lipid II flippase [181]. Evidence of dual activity has opened the door to the 
possibility of other components performing multiple activities including glycosyltransferase activity  
[195]. SEDs protein RodA is known to be essential for bacterial viability and has been shown to 
exhibit glycosyltransferase activity in B. subtilis [179]. Depletion of RodA in various bacterial 
mutant species lacking class A PBPs, arrested growth completely [242]. This suggests that RodA 
may provide glycosyltransferase activity for peptidoglycan synthesis during elongation.  FtsW may 
also provide glycosyltransferase activity during cell division. If this is true, antibiotics could 
possibly be generated to target SEDS in bacterial species where class A PBPs are nonexistent.  
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The integration of fluorescent D-alanine probes was used to show cell wall labelling by 
microscopy.  Clickable EDA and EDA-DA probes were able to label intracellular Orientia and after 
phosphomycin and d-cycloserine treatment, both probes labelled Orientia less efficiently. 
However, EDA and EDA-DA labelling was not as intense as labelling in positive control E. coli. 
This may indicate that the abundance of peptidoglycan in Orientia is low or probe addition was 
not incorporated at the optimal stage of peptidoglycan synthesis during infection which may 
explain why the background labelling of EDA and EDA-DA was very high in infected cells only. 
Furthermore, E. coli presented sepal peptidoglycan labelling (also seen in Chlamydia [225]) and 
in Orientia, the entire body of the bacteria became labelled. Occasionally, localised cell wall 
labelling was visualised, but this was hard to find. The incorporation of these probes is not known 
exactly so labelling may differ in bacterial species.  
HADA and HALA both managed to label the cell wall of Orientia, although the population labelled 
with the latter probe was much smaller. The probes may be taken up via the DA-DA pathway by 
Ddl during peptide chain formation, but it cannot be ruled out that other sites of incorporation may 
occur such as during remodeling of peptidoglycan by class B PBP activity, LD-transpeptidase 
activity (although Orientia lacks LD-transpeptidases) or uptake by Ddl and MurF.  Enzymes which 
are responsible for D-alanine addition into peptidoglycan may not discriminate the L isomer from 
the D isomer.  
D-alanine probe incorporation may differ for all species of bacteria and there may be multiple 
processes which may incorporate D-alanine. Labelling of HADA, HALA, EDA and EDA-DA was 
not consistent in every experiment which may mean host or bacterial factors effect labelling.  This 
can include host cell confluence, host cell line, bacterial infection number, time probe is added 
after infection and media used for probe labelling.  
Peptidoglycan provides protection against osmotic stresses. Orientia is free in the osmotically 
protected cellular environment during its intracellular life cycle in the host cell. This would be one 
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reason for the bacteria not needing peptidoglycan in its cell wall. Since Orientia did not lyse in 
PBS or water, this indicates that there is a protective structure in their cell wall. The morphology 
of bacteria in PBS and water presented a rougher cell envelope compared to bacteria treated with 
SPG. Orientia were also found to grow better after storage in SPG rather than PBS or water, 
which shows that PBS and water exert high osmotic pressure and this may damage the cell 
envelope [138].  
Orientia does not have LPS on its outer membrane. Instead, surface protein TSA56 is abundant 
which is vital for entry in host cells and it contains 3 cysteine residues which have a disulfide 
linked composition on the outer membrane of the bacteria. As shown by treatment of bacteria with 
reducing agent DTT in PBS, SPG and water, bacteria became more fragile. This shows that in 
addition to a peptidoglycan-like structure in the cell wall, this cross-linked outer membrane 
provides support and structural aid to the bacteria similar to the major outer membrane proteins 
of Chlamydia [243]. The cross-linked outer membrane of TSA56 is also vital for infection as shown 
by treatment of Orientia with DTT before entry. Entry may not occur without the crosslinked TSA56 
as the proteins may need to be aggregated or composed in a more sophisticated structure with 
other surface proteins for fibronectin binding to initiate entry.   
In this chapter, I show that there is a peptidoglycan-like structure in the cell wall of Orientia. This 
structure is essential for bacteria growth, structure and osmotic protection. Furthermore, Orientia 
has a network of disulphide cross-linked outer membrane proteins composed of TSA56 and 
possibly other proteins.   
Like Chlamydia, the theory that this organism lacks peptidoglycan has again been disproved for 
Orientia. What does this mean for other Rickettsiales species? Rickettsia species are understood 
to contain a classical peptidoglycan structure but for other less known species, this is unclear. It 
will be interesting to apply the same methodology here to Rickettsiales species with 
uncharacterised peptidoglycan status.  
141 
 
Chapter 5 
Peptidoglycan in Rickettsiaseae and Anaplasmataceae 
 
This research is currently being prepared for publication.  
  
5.1 Introduction 
Both Orientia and Chlamydia are obligate intracellular bacteria that have now been shown to have 
low levels of a peptidoglycan-like structure. Interestingly, a comparison of the genes that are 
present or absent in these organisms showed that both retained many genes involved in 
peptidoglycan biosynthesis, but both lacked any genes for bifunctional class A PBPs. This led to 
an extensive bioinformatics analysis to study the presence and absence of peptidoglycan related 
genes in all major known obligate intracellular bacteria to see if this was indicative of a larger 
pattern. Figure 28. A summary of the key peptidoglycan gene homologs present or absent in 
bacterial species [1]shows a summary of the main genes involved in peptidoglycan biosynthesis 
and their presence in eleven obligate intracellular bacteria and a further 7 related free-living 
bacteria [1]. This work was performed by collaborators and other members of the lab. 
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Figure 28. A summary of the key peptidoglycan gene homologs present or absent in bacterial 
species [1] 
Species in red are obligate intracellular bacteria and free-living bacteria are in black. The status of peptidoglycan in 
these species are predicted on the right.  Colour codes on the right will be used in this thesis to distinguish each group 
based on the bioinformatic gene predictions (orange: no peptidoglycan present, red: classical peptidoglycan present 
and pink: intermediate peptidoglycan). 
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Based on this analysis, bacteria can be divided into three groups. One group lacks almost all 
genes required for peptidoglycan biosynthesis and would be predicted to lack any peptidoglycan. 
One group contains all the key genes involved in peptidoglycan biosynthesis. Finally, one group 
contained almost all genes involved in peptidoglycan biosynthesis but lacks any class A PBPs. 
This last group includes Orientia tsutsugamushi and Chlamydia spp. and other Rickettsiales 
organisms including Wolbachia and Anaplasma marginale. This led to the prediction that these 
organisms might all make a similar peptidoglycan-like structure and this motivated the work in the 
current chapter. 
 
The bacterial species in Rickettsiaceae and Anaplasmataceae families all infect various vectors 
and exhibit different cell cycles in different host cells. This will result in differences in the selective 
pressure for or against peptidoglycan.  
Whilst the genes for peptidoglycan synthesis are known in the genome of these species, it is not 
clear if they are expressed and if peptidoglycan is being synthesised. The difficulty in exploring 
this arises from the fact that these species can only be grown inside host cells and many species 
remain genetically intractable. This chapter will concentrate on representatives from each of these 
predicted peptidoglycan groups and their ability to synthesise peptidoglycan. The presence of 
peptidoglycan in many Rickettsiales species has never been shown so a few species were 
investigated from each family.  
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5.1.a Rickettsia 
Rickettsial bacteria have a complete set of genes for peptidoglycan synthesis and the classic 
peptidoglycan structure has already been shown. The presence of peptidoglycan has been shown 
by electron microscopy for SFG and TG species, showing the similarities of structure of the cell 
wall with well-known E. coli [230]. The addition of penicillin, a peptidoglycan targeting drug, with 
rickettsia species, creates spheroblasts and inhibits growth. This is further proof that 
peptidoglycan is present [231].  Rickettsia prowazekii has also been shown to be sensitive to 
lysozyme and other peptidoglycan targeting drugs [155].  
 
5.1.b Anaplasma marginale 
The genome of A. marginale shows most genes are present for peptidoglycan synthesis. Most 
genes are present for meso-diaminopimelic acid (mesoDAP) but lysA which is required for lysine 
biosynthesis is missing [90]. However, like Orientia, A. marginale is missing class A PBPs [1].  
This indicates that the bacteria, do not possess the activity of bi-functional PBPs. Only 
transpeptidase activity is present through class B PBPs so how the glycan chains are bound is 
unknown.  
 
5.1.c Anaplasma phagocytophilum 
Unlike A. marginale, A. phagocytophilum do not possess most of the genes for peptidoglycan 
synthesis [139] [1] as only murB is present. From this genetic data, it can be assumed that A. 
phagocytophilum does not synthesise peptidoglycan. The cell wall is much weaker and with no 
peptidoglycan for structural support, the bacteria may have to compensate for this loss. A. 
phagocytophilum may instead be dependent on the integration of cholesterol into their membrane 
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although the bacteria lack the genes for cholesterol biosynthesis or modification [244]. The loss 
of the genes needed for lipid A synthesis may have occurred over time.  
Mycoplasma are also known to lack peptidoglycan and this organism incorporates cholesterol into 
its membrane from the environment [245]. This may be for structural purposes, but cholesterol is 
also involved in many roles such as membrane and cellular functions. This may also be the case 
for A. phagocytophilum [139] [146].  A high cholesterol content may facilitate A. phagocytophilum 
infection in patients with HGA, especially since patients are usually older than 50 years of age. 
This indicates that high cholesterol diets in humans can cause them to be more susceptible to 
this bacteria species [244].   
A. phagocytophilum infects monocytes or macrophages, unlike A. marginale which infects red 
blood cells. This difference may have resulted in selective pressure on only A. phagocytophilum 
to lose peptidoglycan.  
 
5.1.d Ehrlichia 
Ehrlichia cannot synthesise peptidoglycan based on genomic analysis, and like A. 
phagocytophilum, only peptidoglycan synthesising gene murB is present [1] [115]. Ehrlichia are 
known to be fragile and may compensate for the lack of physical integrity in their cell wall by also 
integrating cholesterol into the membrane [139]. As Ehrlichia infects monocytes, the genes 
needed for peptidoglycan synthesis may have been selected out over time to avoid recognition 
from toll-like receptors and nucleotide binding oligomerisation domain-containing intracellular 
protein receptors. This uptake of cholesterol into the bacterial membrane may be essential for 
host infection and other cellular functions necessary for bacterial survival [139]. Treatment with 
cholesterol extracting reagent, methylβ-cyclodextrin, results in Ehrlichia bacteria unable to attach 
or invade host cells [139].  As well as the lack of peptidoglycan, Ehrlichia do not synthesise LPS.  
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5.1.e Wolbachia 
Similar to Orientia and A. marginale, Wolbachia encodes most of the genes essential for 
peptidoglycan synthesis but also lacks class A PBP transglycosylase activity.  
What is already known about the cell wall of Wolbachia? Most genes needed for lipid II production 
are present in Wolbachia including the genes needed for mesoDAP formation. Phosphomycin, 
inhibitor of MurA, can affect the growth of peptidoglycan in Wolbachia and the construction of the 
lipid II structure is vital for their growth and cell division [193] [141]. With no glycosyltransferase 
activity, a peptidoglycan structure composed by only transpeptidation of lipid II was hypothesised 
[246]. 
With no racemase for L-alanine to D-alanine conversion, Wolbachia may instead produce D-
alanine via another metabolic pathway such as methionine biosynthesis which exhibit enzymes 
with dual activity, as shown in E.coli [141].  Also, lipoprotein AmiD in wMel strain Wolbachia, was 
found to cleave the MurNac-L-Alanine bond in lipid II so may help to recycle lipid II to avoid the 
immune response from the host [247].  
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5.2 Peptidoglycan in Rickettsiales: Objectives  
 
Objective 1: To grow Rickettsiales species  
 Approach: To develop protocols to grow R. canadensis, A. marginale, A. 
phagocytophilum, E. chaffeensis and Wolbachia in eukaryotic or insect cell lines and 
determine bacterial copy number by qPCR 
 Expected outcome: Validated protocols for propagation and quantification of 5 rickettsial 
species 
 
 
Objective 2:  To label Rickettsiales species  
 Approach: To optimise methods to label R. canadensis, A. marginale, A. phagocytophilum, 
E. chaffeensis and Wolbachia with fluorescent probes (clickable methionine and RNA 
FISH) for fixed microscopy imaging 
 Expected outcome: Validated protocols and images of 5 rickettsial species labelled with 
clickable methionine and RNA FISH. 
 
Objective 3: To measure NOD1 activation in response to Rickettsiales species 
 Approach: To measure the host NOD1 response to R. canadensis, A. marginale, A. 
phagocytophilum, E. chaffeensis, Orientia and Wolbachia by adding heat inactivated 
bacteria to a NOD1 reporter cell line. 
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 Expected outcome: Bacterial species which do not synthesise peptidoglycan will not 
activate the host cell NOD1 response in contrast to those species which do have 
peptidoglycan.  
 
Objective 4: To determine the sensitivity of Rickettsiales species to cell wall targeting drugs 
 Approach: To analyse the effect of cell wall targeting drugs (phosphomycin, penicillin and 
d-cycloserine) on the viability of R. canadensis, A. marginale, A. phagocytophilum, E. 
chaffeensis and Wolbachia using qPCR-based growth measurements.  
 Expected outcome: The growth of species which have peptidoglycan will be reduced. 
Species which do not synthesise peptidoglycan be unaffected.  
 
Objective 5: To establish the subcellular localisation of peptidoglycan in Rickettsiales species  
 Approach: To use D-alanine based peptidoglycan-specific chemical probes to label R. 
canadensis, A. marginale, A. phagocytophilum, E. chaffeensis and Wolbachia for fixed 
imaging, with and without cell wall targeting drug treatment. Peptidoglycan localisation by 
the probe will be compared to the localisation in control species (E. coli and B. subtilus) 
 Expected outcome: Rickettsiales species which do not have peptidoglycan will not be 
labelled by the probe. If species do label, this is evidence of peptidoglycan in the cell wall, 
especially if blocked after the addition of a cell wall targeting drug.  
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Objective 6: To determine the sensitivity of Rickettsiales species to osmotic stress 
 Approach: To isolate bacteria and measure the effect of different osmotic conditions on 
their morphology.  
 Expected outcome: Rickettsiales species lacking the structural support of peptidoglycan 
are expected to be more sensitive to hypotonic buffers than those that synthesise a 
peptidoglycan cell wall. 
  
Objective 7: To determine whether peptidoglycan in different Rickettsiales species contains a 
polymerized glycan backbone. 
 Approach: To determine the sensitivity of Rickettsiales species to lysozyme and 
mutanolysin drugs as assessed by fluorescence microscopy.  
 Expected outcome: Rickettsiales species that lack polymerized peptidoglycan will be 
insensitive to lysozyme and mutanolysin. 
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5.3 Results  
5.3.a Propagation 
All Rickettsiales species, except for Orientia, had not been grown before in this laboratory. 
Therefore, growth of all species had to be verified and quantified in various cell lines. Anaplasmas, 
Ehrlichia and Wolbachia were kindly given by Ulrike Munderloh (University of Minnesota) whilst 
Rickettsia canadensis was donated by Nancy Connell (Rutgers, University of New Jersey).  
Bacteria were added to various cell lines and then quantified by qPCR against the 16s gene. A. 
marginale and R. canadensis were successfully grown in monkey endothelial Vero cells. Ehrlichia 
chaffeensis was grown successfully in Vero and dog macrophage DH82 cells (Figure 29, C).  
Growth for bacteria increased after inoculation and was able to increase up to day 4. However, 
for Wolbachia and A. phagocytophilum, growth was extremely slow. A. phagocytophilum were 
initially grown in human monocytic THP1 cells but growth was not consistent and failed to 
progress. Due to this, A. phagocytophilum were instead grown in human promyeoblast HL60 cells 
and were able to maintain steady but slow growth over time (Figure 29, E). Growth was also tested 
in endothelial RF6A cells which also proved successful (data not shown).  Wolbachia are 
commonly grown in insect cell lines at 28°C. Growth was tested in Aedes albopictus C636 cells 
and fibroblast L929 cells. In both cell lines, growth was slow but consistent (Figure 29 D).  
Although bacteria were grown successfully and used in experiments, further research needs to 
be carried out on bacterial propagation and purification. All bacterial species have been shown to 
grow in insect cell lines such as tick ISE6 cells [144, 151, 248-250], but this couldn’t be achieved 
at this time. Also, lysis of host cells was achieved by the same technique used to lyse Orientia. 
This laboratory has tested extensively the best way to propagate and purify Orientia [138] for 
optimal propagation but these protocols may not be suitable for other Rickettsiales species.. 
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Many species which are predicted to not have any peptidoglycan in their cell wall may be more 
fragile and sensitive so lysis techniques may damage the bacteria and therefore effect entry and 
growth. Although there are research papers which describe how species should be purified, there 
is no literature on tested techniques and results. Without this evidence, the way the bacteria are 
grown may not be optimal and may render experiments inconsistent. This issue will be addressed 
in future work. 
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Figure 29. Rickettsiales growth in various cell lines 
A: R. canadensis growth in vero cells over 4 days. 
B: A. marginale growth in vero cells over 4 days.  
C: E. chaffeensis growth in vero cells (left) and DH82 cells (right). The DH82 infection was not carried out in triplicate. 
D: Wolbachia growth in C636 cells (left) and L929 cells (right).  
E: A. phagocytophilum growth in HL60 cells (left) and THP1 cells (right). The THP1 infection was not carried out in triplicate.  
All bacteria were grown in triplicate and measured from 16s copy number by RT-qPCR. The colour codes next to bacterial species 
indicates the peptidoglycan group they belong to based on gene presence.  
C = Classical peptidoglycan, I = Intermediate peptidoglycan, N = No peptidoglycan 
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5.3.b Methionine  
With no antibodies made for the multiple Rickettsiales species, unlike Orientia, labelling by 
immunofluorescence techniques was difficult. L-Homopropargylglycine (HPG) (Thermofisher, 
USA) or L-Azidohomoalanine (Click chemistry tools, USA) probes used to label Orientia were also 
used to label Rickettsiales species successfully (Figure 30). The probes were added to infected 
cells 30 minutes prior to fixation. As the Anaplasmataceae species exist in two states during the 
infection cycle, there may have been an issue labelling the bacteria when not in active states. 
Bacteria were all labelled at day 3 of infection and this proved to show metabolically active 
bacteria. A phagocytophilum and Wolbachia were also labelled successfully indicating that 
although growth is slow, bacteria are still metabolically active.  The success of this allowed a 
reliable counter label to future labelling experiments.  
 
 
5.3.c RNA FISH 
With no antibody labelling and the fact that methionine labelling can be an issue if the bacteria 
are not active, another more reliable label was sought. Following the success of Orientia, the RNA 
fluorescence in-situ hybridisation (RNA FISH) probe was used to label Rickettsiales species.  
RNA FISH targeting 16s was used at 1ng/ul and successfully labelled all species at day 3 of 
infection (Figure 31).  
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5.3.d NOD1 activation 
NOD1 activation occurs when host cells are subjected to the stimulating ligand, mesoDAP from 
peptidoglycan. Cell line Hek-blue hNod1 (Invivogen, USA) can be used to show the activation of 
NOD1 when infected with bacterial species [251]. This cell line is co-transfected with the human 
NOD1 gene and an optimised secreted embryonic alkaline phosphatase (SEAP) reporter gene in 
Hek293 kidney cells. Once NOD1 is stimulated, NF-kB and AP-1 binding sites are activated, 
inducing the production of SEAP which can then be detected in host cell media using 
spectrophotometry in real time. 
Hek-blue hNOD1 cells were infected with heat inactivated Rickettsia, Anaplasma, Wolbachia, 
Erhlichia and Orientia. Bacteria were rendered inactive after being boiled at 95°C for 30 minutes. 
Equivalent numbers of bacteria from each species were added to Hek-blue hNOD1 cells seeded 
in a 96 well plate. After 24hrs of infection, culture media was removed and replaced with SEAP 
detection media. The intensity of SEAP was quantified at 640nm using a spectrophotometer. E. 
coli was used as a positive control as well as γ-D-Glu-mDAP (iE-DAP) dipeptide.  Statistical t-test 
analysis was achieved by comparing all species to E. coli.  
Results presented higher absorbance intensity of SEAP for species with classic or intermediate 
peptidoglycan status compared to species with no peptidoglycan (Figure 32). These results verify 
the peptidoglycan predicted results by bioinformatics.  
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Figure 32. Nod1 activation in HEK293 cells infected with Rickettsiales species 
Graph showing NOD1 activation by secreted embryonic alkaline phosphatase (SEAP) detection using 
spectrophotometry at the optical density of 640nm. Bacteria were added to transfected HEK293 cells and 3 days post 
infection, detection media was added to cells to allow SEAP detection. All detections were carried out in triplicate. A 
T-test was performed to compare conditions to E. coli SEAP detection and P values are illustrated as follows: ns 
(P>0.05); * (P≤0.05); ** (P≤0.01). 
Positive control = γ-D-Glu-mDAP (iE-DAP) dipeptide recoginsed by NOD1. 
Negative control = cell culture media 
C = Classical peptidoglycan, I = Intermediate peptidoglycan, N = No peptidoglycan 
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5.3.e Drug sensitivity  
Drugs targeting the cell wall structure was used to show the effect on bacterial growth and 
structure. Bacteria were grown in various cells lines, seeded on 96 well plates. After one hour of 
infection, drugs were added for the duration of the infection cycle. After 4 days, bacterial 
quantification was carried out by real-time qPCR of 16s (Figure 33) 
Drugs used in this experiment were chosen after the effect shown on Orientia in the previous 
chapter. These drugs were chloramphenicol, d-cycloserine, phosphomycin and penicillin. 
Chloramphenicol was the positive control in this experiment as it is known to be highly effective 
against Rickettsiales, targeting the 50S ribosome. D-cycloserine targets Ddl and Alr, 
phosphomycin targets MurA and penicillin targets DD-transpeptidases. Results for R. canadensis 
show that as expected, bacteria did not grow in the presence of cell-wall targeting drugs.  A. 
marginale was sensitive to penicillin and D-cycloserine, suggesting the presence of a 
peptidoglycan-like structure that is required for viability, but not phosphomycin. The reason for 
this insensitivity is unknown, since A. marginale encodes murA. E. chaffeensis was not affected 
by any of the cell wall targeting drugs as expected since this species has no genes for 
peptidoglycan synthesis. Given the slow growth of Wolbachia and A. phagocytophilum these 
assays could not be performed on those species. 
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Figure 33. The effect of cell wall targeting drugs on the growth of Rickettsiales species 
A-C: Bacterial copy number per well of a 96 well plate, 4 days post infection in the presence of various drugs. Each 
condition was carried out in triplicate. The copy number of 16s was measured by RT-qPCR. 
Pen = Penicillin, targets PBPs 
Pho = Phosphomycin, targets MurA 
Dcs = D-cycloserine, targets Ddl and Alr 
Cam = Chloramphenicol, targets 50s 
C = Classical peptidoglycan, I = Intermediate peptidoglycan, N = No peptidoglycan 
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5.3.f EDA and EDA-DA 
The presence of peptidoglycan can be shown by the incorporation of EDA and EDA-DA probes, 
as shown in the case of Orientia. EDA and EDA-DA were first tested in E. coli and B. subtilis to 
verify labelling protocols (Figure 34). Peptidoglycan labelling was presented at the septum of the 
bacteria but in some cases only in the cell wall. Due to the similarity in labelling, only EDA was 
used for peptidoglycan labelling in Rickettsiales species in this chapter.  
. 
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Figure 34. Fluorescence microscopy of peptidoglycan probes in E. coli and B. subtilus 
A-B: EDA and EDA-DA probes were added to E. coli with HPG for 10 minutes during exponential phase of growth.  
C-D: EDA and EDA-DA probes were added to B. subtilus with HPG for 10 minutes during exponential phase of 
growth. 
Both probes presented septal labelling. 
Click chemistry was carried out for both label 
Scale bar = 5μm 
C = Classical peptidoglycan 
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Phosphomycin inhibits MurA activity in peptidoglycan synthesis. EDA was added to infected cells 
at 1mM for different incubation times for each species without or without phosphomycin in order 
to test the specificity of labelling. After the addition of a methionine probe, which was conjugated 
to an alkyne moiety in order to enable double ckick labelling, cells were fixed, click-labelled and 
imaged. R. canadensis, which encodes all peptidoglycan genes, presented the clearest 
peptidoglycan labelling (Figure 35) which occurred most frequently at the septum of the bacteria. 
With the addition of phosphomycin, bacteria became rounder and many had lysed, indicated by 
the lack of metabolically active methionine-labelled R. canadensis. Most important, EDA was not 
present with the addition of phosphomycin. 
Intermediate status bacteria, A. marginale and Wolbachia presented very similar results to 
Orientia, another intermediate bacterial species. Both bacterial species exhibited uniform 
peptidoglycan labelling of the whole bacteria with no localised cell wall or septum labelling (Figure 
36, Figure 37). The high background of EDA throughout the host cell cytoplasm was again visible, 
as seen after EDA Orientia labelling (Figure 24). It is interesting that only the intermediate bacterial 
species show this high background. This high background was not observed in uninfected cells 
and therefore was not a labelling artefact. As with Orientia the high background may be due to 
peptidoglycan that has been shed into host cells (Figure 40).  With the addition of phosphomycin, 
EDA labelling was still partly visible even though the bacterial structure had clearly become 
affected by the drug. The residual EDA labelling with phosphomycin may be explained by the 
slower turnover of peptidoglycan synthesis so it would take longer for incorporated EDA to be 
replaced. 
In bacterial species with no peptidoglycan, A. phagocytophilum and E. chaffeensis, show no EDA 
label at all and no EDA background labelling in host cells (Figure 38, Figure 39 ). Bacterial cell 
shape was unaffected by the addition of cell wall targeting drugs. This verifies that these species 
do not synthesise peptidoglycan. 
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Figure 35. Peptidoglycan labelling in R. canadensis 
EDA was added to infected vero cells at day 3 with HPG and fixed after 30 minutes of probe incubation. EDA 
labelling presented septum labelling in bacteria.  
Phosphomycin targets MurA.  
Scale bar = 5μm 
C = Classical peptidoglycan 
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Figure 36. Peptidoglycan labelling in A. marginale 
EDA was added to infected vero cells at day 3 with HPG and fixed after 30 minutes of probe incubation. EDA 
labelling presented surface labelling in bacteria.  
Phosphomycin targets MurA.  
Scale bar = 5μm 
I = Intermediate peptidoglycan,  
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Figure 37. Peptidoglycan labelling in Wolbachia 
EDA was added to infected L929 cells at day 3 with HPG and fixed after 4 hours of probe incubation. EDA labelling 
presented surface labelling in bacteria.  
Phosphomycin targets MurA.  
Scale bar = 5μm 
I = Intermediate peptidoglycan 
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Figure 38. Peptidoglycan labelling in E. chaffeensis 
EDA was added to infected DH82 cells at day 3 with HPG and fixed after 30 minutes of probe incubation. EDA 
labelling was absent in bacteria.  
Phosphomycin targets MurA.  
Scale bar = 5μm 
N = No peptidoglycan 
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Figure 39. Peptidoglycan labelling in A. phagocytophilum 
EDA was added to infected HL60 cells at day 3 with HPG and fixed after 30 minutes of probe incubation. EDA 
labelling was absent in bacteria.  
Phosphomycin targets MurA.  
Scale bar = 5μm 
N = No peptidoglycan 
 
 
170 
 
  
F
ig
u
re
 4
0
. 
A
 s
u
m
m
a
ry
 o
f 
E
D
A
 l
a
b
e
ll
in
g
 i
n
 a
ll
 R
ic
k
e
tt
s
ia
le
s
 s
p
e
c
ie
s
 r
e
s
e
a
rc
h
e
d
 i
n
 t
h
is
 t
h
e
s
is
 
R
ic
k
e
tt
s
ia
le
s
 s
p
e
c
ie
s
 c
a
n
 b
e
 i
d
e
n
ti
fi
e
d
 a
s
 o
n
e
 o
f 
3
 g
ro
u
p
s
 b
a
s
e
d
 o
n
 p
e
p
ti
d
o
g
ly
c
a
n
 p
re
s
e
n
t 
in
 t
h
e
 c
e
ll 
w
a
ll.
  
S
c
a
le
 b
a
r 
=
 5
μ
m
 
 
171 
 
5.3.g Cell wall sensitivity to osmotic stress  
Peptidoglycan in the cell wall provides osmotic protection. Without it, bacteria may be vulnerable 
to lysis in environments of low osmolarity. To investigate the structural rigidity of Rickettsiales 
species, bacteria were treated in conditions that would exert different osmotic pressure on cells. 
Isolated R. canadensis, A. marginale and A. phagocytophilum were resuspended in culture 
media, phosphate buffered saline (PBS), water and sucrose phosphate glutamate (SPG) (Figure 
41).  
These buffers for bacterial treatment were chosen according to the osmotic pressure they may 
cause. For instance, SPG and culture media are isotonic so will not disrupt osmotic pressure in 
the bacteria.  On the other hand, water is hypotonic and osmotic flow will cause the pressure 
inside the bacteria to be elevated and cause osmotic lysis. Water can freely move across the cell 
membrane of bacteria so that there is risk of high osmotic pressure. To withstand turgor pressure, 
the plasma membrane is protected by peptidoglycan, so the absence of it can cause lysis of the 
cell. 
 After 10 minutes of exposure to different buffers bacteria were pelleted and then imaged by 
confocal microscopy after methionine labelling. R. canadensis maintained its structure in media 
and SPG as expected but in water bacteria became rounder (Figure 42). Bacteria did not appear 
to lyse completely which indicates a strong cell wall present. A. marginale also maintained 
structural composure in SPG and media and in water became rounder but did not lyse. In contrast, 
A. phagocytophilum appeared to lyse completely in water compared to SPG and media 
conditions. This would be expected as A. phagocytophilum does not consist of any genes for 
peptidoglycan synthesis so its cell wall must be structurally vulnerable compared to the other two 
species. Taken together this indicates that both R. canadensis and A. marginale have a structure 
conferring osmotic protection whilst A. phagocytophilum does not, further supporting the 
hypothesis of the presence of peptidoglycan-like structures in the first two and not the latter. 
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Figure 41 . Fluorescence microscopy sensitivity to osmotic pressure of Rickettsiales species 
Bacteria were treated with SPG, culture media and water for 10 minutes with the addition of a methionine probe. 
Bacteria were then fixed on to glass slides for click chemistry labelling and imaged.  
Scale bar = 5μm 
C = Classical peptidoglycan, I = Intermediate peptidoglycan, N = No peptidoglycan 
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5.3.h. Cell wall sensitivity to lysozyme and mutanolysin  
Intermediate peptidoglycan species do not have class A PBPs, so are predicted to have no 
glycosyltransferase activity. Lysozyme and mutanolysin both target the β1,4 linkage, which is 
catalysed by glycosyltransferase, between lipid II precursors. Orientia presented a damaged cell 
wall structure after being when treated with lysozyme, confirming the presence of the 
polymerisation of β1,4 linkage between glycans despite an absence of class A PBPs.  To 
investigate whether Rickettsiales species have a peptidoglycan structure polymerised by 
glycosyltransferase activity, bacteria were treated with SPG with 5ug/ml lysozyme and 5ug/ml 
mutanolysin for 10 minutes (Figure 42). Following this, bacteria were pelleted and then imaged 
by confocal microscopy after methionine labelling 
After lysozyme and mutanolysin treatment, R. canadensis became damaged and many bacteria 
had lysed as shown by the surrounding remnants. A. marginale, is missing class A PBPs but still 
become lysed by lysozyme treatment. Bacteria also became lysed after treatment with 
mutanolysin and many bacteria increased in size. This suggests that due to the action of the drugs 
on the glycosidic bond between residues, peptidoglycan is degraded and so without a strong cell 
wall, the bacteria becomes more vulnerable to osmotic stress. However, A. phagocytophilum did 
not change morphology in lysozyme or mutanolysin, which is further evidence it does not have a 
peptidoglycan structure.  
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Figure 42. Fluorescence microscopy cell wall sensitivity to lysozyme and mutanolysin in Rickettsiales 
species 
Bacteria were treated with SPG with and without 5ug/ml lysozyme and mutanolysin for 10 minutes with the addition of a 
methionine probe. Bacteria were then fixed on to glass slides for click chemistry labelling and imaged.  
Scale bar = 5μm 
C = Classical peptidoglycan, I = Intermediate peptidoglycan, N = No peptidoglycan 
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5.3.i Heterogeneity in peptidoglycan probe labelling 
 
As all species in this thesis have different life cycles, the rate of peptidoglycan synthesis will also 
occur at various times of each infection cycle. This complicated labelling as the optimal bacterial 
growth state was needed for labelling.  
 
Probes EDA and EDA-DA were used during this research project with Rickettsiales species. The 
mechanism of incorporation of these probes is not fully known so there was discussion of how 
these probes may label bacteria differently. However, with both EDA and EDA-DA labelling, 
differences were noted in localistion of the probe. In some cases, peptidoglycan labelling was 
consistently at the septum of the bacteria but in other cases peptidoglycan was labelled only at 
the cell wall (Figure 43). This variation of labelling of the same species indicates that peptidoglycan 
labelling will vary according to the bacterial state inside host cells. 
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Figure 43. Heterogeneity in EDA/EDA-DA peptidoglycan labelling 
Both rows show infection in vero cells at day 3 infection. The top row presents EDA-DA labelling as only localised to the septum. 
However, the bottom row shows EDA-DA labelling the cell wall of many of the bacteria. 
Scale bar = 5μm 
C = Classical peptidoglycan 
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5.4. Discussion 
Peptidoglycan in Rickettsiales species had not yet been identified and characterised. With the 
advent of new peptidoglycan labelling probes and with the bioinformatics prediction of a new 
peptidoglycan intermediate group, the presence or absence of peptidoglycan was tested for in a 
group of Rickettsiales species. Orientia was thought to not synthesise peptidoglycan but with most 
genes present to do so, which was showed in the last chapter of this thesis that it does have a 
peptidoglycan-like structure in its cell wall.  Bioinformatics predicted that Rickettsiales could be 
classified into three groups, those with classical peptidoglycan (R. canadensis) those with 
intermediate peptidoglycan (Wolbachia, A. marginale, O. tsutsugamushi) and those with no 
peptidoglycan (A. phagocytophilum, E. chaffeensis). In this chapter, I used a combination of 
approaches to test this hypothesis.  
First, protocols were developed for the growth of species in host cell lines as they were not 
previously grown in the lab. Also, without antibodies available, labelling species was critical. All 
Rickettsiales species successfully labelled with clickable methionine probes and RNA FISH for 
16s. This labelling allows a counter-label for peptidoglycan EDA labelling.  
I found that intermediate status species A. marginale and Wolbachia are sensitive to cell wall 
targeting drugs, activate the peptidoglycan binding host cell protein NOD1 and can be labelled 
with the D-alanine probe EDA (and EDA-DA). The levels of NOD1 activation were similar to that 
for R. canadensis, which is expected to have higher levels of peptidoglycan. This might reflect a 
limitation of the dynamic range of this assay.  
Similar to what was found with Orientia in the previous chapter, EDA labelling in the intermediate 
species proved to less efficient compared to R. canadensis and generated high levels of 
fluorescent background in host cells (Figure 40). This suggests that these species have lower 
levels of peptidoglycan. Since it is not known how exactly EDA is integrated, it may also be that 
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the probe can only integrate in specific stages of peptidoglycan synthesis (such as during peptide 
chain formation). If synthesis is slower or paused during the Anaplasmataceae infection cycle 
labelling would therefore be reduced compared to classical status species.  It is known that these 
species exist in two morphologically different states in the host cell and are enclosed in a vacuole 
for much of the infection cycle. The extracellular infectious dense core cells must be structurally 
different in the cell wall compared to the reticulate cells which are enclosed in the vacuole. 
Another explanation for the low levels of labelling and high host cell background for EDA, is that 
the bacteria may be shedding peptidoglycan. At times, it may be more beneficial for these 
intermediate bacteria to have no peptidoglycan in the cell wall. Some bacterial species with 
established peptidoglycan structures are capable of inducing L-form phase, a cell wall-free state 
[252]. In L-form, bacteria become osmotically sensitive but cell wall targeting antibiotic resistant 
[167]. Division can still occur, not by the usual FtsZ machinery, but by unregulated blebbing.  If 
Orientia or A. marginale were able to induce L-form status during their infection cycles, the 
bacteria may remodel their cell wall by down regulating genes required for peptidoglycan 
synthesis. This could cause the breakdown and emission of peptidoglycan fragments into the host 
cell environment which may explain the very high background visualised after EDA peptidoglycan 
labelling in only intermediate peptidoglycan species. However, the peptidoglycan that is shed is 
likely to trigger the innate immune response through activation of NOD1 and other receptors.  
Like Orientia, these intermediate species have a peptidoglycan-like structure present in their cell 
wall but lack Class A PBP genes which are classically known to be responsible for 
glycosyltransferase activity. I found that these organisms are sensitive to lysozyme which cleaves 
glycan chains, indicating the presence of a polymerized peptidoglycan-like structure. This 
suggests that in the absence of Class A PBPs or monofunctional glycosyltransferases these 
species possess alternate pathways for joining the lipid II precursors. This may occur through the 
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coordination of other complexes such as the SEDS glycosyltransferase proteins, FtsW and RodA 
[181].  
Species with almost no genes for peptidoglycan biosynthesis, A. phagocytophilum and Ehrlichia 
chaffeensis did not present any evidence of peptidoglycan synthesis by drug sensitivity, NOD1 
activation or D-alanine labelling.  Without a peptidoglycan cell wall, both proved to be structurally 
vulnerable when lysed from host cells. With reduced or no peptidoglycan in the cell wall, how do 
bacteria protect themselves from osmotic pressure?  Mycoplasma are cell wall deficient and have 
adapted to this state over millions of years of evolution. Instead of peptidoglycan, the cell 
membrane is composed of sterols which are needed for its growth [211] [212] and contribute to 
the durability of the cell membrane against osmotic shock [213]. Instead of a peptidoglycan 
structure, A. phagocytophilum and Ehrlichia may acquire protection by cholesterol integration 
[139]. Without a peptidoglycan-like structure, the dense core and reticulate cells may instead have 
a crosslinked membrane protein structure to prepare to their external environment and host 
interactions, much like Chlamydia [253] and Orientia.  
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Overall Conclusions 
Orientia can be fluorescently labelled for live and fixed imaging 
Orientia tsutsugamushi is a neglected pathogen and its cell biology is poorly understood. In this 
work I have expanded the toolkit available for working with this bacterium in the laboratory. I have 
shown that Orientia can be fluorescently labelled by antibodies against major membrane surface 
proteins, dyes which label amino acids, DNA or membrane structures and chemical probes for 
methionine, RNA and peptidoglycan labelling. This toolkit of chemical probes is likely to be useful 
for working with other genetically intractable obligate intracellular bacteria including other 
Rickettsiales. 
 
Orientia has a peptidoglycan-like structure in its cell wall 
Using mass spectrometry of mesoDAP, gene expression analysis, drug sensitivity assays, 
peptidoglycan probe integration and host cell NOD1 activation, I have shown that Orientia does 
synthesise a peptidoglycan-like structure that is vital for its viability. I found that this structure is 
further supported by a disulphide crosslinked membrane protein network in the bacterial outer 
membrane.  
 
Rickettsiales species can be classified into three groups: classic peptidoglycan, 
intermediate peptidoglycan and peptidoglycan negative 
Bioinformatics analysis led to the prediction that Rickettsiales could be classified into three groups 
based on their peptidoglycan status: classic, intermediate and negative. Here I have used 
peptidoglycan binding host cell protein NOD1 to show which species are able to cause its 
activation. R. canadensis, A. marginale, Orientia and Wolbachia were able to stimulate NOD1 
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whilst A. phagocytophilum and Ehrlichia were not. Furthermore, R. canadensis, A. marginale, 
Orientia and Wolbachia proved to be sensitive to most cell wall targeting drugs. Cell wall targeting 
drugs did not affect the growth of A. phagocytophilum and Ehrlichia. D-alanine peptidoglycan label 
EDA successfully labelled peptidoglycan in R. canadensis. EDA labelling occurred in A. 
marginale, Orientia and Wolbachia but was not consistent and sometimes unspecific, generating 
host labelling. No EDA was visible in A. phagocytophilum or Ehrlichia. Additionally, R. canadensis 
and A. marginale showed sensitivity to glycosyltransferase inhibitors whereas A. 
phagocytophilum did not.  
R. canadensis, A. marginale and A. phagocytophilum maintained structural integrity in media and 
SPG. R. canadensis and A. marginale showed evidence of osmotic pressure in water. On the 
contrary, A. phagocytophilum did not bear well under osmotic pressure in water and lysed.    
Taken together, these results confirm the bioinformatics-based prediction that R. canadensis 
synthesises classic peptidoglycan A. marginale, Orientia and Wolbachia synthesise an 
intermediate peptidoglycan-like structure and A. phagocytophilum and Ehrlichia do not synthesise 
a peptidoglycan cell wall. 
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Future Directions 
This research leads to further questions.  
The development of a toolkit for labelling Orientia and other genetically intractable obligate 
intracellular bacteria opens a number of new research avenues. For example, live imaging of 
Orientia is a key new tool that will allow us to understand its infection cycle in the host cell. 
Specifically, using the new live imaging probes I observed that Orientia forms large aggregates 
that can enter host cells as a collective. Future work will focus on determining the mechanism of 
entry of these aggregates. Also, Orientia is known to colocalise to the microtubules of the host 
cell for transport. By live imaging and using fluorescent dyes, the colocalisation of bacteria and 
dynein proteins may be visualised in real time. One key step in the life cycle of Orientia, is the 
movement from the perinuclear region to the cell periphery for bacterial exit. By using fluorescent 
labelling, the host factors involved in this transit can be identified as well as the key proteins 
Orientia may utilise.  
Using the new antibodies generated here we discovered that not all subpopulations of bacteria 
could be labelled with all antibodies. This led to a new research avenue in which the distinct 
stages of the intracellular infection cycle of Orientia are being defined. This work is using both 
immunofluorescence and RNA FISH labelling to look at heterogeneity in gene expression.  
In this thesis I showed that a group of Rickettsiales bacteria including Orientia tsutsugamushi, 
Anaplasma marginale and Wolbachia synthesise an intermediate peptidoglycan-like structure. 
Further research needs to be completed in order to understand exactly when peptidoglycan is 
synthesised during the infection cycle for Rickettsiales species. As some species exist in dense 
and reticulate cell form, the level of peptidoglycan in these states must be investigated especially 
as the bacteria are changing in size whilst remaining the same shape. There are still new 
techniques to be used which can further validate this work. EDA integration generated high 
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background in host cells. New probes have recently been developed which only become 
fluorescent once incorporated into transpeptidase reactions [254].   
Though this research may help to understand the timing of peptidoglycan synthesis, the question 
remains by what mechanism Rickettsiales species make peptidoglycan. In other organisms the 
peptidoglycan complex is managed by cytoskeletal proteins FtsZ at the septum and MreB at the 
cell wall. FtsZ is vital for cell division. It would be interesting to image the Z-ring during division in 
Rickettsiales species and identify the colocalisation with peptidoglycan. Additionally, investigating 
whether peptidoglycan negative species such as A. phagocytophilum and Ehrlichia exhibit the Z-
ring at the septum would indicate how these cells divide. The existence of FtsZ in bacteria and its 
role in division can be tested by an FtsZ inhibitor. Various mechanisms have been targeted to 
inhibit FtsZ such as a benzofuroquinolinium derivative which targets the GTPase and 
polymerisation activity  [255, 256].   
Could peptidoglycan positive species switch on and off peptidoglycan synthesis similar to L-forms 
described in free-living bacterial species? Anaplasma marginale for instance, exists in two forms 
during its infection cycle. It might be that one state down regulates peptidoglycan synthesis to 
allow prolonged survival inside host cells. L-form bacteria are known to divide without FtsZ [252] 
so this could be further investigated in intermediate peptidoglycan species by analysing the 
division of the bacteria and identifying the presence or absence of the Z-ring. 
MreB and peptidoglycan work together during cell elongation as a unit. The localisation of MreB 
in Rickettsiales and the rate of peptidoglycan may provide insight to how and when the bacteria 
remodels its peptidoglycan. I spent time during my PhD working on MreB in Shigella and actin 
polymerization (not described in this thesis but published recently) [257]. MreB is known to drive 
actin polymerisation in Shigella  [258] [257].  It is known that spotted fever group Rickettsial 
species can polymerise actin inside host cells [154]. The colocalisation of actin polymerisation 
and nascent peptidoglycan synthesis may indicate any relationships between the two.  
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Another key question is how the structure of peptidoglycan in intermediate peptidoglycan species 
is composed. Results from this thesis show that the linkage between the glycan residues is 
sensitive to lysozyme and mutanolysin, which both to hydrolyse β-1,4 linkages between MurNac 
and GlcNac residues. The absence of class A PBPs indicate that the glycosyltransferase activity 
must be performed by an alternate mechanism.  
In summary, the research presented in my thesis opens several exiting new areas of research 
into the host pathogen cell biology and bacteriology of a medically important and understudied 
group of obligate intracellular bacteria.  
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Appendix 1 
Abbreviations 
 
CFSE = Carboxyfluorescein succinimidyl ester 
CFDA-SE = carboxyfluorescein diacetate succinimidyl ester 
HADA = HCC amino D-alanine 
HALA = HCC amino L-alanine 
EDA = Ethynyl-D-alanine 
EDA-DA = Ethynyl-D-alanyl-D-alanine 
GlcNac = N-acetyl glucosamine acid  
MurNac = N-acetyl muramic acid 
PBS = phosphate buffered saline 
SPG = sucrose phosphate glutamate  
DTT = Dithiothreitol 
NOD = Nucleotide-binding oligomerization domain (NOD) proteins 
SEDS = shape, elongation, division and sporulation proteins  
PFA = Paraformaldehyde  
DMSO = Dimethyl sulfoxide  
RNA FISH = Fluorescent in situ hybridization targeting ribonucleic acid molecules  
mesoDAP = Meso-Diaminopimelic acid  
qRT-PCR = quantitative reverse transcriptase polymerase chain reaction 
Alr = alanine racemase 
Ddl = D-alanine—D-alanine ligase  
BME = ꞵ-mercaptoethanol  
PBPs = Penicllin binding proteins 
E. coli = Escherichia coli 
B. subtilus = Bacillus subtilus  
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Appendix 4 
 
Activity and contributions 2015-2019 
 
Year Activity Location 
   
2015 Oxford Tropical 
Network conference  
Phnom Penh, 
Cambodia 
2015 Croucher’s advanced 
microscopy course 
Hong Kong 
   
2016 Super resolution 
microscopy 
advanced training 
with Dr Graham Clark 
A*Star, Singapore 
2016 Microscopy course Siriraj University, 
Bangkok, Thailand  
2016 Rickettsia meeting, 
Mahidol Oxford 
Tropical Research 
Unit, presentation 
Vientiane, Laos  
2016 ‘The New 
Microbiology’ EMBO 
course, poster 
presentation 
Spetses, Greece 
2016 Lab visit: Dr Michael 
Way (septins and 
microscopy) 
Francis-Crick 
Institute, London, UK  
2016 Lab visit: Dr Jost 
Enninga (live 
micrscopy of the 
cytoskeleton) 
Pasteur Institute, 
Paris, France 
2016 Mahidol Oxford 
Tropical Research 
Unit student poster 
competition (winner)  
Bangkok, Thailand  
   
2017 Rickettsia meeting, 
Mahidol Oxford 
Tropical Research 
Unit 
Bangkok, Thailand  
2017 Lab visit: Dr Serge 
Mostowy (9 month 
project on the 
cytoskeleton of 
Shigella flexneri) 
Imperial College, 
London, UK 
   
202 
 
2018 BSL2/BSL3 set up Public Health 
Research Institute, 
Rutgers University 
New Jersey, USA 
2018 American society of 
Rickettsiology 
conference, poster 
presentation  
Wisconsin, USA 
   
2019 American society of 
Rickettsiology 
conference, poster 
presentation 
New Mexico, USA 
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Improved Quantification, Propagation, Purification and Storage of the Obligate Intracellular 
Human Pathogen Orientia tsutsugamushi, Giengkam S, Blakes A, Utsahajit P, Chaemchuen S, 
Atwal S, Blacksell SD, Paris DH, Day NP, Salje J. 2015. PLoS Negl Trop Dis 
 
Live imaging of the genetically intractable obligate intracellular bacteria Orientia tsutsugamushi 
using a panel of fluorescent dyes, Atwal S, Giengkam S, VanNieuwenhze M, Salje J. 2016. J 
Microbiol Methods 
 
Evidence for a peptidoglycan-like structure in Orientia tsutsugamushi, Atwal S, Giengkam S, 
Chaemchuen S, Dorling J, Kosaisawe N, VanNieuwenhze M, Sampattavanich S, Schumann P, 
Salje J. 2017. Mol. Microbiol 
 
Shigella MreB promotes polar IcsA positioning for actin tail formation, Krokowski, S, Atwal S, 
Lobato-Marquez, D, Chastanet, A, Carballido-Lopez, R, Salje, J, Mostowy, S. 2018. J Cell Sci 
 
